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1.1. Summary (English version) 
 
 HIV is a major public health problem in the European Union (EU) and the 
European Economic Area (EEA). The HIV epidemic in the EU/EEA is predominantly 
masculine and its epidemiological characteristics vary within the different regions that 
conform the EU/EEA. While in Central and Western Europe the transmission among 
men who have sex with men (MSM) and heterosexuals is the most prevalent route of 
infection, in the Eastern European countries heterosexuals and intravenous drug users 
(IDU) are the most affected groups. 
 Migrant populations are exposed to experiences that could potentially affect 
their health in a negative way; they face greater vulnerability to HIV infections and its 
consequences and face specific barriers to access health care. The objective of this 
Doctoral Thesis is to analyse the HIV epidemic in migrant populations in the EU/EEA, as 
well as the strategies developed by the countries to increase HIV testing uptake. 
Finally, our position regarding the importance of real access to antiretroviral therapy 
(ART) by this population is stated. 
 A search of national policy documents and a survey to EU countries 
representatives was conducted to analyse national policies on HIV testing in migrant 
population. The documents published by different international organizations (IOs) on 
HIV testing were reviewed to assess specific recommendations for migrants and ethnic 
minorities. Furthermore, a systematic review of the available scientific literature was 
developed to analyse the barriers to HIV testing and access to health care and 
prevalence of HIV testing in migrants. In addition, a qualitative study was conducted 
with key informants to identify challenges in the implementation of these policies and 
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propose innovative interventions to promote HIV testing. European Surveillance data 
on new HIV diagnosis in the EU/EEA were analysed according to geographical origin 
and sex to determine the relative importance of this group in the epidemic. Finally, the 
available information on magnitudes and trends of migrant population recorded in 
European data sources such as Eurostat were analysed. 
 The availability of ART since 1996 has been a turning point in the HIV epidemic 
in Europe. Many countries acknowledge the benefits of early diagnosis in their policy 
documents, both at individual and at community level and most of them identify 
migrants as vulnerable populations to HIV infection and its consequences. This 
vulnerability is related to social, economic and legal issues, as well as cultural 
differences and gender imbalances. However, not all countries specifically recommend 
HIV testing in migrants. 
 International Organizations such as UNAIDS, recognize the importance of HIV 
testing in migrant population and emphasize the need to link HIV testing with universal 
access to ART. In addition, IOs unequivocally indicate the test must always be 
voluntary and with informed consent, and call against mandatory testing practices at 
the country entry done in some places. 
 The main barriers to access health care and HIV testing are related to poverty, 
low social status and inequality, and to the fear that the test results may negatively 
affect their visa application. HIV testing rates varies greatly in the different studies 
analysed. Specific initiatives aimed at increasing HIV testing in this population, 
especially those that take place in community settings, are proposed. 
 HIV testing strategies targeting specific groups are able to reach individuals at 
high risk, but are perceived as discriminatory. While general population HIV testing 
HIV/AIDS in migrant populations in Europe: epidemiology, testing strategies and access to antiretroviral 
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strategies are more likely to prevent discrimination, they may not reach some groups 
of migrants. In general, the importance of developing innovative strategies and using 
community settings to increase the number of HIV tests conducted in migrants are 
stressed. 
 Migrants account for two-fifths of new HIV diagnoses in the EU/EEA. The 
relative and absolute numbers show a decline in new HIV reports between 2007 and 
2012 which may be reflecting a true decline in the number of infections or a decrease 
in the number of the HIV tests performed or a decrease in the number of migrants. In 
Western Europe, migrants from Sub-Saharan Africa, Latin America and other Western 
European countries are the most common among new HIV infections, while migrants 
from Eastern Europe are the most common in Central Europe. 
 Regarding population registries, available data on cumulative numbers of 
migrants are heterogeneous and incomplete and do not allow to confirm what has 
happened with migrant flows in the current scenario of financial constraints. However, 
migrant flows show a deceleration and this could be one of the explanations for the 
decrease in the number of new HIV diagnoses in migrant populations. 
 These results are key to understand the specific vulnerability to HIV of migrants 
in order to develop policies aimed at promoting HIV testing and to ensure access to 
ART in these populations. 
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1.2. Resumen 
 
 El VIH es un problema de Salud Pública clave de en la Unión Europea (UE) y el 
Espacio Económico Europeo (EEE). La epidemia de VIH en la UE/EEE es 
fundamentalmente masculina y sus características epidemiológicas varían en las 
distintas regiones que conforman la UE/EEE. Mientras que Europa Central y Occidental 
la transmisión entre hombres que tienen sexo con hombres (HSH) y personas 
heterosexuales son las vías de transmisión predominantes, en los países de Europa del 
Este las infecciones adquiridas por vía heterosexual y entre usuarios de drogas 
interparenterales (IDU) son las que, en mayor medida, caracterizan la epidemia.  
 La población inmigrante, expuesta a experiencias que potencialmente pueden 
afectar de forma negativa a su salud, sufre una mayor vulnerabilidad a la infección por 
VIH y sus consecuencias y presenta barreras específicas de acceso al sistema sanitario. 
El objetivo de esta Tesis Doctoral es analizar la epidemia del VIH en población 
inmigrante en la UE/EEE, así como las estrategias desarrolladas por los países para 
incrementar el acceso a la prueba de VIH. En último término, se realiza una reflexión 
acerca de la importancia del acceso real al tratamiento antirretroviral (TAR) de dicha 
población.   
 Se realizó una búsqueda de documentos de políticas nacionales y un sondeo 
con cuestionario a los representantes de los distintos países de la UE/EEE para analizar 
las políticas nacionales sobre la prueba de VIH en población inmigrante. Se revisaron 
los documentos sobre prueba de VIH publicados por distintas Organizaciones 
Internacionales (OI) para evaluar las recomendaciones específicas para inmigrantes y 
minorías étnicas. Por otro lado, se desarrolló una revisión sistemática de la literatura 
HIV/AIDS in migrant populations in Europe: epidemiology, testing strategies and access to antiretroviral 
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científica disponible para analizar las barreras de acceso y la prevalencia de la prueba 
de VIH en inmigrantes. Además, se realizó una investigación cualitativa con 
informantes clave para identificar los retos en la implementación de este tipo de 
políticas y para definir propuestas innovadoras para promover la prueba de VIH. Se 
analizaron los datos de vigilancia europea del VIH en la UE/EEA para conocer en 
función del origen geográfico y el sexo la importancia relativa de este grupo en la 
epidemia. Finalmente, se analizó la información disponible sobre población inmigrante 
registrada en Europa, de fuentes de datos secundarios como Eurostat. 
 La disponibilidad de TAR desde 1996 ha supuesto un punto de inflexión en la 
epidemia de VIH en Europa. Varios países reconocen en los documentos de políticas 
sanitarias revisados en este trabajo los beneficios del diagnóstico temprano de la 
infección por VIH, tanto a nivel individual, como a nivel comunitario y la mayoría 
identifican a los inmigrantes como población vulnerable a la infección por VIH y sus 
consecuencias. Dicha vulnerabilidad se relaciona con los problemas sociales, 
económicos y legales y, también, con las diferencias culturales y las desigualdades de 
género. Sin embargo, no todos los países recomiendan específicamente la prueba del 
VIH en inmigrantes.  
 Las Organizaciones Internacionales, como UNAIDS, reconocen la importancia de 
realizar la prueba a la población inmigrante, insistiendo en la necesidad de vincular la 
prueba con el acceso universal al TAR. Además, estas organizaciones señalan que la 
prueba siempre ha de ser voluntaria y con consentimiento informado, por lo que se 
muestran en contra de la obligatoriedad de la realización de pruebas de VIH a la 
entrada del país que se practica en algunos lugares. 
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 Las principales barreras de acceso al sistema sanitario y a la prueba están 
relacionadas con la pobreza, el bajo estatus social y la desigualdad, además del miedo 
a que el test afecte de forma negativa a una solicitud de visado. La prevalencia del test 
es muy distinta en los diferentes estudios analizados y se proponen iniciativas 
específicas para incrementar el test en esta población, especialmente aquéllas que se 
efectúan en entornos comunitarios. 
 Las estrategias de la oferta de la prueba de VIH dirigidas a grupos específicos 
son capaces de alcanzar a individuos a riesgo, pero son percibidas como 
discriminatorias, mientras que las estrategias de oferta a la población general 
minimizan la discriminación, pero no alcanzan a algunos grupos de inmigrantes. De 
forma general, se subraya la importancia de desarrollar estrategias innovadoras y en 
entornos comunitarios para incrementar el número de pruebas de VIH realizadas a 
inmigrantes. 
 Los inmigrantes representan dos quintas partes de los nuevos diagnósticos de 
VIH en la UE/EEE. Las cifras relativas y absolutas muestran un descenso de nuevos 
diagnósticos de VIH entre 2007 y 2012, pudiendo estar reflejando un descenso 
verdadero del número de infecciones, un descenso en el número de pruebas de VIH 
realizadas o un descenso del número de inmigrantes. En Europa occidental, los 
inmigrantes provenientes de África Subsahariana, América Latina y Europa Occidental 
son los más comunes entre las nuevas infecciones de VIH, mientras que los 
inmigrantes de Europa del este son los más comunes en Europa central. 
 Con respecto a los registros de población, cabe señalar que la información 
disponible sobre el número acumulado de inmigrantes es heterogénea y está 
incompleta, por lo que no es posible saber qué está pasando con los flujos migratorios 
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en el escenario actual de crisis económica. Sin embargo, los flujos migratorios 
muestran una ralentización que podría explicar el descenso del número de nuevos 
diagnósticos de VIH en la población inmigrante. 
 Estos resultados son importantes para conocer la vulnerabilidad específica de 
los inmigrantes con respecto al VIH, y respaldan la necesidad de desarrollar políticas 
orientadas a promover la prueba del VIH y a garantizar el acceso al TAR en estos 
grupos poblacionales. 
 11 
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2.1. Epidemiology of HIV and AIDS in migrants in the HAART 
era in Europe (1996-2010) 
2.1.1. Epidemiology of HIV/AIDS in Europe 
The HIV epidemic is a key public health issue in the European Union (EU) and 
the European Economic Area (EEA). The number of HIV infections has grown steadily 
since the HIV reporting mechanisms were put in place in Europe in 1999. 
 In 2010a, the incidence of HIV in the EU/EEA countries was 5.7 per 100,000 
population, corresponding to a total of 27,116 new HIV diagnosesb.  In that same year, 
4,666 cases of AIDS were reportedc, leading to an incidence rate of 0.9 cases per 
100,000 population. From the beginning of the epidemic up to 2010, 319,913 
individuals were diagnosed with AIDS in the EU/EEA 1. 
The trend of HIV diagnoses rates reported by the EU/EEA countries in the 
period between 2004 and 2010 was moderately stable. In fact, the rate of HIV 
diagnoses per 100,000 population slightly decreased from 6.5 per 100,000 in 2004 
(27,996 cases) to 6.2 per 100,000 in 2010 (29,556 cases, estimated rate adjusted by 
reporting delay). 
In 2010, 11% of new HIV diagnoses were reported among young people (15-24 
years) and the male-to-female ratio was 2.81. The main transmission mode was MSM 
(38%, 10,251 diagnoses) followed by heterosexual contact (10,328 diagnoses). A very 
                                                     
a
 This section describes the Epidemiology of HIV/AIDS in Europe since 2010, the year in which this 
Doctoral Thesis has been started. 
b
No data from Monaco, Liechtenstein, Russia, Uzbekistan; countries with no data on age and 
transmission mode are excluded 
c
No data from Sweden and Liechtenstein 
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significant part of the heterosexually acquired cases were people originating from sub-
Saharan African countries with a generalised HIV epidemic (17%, 4,116 cases).   
Before 2004, between 1999 and 2004, the trend of the total number of new 
HIV diagnoses reported in the 20 EU countries with surveillance data increased 
steadilyd. HIV diagnosed rates were not reported by the EU, but the total numbers 
shown how HIV new infections increased from 11,918 new cases in 1999e, to 21,164 
cases in 2004f. In this period, AIDS incidence decreased slowly, by an average of 
around 7% per year (2000-2004) from 10,635 cases in 1999 to 7,236 AIDS new cases in 
20042. 
HIV and AIDS in the WHO European regions 
 The WHO organizes the HIV Epidemiological data within Europe classifying 
countries in three different areas: East, Centre and West. The following map shows the 
areas classification: 
                                                     
d
 “Consistent HIV reporting system for the last 4 years”, ie. all EU countries in 2004 excluding France, 
Italy, Malta, Netherlands and Spain. 
e
 In 1999 data not available for France, Malta, Portugal, Spain. 
f
 In 2004, data not available for Spain and Italy. 
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Figure 1. Geographical representation of countries: WHO European Region, West, Centre and East
g
. 
Extracted from “HIV/AIDS surveillance in Europe 2010”
1
 
 
 Table 1 summarises HIV and AIDS cases diagnosed in the WHO European region 
by areas and mode of transmission in 20101. This table shows different patterns 
depending on the European region of HIV reporting country.  
  
                                                     
g
West (23 countries): Andorra, Austria, Belgium, Denmark, Finland, France, Germany, Greece, Iceland, 
Ireland, Israel, Italy, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, 
Sweden, Switzerland, United Kingdom. 
Centre (15 countries): Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, 
Hungary, the former Yugoslav Republic of Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, 
Slovenia, Turkey. 
East (15 countries): Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, 
Lithuania, Moldova, Russia, Tajikistan, Turkmenistan, Ukraine, Uzbekistan 
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Area HIV cases 
Rate 
Heterosex. 
transmission 
IDU MSM MTCT 
Other/ 
Unknown (per 100 
000) 
Eastern Europe             
HIV 90 198* 31.7 48% 43% 0,7% 1,4% 7,3% 
AIDS 2881 2.0 38% 52% 1,1% 1,6% 7,1% 
                
Central Europe             
HIV 2478 1.3 24% 4,3% 29% 0,6% 42% 
AIDS 584 0.3 36% 16% 23% 1,9% 23% 
                
Western Europe             
HIV 25659 6.6 40% 3,6% 39% 0,9% 16% 
AIDS 4249 1.0 46% 14% 29% 0,4% 11% 
 
Table 1. HIV and AIDS cases diagnosed in the WHO European region by areas and mode of transmission 
in 2010 (table based on “HIV/AIDS surveillance in Europe 2010”
1
. (*)Transmission mode only reported 
for 27617 cases, Russia has been excluded. 
  
 In Eastern Europe, heterosexual transmission of HIV was the principal mode of 
HIV transmission (48% HIV cases) in 2010, followed by the IDU category (43%). In this 
region, historically, the predominant category of HIV transmission was IDU which 
increased by 42%: from 8,256 reported cases in 2004 to 11,690 reported cases in 2010. 
This trend appears to have changed in 2010 as in that same period, the number of HIV 
cases acquired through heterosexual contact grew by 151%: from 5,252 HIV reported 
cases in 2004 to 13,192 HIV cases in 2010, thus explaining the higher number of 
heterosexual transmission in 2010.  Among AIDS cases, IDU category remains the 
principal mode of transmission in the Eastern European WHO Region (52%).  
 The Central and the Western countries of the European Region show similar 
patterns although different rates. In Central Europe we observe a very high proportion 
of cases with unknown mode of transmission (42% among HIV and 23% among AIDS 
new diagnosed). In Central Europe, while the main HIV transmission category is MSM 
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(29%) followed by heterosexuals (24%), AIDS was mostly diagnosed among 
heterosexuals (36%) than MSM (23%) or other groups of importance. In Western 
European countries on the other hand, HIV heterosexual transmission and MSM 
transmission had the same importance (40%), while AIDS cases were more frequent 
among heterosexuals (46%) than among MSM (29%) or other groups. In both areas, 
Central and the Western Europe, IDU had a limited importance in 2010 comparing with 
the observed in the Eastern countries.  
 Regarding changes in the epidemiological trends, HIV cases among MSM in 
Central Europe had more than tripled in the period between 2004 and 2010 (170 cases 
in 2004 to 720 cases in 2010). The report in which this section is based also highlights 
that in Western countries “Forty percent of the HIV cases were acquired through 
heterosexual contact (10,214 cases). However, when cases (4,105) originating from 
countries with generalised epidemics were excluded, the percentage decreased to 
24%”1. 
2.1.2. Migrants’ vulnerabilities to HIV/AIDS 
 The migration experience can potentially have a negative impact on migrants’ 
health.  Previous studies have shown that economic migrants are a selected population 
of healthy and young people3. However, available evidence suggest that migrant are 
more vulnerable to certain communicable and non-communicable diseases4:  migrants' 
health depends on different factors such as the migratory process itself, individual 
characteristics (such as sex, age or country of origin), socioeconomic circumstances in 
the host country, migration status and access to health services5.  This means that 
migrants' physical and mental health is affected from the moment they leave the 
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country of origin. Health outcomes depend on migrants’ experiences of social 
exclusion and vulnerability, and other factors related to their migration itinerary and to 
their integration process after arrival to the new country6;7. 
The negative consequences are different depending on migrants’ gender. 
Migrant women may face specific gender stressors that may increase their 
vulnerability. Llácer et al.8 addressed in their 2006 paper how migrant women are 
more exposed to violence and also to differential health effects of the migrant specific 
stressors. The sexual division of the labor market derives in a differential value of 
women’s productive work. Additionally, women should exclusively take charge of the 
unpaid reproductive work (i.e. domestic work), increasing their vulnerability associated 
with their living and working conditions. 
All these factors support the importance of studying migrants' health from the 
perspective of social inequality, focusing on the consequences of social exclusion and 
vulnerability on their physical and psychological wellbeing9;10. 
 Regarding HIV and AIDS, the United Nations considers migrants as vulnerable 
populations for HIV and addresses the need of ensuring their access to HIV prevention, 
treatment and care11. Migrant populations suffer an increased risk or HIV related to 
economic deprivation, social inequality as well as human rights abuses, more frequent 
in women, who become even more vulnerable to HIV12.  
UNAIDS 2013 Global Report acknowledged how migrant women are more 
vulnerable to sexual abuse and how their fear of social stigmatization impedes them 
from reporting these incidents. These women have to face the psychological and 
physical consequences of the abuse and the anxiety derived from HIV exposure13.  
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Migrant populations living with HIV/AIDS also show higher rates of late 
diagnosis, barriers to health care and antiretroviral treatment access, lower treatment 
adherence and higher comorbidity14-16.  
2.1.3. Epidemiology and trends of HIV/AIDS in migrants in the HAART 
era in Europe 
HIV trends 
 The report “Epidemiology of HIV and AIDS in migrant communities and ethnic 
minorities” led by Del Amo et al.17 had the objective of determining the burden of HIV 
infection in migrant populations and ethnic minorities and its contribution to the 
epidemiology of HIV in Europe in the period 1999 to 2006.  First of all, it is necessary to 
acknowledge that surveillance data are limited in its generalizability by the large 
number of missing data on two important variables; transmission category and 
geographical origin. 
 The Figure 2 shows the geographical origin of the HIV cases reported in EU-27 
plus Norway and Iceland during the period between 1999 and 2006. 
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Figure 2. Absolute number of HIV cases in males and females reported in EU27 plus Norway and Iceland 
according to geographical origin, 1999–2006. Extracted from: “Migrant health: Epidemiology of HIV 
infection and AIDS”
17
 
 
This figure shows a differential pattern among males and females. Among men, 
the native group –people originating from the same country of report- is the most 
important, followed by the group from SSA. Nevertheless, among women, those from 
SSA account for the largest group, surpassing native women. 
In 2006, 26,712 cases of HIV infection were reported by 23 EU countries plus 
Norway and Iceland (except Bulgaria, Italy, Malta and Romania): 17,646 in males (66%) 
and 9,066 in women (34%). Regarding the country of birth of these new diagnoses, 
29% were missing values17.  
In 2006, SSA were the second largest group of new HIV infections (5,046 cases), 
just after the cases in people originating from the same country of report (11,195). 
Women among SSA were disproportionally affected by HIV (3,145 cases, 62%). The HIV 
epidemic feminisation among SSA could be related with biases derived from the high 
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rate of cases with unknown “country of origin” and selective HIV testing of women 
during pregnancy may be taking place, but unlikely to explain all the observed 
differences compared with men. People originating from Western Europe (539 cases) 
represented the third major group, followed by Latin American (456 cases) and 
Caribbean migrants (329 cases). Figure 3 shows the relative distribution of the 
geographical origin of HIV cases reported in 27 EU countries plus Norway and Iceland 
in each transmission category in 200617. 
 
Figure 3. Relative distribution of the geographical origin of HIV cases reported in 27 EU countries plus 
Norway and Iceland in each transmission category in 2006. Extracted from: “Migrant health: 
Epidemiology of HIV infection and AIDS
17
” 
  
 The 2010 surveillance report at European level, “HIV/AIDS surveillance in 
Europe 2010”1 showed that among the 27,116 HIV diagnoses reported in the EU/EEA, 
half of the cases were among people from the country of report (13,724, 51%) and 
17% (4,520 cases) in people from countries from Sub-Saharan Africa. In all, 993 cases 
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were reported in people from Central & Eastern Europe (4%) and 797 cases in people 
from Western Europe (3%).  
 Regarding HIV trends, this report also shows that the number of infections 
clearly increased between 1999 and 2004. Unfortunately, the issues related with 
changes in the European HIV Reporting System and the large number of HIV cases 
without geographical origin information (47% of all new reports in 1999 and 32% of 
these in 2006) complicates establishing an accurate picture of HIV trends in Europe in 
both, people from the country of report and people born overseas1. 
 The 2010 ECDC and WHO surveillance report1, shows how the majority of the 
HIV cases in people originating from SSA countries (4,431 cases) was acquired through 
heterosexually contacts (3,905 cases, 88%). SSA represented a disproportionally large 
group in both heterosexually acquired HIV infections (38% of the total infections in 
EU/EFTAS countries) and MTCT (49% of the total MTCT) in 2010. 
 In migrants from Central & Eastern Europe, the proportion of new HIV 
diagnoses acquired through injecting drug use was comparatively high (150 cases, 12% 
of all HIV diagnosis in people originating from this area), compared with the 881 cases 
due to injection drug use (6% of the total of diagnoses performed) in people whose 
geographical origin was the country of report1. 
AIDS trends 
 Regarding AIDS, the countries of origin of reported cases in men and women 
between 1999 and 2006 are displayed in the Figure 4. 
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Figure 4. Absolute number of AIDS cases reported in EU27 plus Norway and Iceland according to 
geographical origin, 1999–2006. Extracted from: “Migrant health: Epidemiology of HIV infection and 
AIDS” 
  
 In this period, a total of 75,021 AIDS cases were reported in the area, 27% of 
them in women; 26,098 cases were in migrants (34% of them were females). After 
native populations, the largest group among AIDS cases were SSA migrants, which 
increased by 89% from 1996 to 2006. Reported AIDS cases among women SSA 
increased by 123% between 1999 and 2006.  
 The 2010 European Surveillance report1 shows how AIDS cases in people 
originating from the same country of report and in migrants from other Western 
European countries decreased from 1999 to 2006. The decline ranges between 42% in 
the former and 40% in the latter. This reduction is related, in this report, with the 
effectiveness of antiretroviral treatment in the population. An important increase in 
the period between 1999 and 2006 was observed in AIDS reported cases in people 
whose geographical origin was Eastern Europe (by 200%), SSA (by 89%) or Latin 
America (by 50%).  
Men Women
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 In total, 6,746 AIDS cases were reported in the EU plus Norway and Iceland in 
200617; 4,885 (72%) in men and 1,861 (28%) in women. The reported AIDS infections in 
people from SSA (1,225 cases) represented the second largest group, after native 
population. Among SSA, the burden of AIDS infection disproportionally affected 
women: 623 cases were reported in women versus 602 cases reported in men.  The 
third largest group, with 209 AIDS cases, were people originating from Latin America.  
Figure 5 shows the distribution of the geographical origin of AIDS cases 
reported in 27 EU countries plus Norway and Iceland in each transmission category in 
2006. 
 
Figure 5. Relative distribution of the geographical origin of AIDS cases reported in 27 EU countries plus 
Norway and Iceland in each transmission category in 2006. Extracted from: “Migrant health: 
Epidemiology of HIV infection and AIDS
17
” 
 
  Transmission categories vary substantially depending on migrants’ country of 
origin. The ECDC report “Epidemiology of HIV and AIDS in migrant communities and 
ethnic minorities”17 showed that in 2006 the largest number of migrants was found 
among heterosexually transmitted cases. Half of the AIDS cases within the 
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heterosexual contacts and with known geographical origin (2,988 cases), were from a 
country different to that reporting the case (1,373 cases, 50%), and the majority of 
these cases (1,050 cases) were from Sub-Saharan Africa (38% of total cases).  
 The AIDS cases due to MTCT in SSA migrants were also very high: of the 60 
cases of AIDS with known geographical origin, 13 cases (23%) were in children with 
mothers from SSA. 1,404 AIDS cases were diagnosed in MSM in 2006. Close to 20% of 
the total MSM cases (244 cases) were migrants, largely from Latin America (106 cases, 
8% of the total) and from Western Europe (52 cases, 4% of the total). Finally, among 
the 1,545 IDU cases, 7% (100 cases) were observed in foreign people, and the most 
common regions of origin were other Western European countries and North Africa & 
Middle East.    
Probable country of HIV acquisition 
Different studies support the thesis that people from foreign origin are 
increasingly becoming infected with HIV in EU countries. Burns et al. reported that as 
many as a quarter of HIV infections diagnosed among heterosexuals and half among 
MSM from Africa may have been acquired in the UK18. Fenton et al documented the 
high proportion of people engaging in unprotected sex when travelling to home 
countries19. There is evidence from seroconversion studies that a large proportion of 
HIV-positive MSM from Latin America have been infected in Spain5. 
However, the majority of HIV infections in people from SSA are thought to have 
occurred in the countries of origin, when comparing the average duration of stay in 
Europe with the value of the CD4 cell count at HIV diagnosis20. 
Country of HIV acquisition has important implications for Public Health, 
especially for prevention programs. The variable “Probable country of infection” has 
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been collected since 2008 for the European Surveillance reports issued by WHO and 
ECDC, but it is a subjective variable and the level of completion is below 25%1. 
2.1.4. Migration and HIV in the European Agenda 
In 2004, representatives of States and Governments from Europe and Central 
Asia signed the “Dublin Declaration on partnership to fight HIV/AIDS in Europe and 
Central Asia”21 that underlines that poverty, underdevelopment and illiteracy are 
among the principal contributing factors to the spread of HIV/AIDS. In this document, 
migrants “which have close links to high prevalence countries” were identified as 
vulnerable for HIV. The signatory countries, among other requests, asked the Global 
Commission on International Migration to take into account in its work the threat of 
exposure to HIV/AIDS particularly to migrant women and unaccompanied and 
orphaned children. 
As a further step, in 2007 the Portuguese Presidency of the EU chose as their 
main theme “migration and health”. In response to this arising priority, the European 
Centre for Diseases Prevention and Control (ECDC) commissioned a series of 
reports17;21-24 on migration and HIV: HIV/AIDS Epidemiology, Testing and early 
diagnosis or barriers to access health services, among others. Table 2 summarises 
these reports and the main findings of each one:  
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Title Year Authors Type Main findings 
Barriers to HIV testing 
in Europe: a systematic 
review 
2008 
Deblonde 
J. et al 
Article 
Some barriers to HIV testing and counselling 
have been identified. There is no structured 
information considering: 
- Legal, administrative and financial factors 
- Attitudes and practices of health care 
providers 
- Perception of patients 
Migrant health: Access 
to HIV prevention, 
treatment and care for 
migrant populations in 
EU/EEA countries. 
2009 
Bröring G 
et al.  
Technical 
report 
-The most relevant migrants in terms of HIV 
are from SSA, Eastern Europe, Asia, Latin 
America and the Caribbean 
- HIV migrant vulnerability is due to 
language barriers, marginalisation and 
social exclusion, legal obstacles, cultural 
attitudes, religion, fear of discrimination 
and low HIV knowledge in migrant 
communities 
- Barriers to health services access are 
related to policies and laws, service 
delivery, migrant communities themselves 
and wider society 
Epidemiology of HIV 
and AIDS in migrant 
communities and 
ethnic minorities in 
EU/EEA countries 
2009 
Del Amo J 
et al. 
Technical 
report 
-Migrant populations, largely people from 
SSA, represent a considerable fraction of 
AIDS/HIV cases in the EU/EFTA countries 
(1999–2006) 
-The feminisation of the HIV/AIDS migrant 
epidemic in the EU is taking place. 
-It is necessary to acknowledge the sexual 
diversity of migrants living with HIV/AIDS; 
increasing number of MSM among migrant 
HIV/AIDS reports 
-Late HIV diagnosis is an important issue 
even greater for the HIV-positive migrant 
population of non-Western origin 
- Data have limitations given the 
heterogeneity in the implementation of the 
HIV reporting systems and the poor 
completion of the variable ‘geographical 
origin’ in EU Member States 
Testing in Europe: from 
policy to effectiveness 
2010 
Kall M et 
al. 
Technical 
report 
-HIV testing strategies are failing (a high 
proportions of undiagnosed and late 
diagnosed infections remain) 
- HIV testing barriers are mainly related to 
low risk perception, fear and stigma around 
HIV, and lack of knowledge about HIV 
testing policies and information around the 
test itself 
- Normalisation of HIV testing may help to 
reduce stigma around the test 
-Verbal informed consent can replace 
written informed consents 
Table 2. Reports issued by ECDC and main findings. 
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 Finally, the report “Implementing the Dublin Declaration on Partnership to 
Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report”25 revealed how near 
to two thirds of the EU/EFTA countries considered migrants as a key sub-population in 
their response to HIV, showing the importance of migration and HIV in the EU/EFTA 
member countries’ agenda (29 countries, 59%). Figure 6 shows the extent to which 
countries identify migrants as an important subpopulation in the national response to 
HIV and AIDS. 
 
Figure 6. Map showing the extent to which countries identify migrants as an important subpopulation in 
the national response to HIV and AIDS. Extracted from “Implementing the Dublin Declaration: 2010 
progress report”
25
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2.2. Migration in Europe. 
2.2.1. Looking for a definition for “migrants” 
Various international documents acknowledge the difficulties of defining 
migrants and ethnic minorities and state the operative definitions to be used according 
to the available sources of information17;23;24. The definition of “migrant” used by 
EuroHIV surveillance was based on nationality and country of birth but did not make 
any reference to ethnic minorities26. Ethnic minorities include established minorities as 
well as those resulting from recent migratory waves.  
Migrants and their descendants, sometimes termed second-generation or 
third-generation migrants, often become part of the ethnic minority community17. 
Bhopal and others define ethnicity as a construct reflecting the community’s shared 
ancestral and geographical origins as well as cultural traditions, religions and 
languages26. 
In the IOM report “World Migration Report”27, “economic migrant” is defined 
as “a person leaving his/her habitual place of residence to settle outside of his/her 
country of origin in order to improve his/her quality of life. In its technical document 
“Recommendations on statistics of international migration”, the United Nations 
defined a migrant as a “person who moves to a country other than that of his or her 
usual residence for a period of at least a year”28. This term is often loosely used to 
distinguish migrants from refugees fleeing persecution and is also similarly used to 
refer to persons attempting to enter a country without legal permission and/or by 
using asylum procedures without bona fide cause. It may equally be applied to persons 
leaving their country of origin for the purpose of employment”. 
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The report from ECDC and IOM “Improving HIV data comparability in migrant 
populations and ethnic minorities” pointed out the difficulty to define “migrants” and 
“ethnic minorities” specifically for surveillance purposes. The most commonly used 
definitions for migrants are based on the following variables: “country of birth”, 
“country of origin” (previously collected as “region of origin”), “country of nationality”, 
“ethnicity or ethnic origin”, “migration status”, “length of stay in current country”. The 
report did not provide a consensus definition but recommends surveillance and 
researchers to provide a clear definition when reporting their results and explicitly say 
how migrants were defined.  Nevertheless, the report recommends using definitions 
based on “country of birth” or “country of nationality” rather than “region of origin” 29.  
2.2.2. Migratory trends in Europe between the 1990s and 2007 
The Twentieth Century was characterized by great economic, social and 
political changes. These changes have been closely related to migration trends and 
changing migration flows over the years.  
After the post-World War II reconstruction period (1940s-1950s) an important 
economic boom took place in Europe and countries such as Germany, United Kingdom 
and France demanded workers. This period was characterized by intra-European 
movements between the 1950s-1960s and 1973. These workers came from the 
Southern European countries (Italy, Spain and Portugal) and also from the former 
colonies of the countries demanding work force30.  
The Oil Crisis of 1973 and the financial crisis that would follow started a new 
period of “closed doors” and European countries expected migrant workers to leave. 
In the period between 1974 and the mid-1980s, countries such as Greece, Spain and 
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Portugal joined the Economic European Community (EEC) making these new countries 
attractive destinations for immigrants.  
After the 1970s, migration was characterized by flows from developing 
countries into Europe. Total net migration in the European Union Member States 
increased from 1.1 million in the 1960s to almost 10 million in the 1990s, due to the 
influx of migrant flows from non-European areas and wide range of origins. 
The period between mid-1980s and 2001 was characterized by political 
disorders after the collapse of communism and the growth of the asylum seekers and 
refugees. Difficulties in obtaining residence permits or refugee status caused many 
migrants to enter countries without documentation31.  
Between 1981 and 2000, most UE Member States, particularly Scandinavia, 
Italy, Spain and the Netherlands, received an increasing number of foreigners from 
Africa or Asia31. These migration patterns were even more pronounced during the 
period from 2002 to 2007, when migration flows in EU were particularly high32. 
Internal EU migration flows were also very important: 36% of migrants to EU-27 
Member States in 2008 were intra-European migrants33. 
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2.3. Migration policies in the European Union. 
2.3.1. Classification of migrants regarding their category of entry 
The report “The migration development Nexus” issued by IOM and UN30 in 2003 
classified migrants in four categories of entry: 
- Labour migration: composed by long and short-term migrant workers and 
seasonal workers. 
- Family reunification: composed by the close relatives of long terms migrants 
- Undocumented migrants: composed by people that entry the country without 
the official permits. 
- Asylum seekers: composed by people that has asked for asylum, and who 
become refugees when asylum is conceded.   
 
 The IOM has developed in 2011 a glossary of concepts in the field of migration 
entitled “Key Migration Terms”34. In this, migrant are classified as follows; 
- Documented migrant. A migrant who enters the host country observing the 
laws of that country. 
- Economic migrant. A migrant who leaves his country of origin to improve his or 
quality of life. 
- Irregular migrant. A migrant who meet one or more of the following: entered 
to the country without authorisation, does not meet any of the entry criteria, 
his/her visa has expired, or do not have a legal status in the country of transit 
or destination. 
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- Skilled migrant. A migrant who due to his/her professional’s skills receives a 
preferential treatment in the admission process.  
- Temporary migrant worker. A migrant who is skilled, semi-skilled or unqualified 
worker and remains in the host country for a definite period. 
- Refugee. A person who owing to a well-founded fear of persecution for reasons 
of race, religion, nationality, membership of a particular social group or political 
opinions, is outside the country of his nationality and is unable or, owing to 
such fear, is unwilling to avail himself of the protection of that country. 
 
 Migrants living with HIV can be found in any of these groups, but particularly 
among economic migrants, temporary migrant workers and irregular migrants.  
 On the other hand, regarding refugees, United Nations High Commissioner for 
Refugees (UNHCR) has recognized sexual orientation among the causes the nations 
may persecute their citizens. Actually, UNHCR recognizes that an asylum seeker can 
based their claim on his/her sexual orientation if “fears persecutory harm on account 
of his or her actual or perceived sexual orientation, which does not, or is seen not to, 
conform to prevailing political, cultural or social norms”35. Following this principle, 
MSM living with HIV in a country where their sexual orientation is punished or are 
heavily exposed to homophobia could claim for asylum in another country where this 
situation is not found. 
2.3.2. Models for migrant integration 
 In a succinct way, three main models for migrant integration have been 
developed in Europe in the second half of the 20th Century36-38: 
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- “Gastarbeiter” model or “guest worker model". This has been the integration 
model adopted by Germany, seeking migration as part of a formal guest worker 
programme (“Gastarbeiterprogramm”). The host country expects migrants to 
return to their home countries once the migration period is finished and family 
reunification is not contemplated. The migrant worker is considered as 
“Rotational migrant”. Following this model the worker was never integrated, 
since his/her stay in the host country was considered temporary, and 
subsequently the host country did not provide them with the necessary 
services and resources to help them in their integration process36;39. 
- Assimilation, the model followed by France. This model was based on the 
collective abandonment of migrant culture in favour of the culture of the host 
country. In the case of France, the population is expected to give up their 
culture and religious beliefs in favour of a civic culture of secularism, where 
religion and practices derived from a different culture is reserved for private 
space. The result is not just the integration of migrants in the strict sense, but 
the explicit renunciation of migrants to their habits and customs of origin and 
the segregation derived from it38.  
- Multiculturalism, the model developed in United Kingdom, was based on 
respect for the cultures of foreign people, respect for their own practices and 
promoting such practices. In practice, this model also leads to the integration of 
the migrants; however it has resulted in a high segregation in neighbourhoods 
and spaces, margined of the native population36. 
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 Finally, in the most recent years the “Interculturalism” approach has been 
developed. It has arisen as a criticism to the issues related with multiculturalism. This 
approach is based on the cross-cultural interaction where all cultures enrich each 
other, and their identity and their diversity are socially legitimized36;40. 
2.3.3. Migration policies in Europe from the 1950s to 2007. 
According to Joaquin Arango, migration policies include different rules and laws 
that comprise the following36;41: 
 Rules and practices aimed to migratory flows regulation and control 
 Regulations and practices related to application for asylum 
 Measures aimed at the integration of immigrants and ethnic minorities, 
including the definition of citizenship and access to it 
 Policies developed to combat racism and discrimination experienced by foreign 
people living in the host country. 
 
Migration policies reflect the integration approaches assumed in each context. 
Migration policies and recommendations have changed in Europe over the years. The 
first migratory policies started in the mid-1970. After the initial period of open borders 
previously described in which workers came from the Southern European countries 
during the 1950s and the 1960s, receptor countries decided to close the borders. 
When countries realized that a substantial part of these migrants had decided to 
remain in the host country, the inevitability of also developing integration policies 
became evident in order to avoid social conflict and support social cohesion36;42. 
2. Background                                          Débora Álvarez del Arco 
36 
In fact, the need to develop migrant policies was driven by the limited 
absorption capacity of European States. This resulted in integration policies aimed at 
migrants already established in the country as well as for those who could acquire the 
right to remain. In this context, access to rights in equal terms to nationals became the 
standard and access to health care services was one of these fundamental rights. At 
the same time, complementary policies intended to eliminate the economic drivers of 
migration in countries of origin, through international cooperation and macro-
economic co-development42.  
In this section, European policies are described. It is important to note that, 
throughout the period described, European countries maintained the power to 
develop their own migration laws, although the European Union set the guidelines that 
each single country should contemplate.  
Migration policy in the European Union has evolved over the years. In 1957, the 
Treaty of Rome created the European Economic Community (EEC). This treaty allowed 
a given citizen from one member state to work or to seek work in another member 
state. 
In 1976, the Trevi Group (“Terrorism, Radicalism, Extremism and Violence 
International”) was created as a framework for cooperation in laws and terrorism in 
the EEC area. After 1986 the group started to consider migration issues and in 1990 
the `Programme of Action' for the control of organised illegal migration'43 was 
approved. 
In 1985 the Schengen Agreements were signed, firstly by France, Germany, 
Belgium, Luxembourg and the Netherlands. The idea of this agreement was to abolish 
internal border checks and strengthen external borders44.   
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In 1987, through the Single European Act, the EEC Member States planned the 
creation of a unified market and to cooperate on foreign policies. In 1992, The 
Maastricht Treaty, the treaty that created the European Union (EU), defined the terms 
of the political cooperation among Member States, including foreign policies and in 
1999 the Treaty of Amsterdam incorporated the Schengen Agreements into the EU 
and intended to achieve a minimum agreement in asylum policies and practices by 
2004. The Nice Treaty issued in the 2000 considered that non-EU citizens with 
residence or work permit could have the same freedom of movements as EU nationals.  
1957.  Treaty of Rome. European Economic Community (EEC) creation. This treaty allowed a given 
citizen from one member state to work or to seek work in another member state 
 
1976. Trevi Group creation. It was created as a framework for cooperation in laws and terrorism in the 
EEC area. In 1986 the group started to consider migration issues. 
 
1985. Schengen Agreements. This agreement was aimed to abolish internal border checks and 
strengthen external borders. 
 
1987. Single European Act. The EEC Member States planned the creation of a unified market and to 
cooperate on foreign policies. 
 
1992. Treaty of Maastricht. This treaty created the European Union (EU) and defined the terms of the 
political cooperation among Member States, including foreign policies. 
 
1999. Treaty of Amsterdam. Incorporated the Schengen Agreements into the EU and intended to 
achieve a minimum agreement in asylum policies and practices by 2004. 
 
2000. Treaty of Nice. Considered that non-EU citizens with residence or work permit could have the 
same freedom of movements as EU nationals. 
 
2001. Extraordinary Council of Justice and Internal Affairs. European Commission recommended their 
Member States to deny the admission of third-country citizens in cases of public or internal security. 
 
2004. Hague Program. Proposed measures regarding migration control included: the definition of a 
common approach for the management of migration, an integrated management of external borders, 
the establishment of a common asylum procedure and the maximization of the positive impact of 
migration. 
Box 1. Summary of treaties and milestones of the EU. 
 
Finally, it is necessary to acknowledge that European migration policies 
changed after the terrorist attacks of September 11, 2001. In the Extraordinary Council 
of Justice and Internal Affairs held on 20th September 2001, the European Commission 
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issued a document recommending their Member States to deny the admission of 
third-country citizens in cases of public or internal security. This included legal 
migration, family reunification, long-term residence and student-visa demands. In this 
sense, the 11th September to led improvements in countries' security in the migratory 
movements but also forced a more restrictive approach to migration and therefore, a 
greater difficulty for policy convergence among the EU Member States45. 
In 2004 The Hague Program was signed, with the objective of advancing in 
setting justice, freedom and security in the EU. Proposed measures regarding 
migration control included: the definition of a common approach for the management 
of migration, an integrated management of external borders, the establishment of a 
common asylum procedure and the maximization of the positive impact of migration46. 
2.3.4. Health care access and integration policies for migrant 
populations. 
Integration policies defined also migrants’ rights in the host country. The 
Universal Declaration of Human Rights (UDHR)47 issued in 1948 states in its Article 2 
that all persons have the same rights “without distinction of any kind, such as race, 
color, sex, language, religion, political or other opinion, national or social origin, 
property, birth or other status”. This Declaration in its Article 22 indicated that 
“Everyone, as a member of society, has the right to social security and is entitled to 
realization, through national effort and international co-operation and in accordance 
with the organization and resources of each State, of the economic, social and cultural 
rights indispensable for his dignity and the free development of his personality”. 
However, the migrants’ access to general rights and specifically the access to health 
care rights are not occurring in equal terms comparing with nationals. The Platform for 
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International Cooperation on Undocumented Migrants (PICUM) published the Report 
of the International Conference on Access to Health Care for Undocumented Migrants 
in Europe developed in Lisbon in 200748. This report classified countries in five main 
groups regarding the health access provided to undocumented migrants at the time of 
this report, bearing in mind these policies change over time to more or less restrictive 
access depending on the political and social climate: 
- Countries that provided healthcare on a payment basis (Austria, Sweden). 
- Countries that did not provide free of charge care and public health officials 
were required to report undocumented migrants to authorities (Hungary and 
Germany). 
- Countries that generally provided better access but entitlements were unclear 
to both recipients and providers (Portugal and the UK). 
- Countries that had adopted parallel administrative systems to address payment 
issues for undocumented migrants (France, Belgium, Netherlands). 
- Countries offered universal access to migrants (Spain, Italy). 
Entitlement to cART, feature unique to migrant populations, challenges the 
effectiveness in the application of the pro-active HIV testing approaches that rely on 
the pillar that HIV testing must be linked to care as declared by different international 
organizations49-51. 
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2.4. Access to HIV testing, treatment and care for migrant 
populations in Europe (1997-2010) 
2.4.1. HIV testing barriers in migrants 
Several barriers to access HIV testing and care by migrants and ethnic 
minorities have been published22;52;53: time or financial constraints, administrative, 
legal, language and cultural barriers and living and working conditions54. Other barriers 
are HIV-specific such as insufficient knowledge of HIV, fear of stigmatisation, low risk 
perception, lack of knowledge about testing sites and concerns about confidentiality.  
Barriers to HIV prevention and treatment for migrants in the EU were covered 
by Bröring et al. who looked into the practices, and especially the barriers, to access 
HIV treatment among migrant populations, including undocumented migrants, and 
ethnic minorities in the EU23.  
Munier-Jack et al. in the document “Testing Times: Unmet need in testing, 
treatment and care for HIV/AIDS in EUROPE”55 raised that few studies in Western 
Europe had investigated HIV testing behaviour in migrants. Among the few which 
have, Fenton et al.56 conducted a survey in London among SSA; 30% of men and 26% 
of women reported having had an HIV test in the preceding five years. The study 
developed by Stolte et al. in the city of Amsterdam57 showed that overall, 38% of 
heterosexual migrants reported ever being tested for HIV, with greater differences by 
sex due to antenatal testing programmes (27% men versus 47% in women). 
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2.4.2. Access to HIV treatment and care 
The different epidemiological patterns of HIV infection in migrants and ethnic 
minorities in Europe and the migrants’ unique barriers to HIV testing and care may 
compromise pro-active HIV testing approaches based on the premise that HIV testing 
must be linked to care21;49;58. The report of “HIV in Europe”59 showed that in 2007 only 
11 out of 24 countries participating in the survey had laws that provided universal 
access to cART to undocumented migrants. A number of other countries also provide 
in the practice cART to migrants of uncertain status, but through non-official initiatives, 
often Non-Governmental Organizations (NGOs) and Community-Based Organizations 
(CBOs). 
As previously acknowledged, some EU countries do not provide HIV care for 
people of uncertain legal status48. Therefore, the lack of any medical benefit for 
individuals found to have HIV, in addition to the fear of deportation may hamper 
public health initiatives promoting HIV testing in migrants.  
The report “Implementing the Dublin Declaration: 2010 progress report”25 did 
show how in 2010 approximately all (94%) of the participant countries had promoted 
comprehensive HIV treatment, care and support for people living with HIV/AIDS. Four 
of the five countries with this strategy specifically addressed barriers among women 
and highly vulnerable subpopulations; although half of them reported that the country 
had laws, regulations or policies that presented obstacles to effective HIV treatment, 
care and support for these specific subpopulations. Indeed, 54% of these countries 
identified obstacles for migrants. 
2. Background                                          Débora Álvarez del Arco 
42 
2.5. HIV testing strategies in Europe. 
2.5.1. The importance of late diagnosis of HIV infection 
 Prioritisation of HIV within the global European health policies and of the HIV 
testing interventions effectiveness could be measured through late diagnosis rate. 
Expert consensus defines as late diagnoses people diagnosed with CD4 cell count 
<350/mm3 or AIDS defining event, while presentation with advanced HIV disease 
(AHD) is defined as presentation with CD4 <200/mm3 or AIDS60.  
In Europe, cases with information on CD4 cell counts at the time of diagnosis 
were limited and this information was only available for 18 of the 29 EU/EFTA 
countries in 2010 (15 882 cases, 59% of all reported cases)1. Half of these cases (49%) 
were late diagnoses and 29% had been diagnosed in a stage of advanced HIV infection.  
The 2010 surveillance report1 highlighted there was no information about 
subpopulations most affected by late diagnosis. Nevertheless, in the surveillance 
report of 201161 late diagnosis was higher among the following subpopulations: 
 Heterosexually acquired cases among SSA (63%) 
 IDU (48%) 
On the other hand, the proportion of late presenters was lower among MSM 
(38%) and in MTCT cases (21%). 
Late diagnosis has important implications for individuals’ health, as it delays 
initiation of cART and thus increases the risk of developing AIDS and death.  
Late diagnosis represents a failure on HIV testing strategies. Understanding that 
HIV may have no signs or symptoms for many years, early diagnosis can only be 
reached through accurate HIV testing strategies, aimed to early referral individuals for 
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treatment and care62. Besides, avoiding new HIV infections generated from people 
who are not aware of being HIV positive is the other major advantage of early HIV 
diagnosis.  
Diverse approaches for HIV prevention and testing have been assumed during 
the last years. Geoffrey Rose in his classic 1992 book “The strategy of preventive 
medicine”63 describes two different strategies aimed for prevention in general, not 
specifically for HIV:  
 The “high risk strategy”, based on an approach designed to identify 
individuals with special needs (or at high risk). The strategy to be put in 
place implies controlling the level in which the subjects are exposed to 
the cause and/or by providing protection against the effects of this 
exposure, in order to prevent for additional complications.  
 The “population strategy”, based on the principle of common diseases 
implies that mass exposures call for mass interventions. Every single 
society has their own characteristics that are related with specific health 
outcomes. A wide prevention population approach is needed to respond 
to these population exposures. 
The different HIV testing strategies designed by the different countries have 
these dual preventions approaches, to avoid late diagnosis: a “high risk strategy” and a 
“population strategy” for HIV testing. 
In order to understand the changes in the relative importance of each of these 
two approaches it is indispensable to take into account the evolution on the paradigm 
of HIV from a historical perspective. 
2. Background                                          Débora Álvarez del Arco 
44 
2.5.2. From the paradigm of the AIDS excepcionalism to HIV 
normalization. 
AIDS exceptionalism was a term developed in the beginning of the HIV 
epidemic which aimed for “an exceptional” treatment for HIV infection as compared to 
other infectious diseases64-66. AIDS exceptionalism emphasized clinical confidentiality, 
documented informed consent for HIV testing and anonymous surveillance. The 
reasons behind this movement, which emerged at a time when antiretroviral 
treatment had not been discovered, were to protect people living with HIV from abuse 
and discrimination. AIDS exceptionalism was the “Western response to an epidemic 
that threatened the lives and rights of specific populations in the developed world”67. 
However, when antiretroviral treatment became available and numbers of new 
infections did not cease to increase, some public health professionals started 
questioning whether this approach was still a valid paradigm.  
Actually, De Cock and Johnson discussed in a 1998 paper68 that the therapeutic 
advances in the treatment of HIV had shown effects in altering the clinical course of 
the infection and proved successful in reducing MTCT, which had a population 
approach. The authors acknowledged the benefits of the exceptional strategy in that it 
increased patient’s autonomy and strengthened confidentiality. Nevertheless, based 
on the therapeutic advances, they proposed to extend HIV testing to areas where HIV 
prevalence was high, as well as in hospital settings, STD clinics and as a routine practice 
in antenatal care. According to these authors, these strategies should not compromise 
informed consent and confidentiality therefore being a model for other areas of 
medicine. 
Later Frieden et al., in a classical paper published in 200569, argued that due to 
the advances in the HIV/AIDS treatment and the antidiscrimination interventions, it 
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was necessary to call for an end to exceptionalism. They supported the idea of 
applying public health principles to control the HIV epidemic; case finding, interrupt 
transmission, ensure treatment and case management, monitor infection and control 
efforts at population level.  
2.5.3. The HIV normalisation era: fighting stigmatization. 
In 2006, the Centers for Disease Control and Prevention (CDC) published the 
document entitled “Revised recommendations for HIV testing of adults, adolescents, 
and pregnant women in health-care settings” with the aim to increase HIV testing and 
expand the role of health-care providers in the testing process70. This publication 
explicitly assumed the end of AIDS exceptionalism.  
The rationale was to de-stigmatize HIV testing. The CDC aimed for a new testing 
strategy based on the following characteristics: 
 Routine HIV testing  
 Voluntary HIV screening for all persons aged 13-64 
 Performed in health care settings independently of any HIV risk 
assessment.  
 In places with local undiagnosed HIV prevalence higher than 0.1%  
 Without a separate signed consent for HIV testing as part of the pre-
counselling 
 The recommendations indicated that specific sites for HIV testing for MSM and 
other groups at risk should not be stopped, but rather complemented by the above 
opt-out strategies. The document stressed the need to diminish missed testing 
opportunities in non-traditional health care settings, in particular among 
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disadvantaged populations. For people with known HIV risk, tests should be repeated 
at least annually. 
In this same line, WHO published in 2007 “Guidance on provider-initiated HIV 
testing and counselling (PITC) in the health facilities”71. Until that publication, the 
approach for HIV testing and counselling had been voluntary counselling and testing. In 
following this approach, individuals had to actively seek an HIV test in health or 
community testing sites. This strategy had its limitations as highlighted by low 
coverage of services, fear of stigma and discrimination, and the perception by many 
people that they were not at risk for HIV. PITC aimed for the health care provider 
specifically recommending an HIV test to patients attending health facilities. Testing 
remains strictly voluntary, consented and confidential and patients have the right to 
decline. Under this recommendation, pre-test counselling is replaced by pre-test 
information and post-test counselling remains as a key intervention. WHO underlines 
testing must be linked to appropriate HIV prevention, treatment, care and support 
services in an adequate supportive social, policy and legal framework that has to 
guarantee the positive outcomes and minimize the potential harm. This guidance, built 
on the evidence that PITC had already been successfully implemented in both low- and 
middle-income countries as well as in pre-natal care in many high-income countries, 
was an important step compared to previous positions.  
By the end of 2007, AIDS Action Europe and WHO Europe organised in Brussels 
the conference “HIV in Europe 2007: Working together for optimal testing and earlier 
care” to put together HIV advocates, clinicians, public health professionals and policy 
makers59. The overall objective of HIV in Europe was, and still is, to ensure that HIV 
positive patients enter care earlier in the course of their infection, as well as to study 
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the decrease in the proportion of HIV positive persons presenting late for care. Based 
on the ‘call to action’ of the Conference previously mentioned, a Roundtable in the 
European Parliament in September 2008 initiated a discussion that resulted on the 
European Parliament adoption of the "Joint Resolution on HIV/AIDS: early diagnosis 
and early care"72.  
Together with these innovative initiatives, challenges to implement and 
monitor these new interventions were also put forward. Various authors73;74 had 
highlighted some of the challenges that these key elements of the CDC guidelines 
could rise.   
2.5.4. HIV testing policies and practices in Europe 
In 2007, ECDC commissioned the International Centre for Reproductive Health 
(ICRH) from Ghent University a study on HIV testing policies, practices and barriers in 
the EU. By January 2008, an expert meeting “HIV Testing in Europe: From policies to 
effectiveness”54 took place in Stockholm to discuss critical issues regarding HIV testing 
and counselling and to contribute to the previously mentioned commissioned 
project24. 
The priorities for prevention in the EU were to increase uptake of HIV testing 
and counselling, to decrease the number of undiagnosed, to improve prevention and 
care in high-burden countries, to develop innovative prevention approaches for MSM 
and to provide specific services for migrant communities26.  
However, at this time, no European recommendations about HIV testing had 
been published. In fact, ECDC started to raise the question on how to build an 
European level HIV testing recommendations guidance and needed to collect evidence 
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on this topic. Additionally, the 2006 CDC recommendations for HIV testing had 
changed the paradigm launching a new approached based on the idea to expand and 
normalize HIV testing58;62;75-77.  
Increasing HIV testing at population level was a challenge, and doing so in 
migrants and ethnic minorities posed additional difficulties. 
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Objective 1. To describe EU/EFTA Member States’ policies and recommendations 
regarding HIV diagnosis and testing in migrant populations and ethnic minorities in 
2010. 
 
Objective 2. To describe International Organizations recommendations (WHO, 
UNAIDS, IOM, ILO and IUSTI) regarding HIV diagnosis and testing in migrant 
populations and ethnic minorities in 2010 and analyse its content. 
 
Objective 3. To analyse available scientific evidence on HIV testing and counselling 
strategies targeting migrants and ethnic minorities in high-income countries and to 
describe migrant-specific barriers to HIV testing and counselling (2005-2010).  
 
Objective 4. To examine the challenges for implementing and expanding HIV testing 
and counselling strategies targeting migrants in 2010. 
- Objective 4.1. To assess feasibility and objective benefits of the different 
approaches aimed at expanding HIV testing in migrant populations.  
- Objective 4.2. To evaluate how the specific HIV testing recommendations 
are being implemented at national level. 
 
Objective 5. To describe trends in new HIV diagnosis and risk factors for presentation 
with Late HIV Disease between 2007 and 2012 in male and female migrant populations 
in Europe and to analyse the changes of migratory trends in Europe between 2007 to 
2012.
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4.1. Methods for Objective 1: To describe EU/EFTA Member 
States’ policies and recommendations regarding HIV 
diagnosis and testing in migrant populations and ethnic 
minorities in 2010 
4.1.1. Survey to EU/EEA/EFTA Member States policies and 
recommendations review. 
Survey to EU/EEA/EFTA country representatives (2010) 
An on-line survey based on a brief questionnaire was conducted among 31 
EU/EFTA Member States in 2010. Key informants were selected by ECDC within the 
competent health authorities (Ministries of Health and Public Health institutions) and 
are listed in the APPENDIX 1. Various e-mail reminders were sent to encourage 
participation between February and September 2010. The country representatives 
were asked to send the official documents describing HIV testing in migrant/ethnic 
minorities. 
Search and review of guidelines, policies and other publications on HIV 
testing & counselling from the EU/EEA/EFTA Member States in 2010. 
An additional search in the web pages of the different competent bodies of the 
EU/EFTA Member States (National AIDS Plans, Ministries of Health, Public Health 
Agencies etc.) for national recommendations, guidelines or any other policy 
documents was performed in 2010.  Search strategy is listed in APPENDIX 2. 
Documents in English, Spanish, Italian, Portuguese, German and French were 
reviewed.  
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4.1.2. Instruments for collecting information 
Questionnaire for the survey to the country representatives 
The content of the questionnaire sent to the country representatives included 
the following items: 
- Existence of specific HIV testing & counselling recommendations targeting 
migrant population and/or minorities 
- Year of publication of these recommendations 
- Special mention of any particular geographical origin in the recommendations.  
 
 The most recent document where these recommendations were contained was 
requested too.  Questionnaire full content is shown in ‎9.2.3. 
Data collection form for the documents review 
A preliminary data extraction form was designed and piloted. Changes from the 
pilot were incorporated and the final data collection form is included in the APPENDIX 
4.  The data collection form contained the following information:  
- Type of document (HIV testing guideline, Health Plan etc.) 
- Year of publication. 
- Institution issuing the publication. 
- Whether background information on reasons to improve and expand HIV 
testing, in general and in particular for migrants and ethnic minorities, was 
mentioned. 
- If definitions (if any) of migrants and ethnic minorities were stated. 
- Whether migrants and ethnic minorities were identified as vulnerable 
populations for HIV infection. 
- Whether there were recommendations to test these groups.  
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- Whether routine and universal HIV testing strategies were being recommended  
- If there are targeted HIV testing strategies for migrants and ethnic minority 
groups. 
- Frequency and the site for HIV testing. 
- Recommendations for pre and post counselling (or pre and post-test 
discussion), paying special attention to specific recommendations for migrant 
and ethnic minorities. 
- Novel strategies for HIV testing for migrants and ethnic minorities within the 
community.  
- Issues on HIV testing on arrival, about legal consequences for testing migrants 
and gender dimension of the testing policies. 
Response rate 
The response rate was very high; 29 of 31 country representatives responded 
the survey (94%). 
4.1.3. Review strategy 
Teams of two independent researchers read the full documents and collected 
the information in the designed data collection form. 
Additional collaboration from the national representatives was demanded 
when the documents were in other languages than English, French, German, Italian, 
Portuguese or Spanish. However, in three European countries (Poland, Slovakia and 
Netherlands) documents could not be reviewed and only responses from national key 
informants were used. 
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4.1.4. Data entry and analysis. 
The responses from the country representatives were collected in a database in 
excel, in order to organize all the information. The information contained in the data 
collection form was coded and organized in the database. A descriptive content 
analysis was carried out. 
4.1.5. Results of the search strategy 
The research flow chart is described in Figure 7. Overall, 28 documents from 27 
EU/EFTA Member States were identified: sixteen HIV/AIDS National Strategies, three 
HIV testing Guidelines, four miscellaneous documents about HIV testing 
recommendations, two internal working documents, one piece of legislation, one 
National Strategy on Communicable Diseases and one national communicable diseases 
surveillance bulletin. This heterogeneity, derived from the different Member States 
context, hampers an exclusively quantitative approach. 
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Figure 7. Research flow chart. (*) Documents in languages other than English, French, Spanish, Italian, 
German or Portuguese and translation not provided by FP 
 
Regarding country representatives responses, of the 31, the research team 
received 29 responses from the participants already listed in APPENDIX 1. All the 
retrieved documents are recorded in APPENDIX 5.  
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4.2. Methods for Objective 2: To describe International 
Organizations recommendations (WHO, UNAIDS, IOM, ILO 
and IUSTI) regarding HIV diagnosis and testing in migrant 
populations and ethnic minorities in 2010 and analyse its 
contents. 
4.2.1. Search of guidelines, policies and other publications on HIV 
testing & counselling from International 
Agencies/Organizations/Societies in 2010. 
 A search of documents published by the most significant International 
Organizations (WHO, UNAIDS, IOM, ILO, IUSTI) was carried out by accessing all relevant 
webpages listed in the APPENDIX 6. 
4.2.2. Instrument for collecting information 
 The same data extraction form used for countries’ policies and 
recommendations review was used. The final data collection form is included in the 
APPENDIX 7.   
4.2.3. Search strategy 
Teams of two independent researchers read the full documents and collected 
the information in the designed data collection form. 
All retrieved documents were in English.  
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4.2.4. Data entry and analysis. 
The information contained in the data collection form was coded and organized 
in an Excel database. A descriptive content analysis was carried out. 
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4.3. Methods for Objective 3: To analyse available evidence on 
HIV testing and counselling strategies targeting migrants 
and ethnic minorities in high-income countries and to 
describe migrant-specific barriers to HIV testing and 
counselling. 
4.3.1. Methods: Systematic review of the literature 
To reach Objective 3, a literature search in Pubmed, Embase, CRD York 
database, Cochrane and Web of Knowledge was performed.  
4.3.2. Inclusion criteria of the articles 
The inclusion criteria to consider the articles eligible for inclusion were the 
following: 
 Written in English language. 
 Published between 2005 and 2009. 
 Published in or about research or interventions conducted in similar western 
contexts: European countries, Canada, United States of America or Australia. 
 Including at least one keyword of any of these groups (i) ethnic groups, 
minority groups, transients and immigrants, refugees; (ii) mass screening, 
diagnosis, AIDS Serodiagnosis, public policy, prevention and control, Centres for 
Disease Control and Prevention (USA), counselling; and (iii) Acquired 
immunodeficiency syndrome, HIV, HIV Infections.  
Mesh terms used in data bases that use Mesh indexing system (Pubmed, Cochrane): 
(("Minority Groups"[Mesh] OR "Transients and Migrants"[Mesh] OR "Emigrants and 
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Immigrants"[Mesh] OR "Refugees"[Mesh]) AND ("Mass Screening"[Mesh] OR 
"Diagnosis"[Mesh] OR "AIDS Serodiagnosis"[Mesh] OR "Public Policy"[Mesh] OR "prevention 
and control"[Subheading] OR "Centres for Disease Control and Prevention (U.S.)"[Mesh] OR 
"Counselling"[Mesh]) AND ("Acquired Immunodeficiency Syndrome"[Mesh] OR "HIV"[Mesh] 
OR "HIV Infections"[Mesh]). In the rest of the cases we used “topics” related with: migrants 
and minorities (migrant workers, minority, asylum or refugee status) AND testing or linked 
issues (mass screening; diagnosis; AIDS serodiagnosis; public policy; prevention and control; 
counselling) AND HIV/AIDS (Acquired Immunodeficiency Syndrome (AIDS), HIV). 
4.3.3. Articles screening: the systematic review results. 
Stage 1. Databases search results 
As described in Figure 8, 1,185 articles were identified in the searched 
databases, and of those, 151 were duplicates.  Figure 8 shows the complete results of 
the systematic review performed, in terms of number of articles screened in each 
stage of the systematic review. 
 
Figure 8. Systematic review process 
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Stage 2. Abstract read results 
Two members of the research team read all the 1,034 abstracts to disregard 
those who did not meet the inclusion criteria. A conservative strategy in this second 
stage has been used and only abstracts that did not refer to migrants or ethnic 
minorities in Europe, USA, Canada and Australia and HIV testing and/or counselling 
were eliminated at this stage.  Therefore, articles not meeting these inclusion criteria 
were excluded in a second phase.  
Agreement on which articles to include was 95% among the two researchers 
and in the 5% on which there was disagreement, a third reviewer was responsible for 
the final decision. After steps 1 and 2, 970 articles were discarded and 64 selected for 
full review. 
Stage 3. Full paper read results 
In this third step, eligibility criteria were applied again to the 64 papers given 
the conservative selection strategy for the abstracts phase. Teams of two people read 
the 64 articles and applied eligibility criteria; 31 articles were rejected for not dealing 
with either HIV testing (n = 22), migrants or ethnic minorities (n = 13), countries not 
meeting the criteria (n=3) or for them being of poor quality (n = 1). The review of these 
64 articles bibliography identified seven new manuscripts, from the manuscripts’ 
references, of which four met inclusion criteria.  Finally, the analyses were based on 37 
articles.  
HIV/AIDS in migrant populations in Europe: epidemiology, testing strategies and access to antiretroviral 
treatment 
 
65 
4.3.4. Instrument for collecting data 
A preliminary data extraction form was designed and piloted in 14 articles. 
After incorporating the changes suggested by the pilot, teams of two independent 
researchers read the full 64 papers and extracted the information in the template. 
Complete data collection form is included in APPENDIX 7. 
The data collection form inquired about the following aspects: 
 Objective of the paper 
 Brief summary of the paper, describing the main findings 
 Year of the study  
 Setting and populations studied 
 Definition (if any) of “migrants” and “ethnic minorities”  
 Key methodological questions such as the type of design and the sample size. 
 If the paper described barriers to HIV testing, a description of those barriers 
was collected, so were the recommendations suggested to overcome those 
barriers.  
 A question on whether there was a justification on why to study certain groups 
of migrants and ethnic minorities was included and gathered if gender issues 
were explicitly mentioned. 
 Mention of the consequences of HIV diagnoses in migrants of uncertain legal 
status and criminalization of HIV was also looked for.  
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4.3.5. Quality assessment of the articles 
The data collection form also included an evaluation of the quality of the paper 
based on the Carlson et al. article “Study design, precision, and validity in 
observational studies”78 and organized in 5 main aspects: 
1. A clearly defined research question 
2. Internal validity: the study is well designed, according to its characteristics, 
allowing, where appropriate, to minimize bias. 
3. Results are well described, are useful and accurate 
4. External validity. The results are generalizable to the population and context in 
which they are expected to be applied 
5. Overall quality rating of the article 
The article quality was evaluated using the following scale:  
 Very good 
 Good 
 Poor 
 Very poor 
The categories “Without information” and “Does not apply” were also included. 
4.3.6. Data entry and analysis. 
To organize all the data, all the information was coded and recorded in an Excel 
database. A descriptive content analysis of the collected qualitative information was 
performed.  
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4.4. Methods for Objective 4: To examine the challenges for 
implementing and expanding HIV testing and counselling 
strategies targeting migrants. 
4.4.1. Methods 
Qualitative methodology was developed to reach the Objective 4. Semi-
structured interviews to key stakeholders and group interviews were carried out. 
Semi-structured interviews to key stakeholders  
On one hand, semi structured interviews to 13 key informants described below 
in Table 3 were carried out.  
The participants were from both governmental and non-governmental 
organizations and were chosen because of their knowledge on HIV testing & 
counselling, their knowledge on migrants and ethnic minority health issues and, 
preferably, knowledge on both topics. The research team aimed for a pan European 
representation and for a balance between governmental and non-governmental 
organizations.  
11 interviews in which 13 expert participated (in Italy three experts participated 
at the same interview) was determined by logistic restrictions as well as by “saturation 
criteria”, that is, after a given number of interviews; most information does not add 
more to the research and starts becoming redundant. 
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Participants Position Institution Country 
Maureen 
Louhenapessy 
Project Manager Sid Aids migrants-Siréasasbl Belgium 
Jessica Deblonde Researcher 
International Centre for 
Reproductive Health, Ghent 
University 
Belgium 
Olivier Scemama 
Deputy Head, Economic and 
Public Health Assessment 
Department 
National Health Authority France 
Ramazan Salman Executive Managing Director Ethno-Medical Centre Germany 
Laura Camoni 
Research Assistant, AIDS 
Operational Centre 
Department of Infectious, 
Parasitic and Immunomediated 
Diseases, National Institute of 
Health 
Italy 
Anna Colucci 
Researcher, Research 
Coordinator, Operational Unit of 
AIDS Telephone of Information 
Department of Infectious, 
Parasitic and Immunomediated 
Diseases, National Institute of 
Health 
Italy 
Anna Maria Luzi 
Researcher, Scientific Chief, 
Operational Unit of AIDS 
Telephone of Information, and 
Italian National Focal Point AIDS 
& Mobility 
Department of Infectious, 
Parasitic and Immunomediated 
Diseases, National Institute of 
Health 
 
Italy 
Henrique Barros National Coordinator National AIDS Coordination Portugal 
Olivia del Castillo 
Head, Prevention and 
Coordination of the Department 
for National AIDS Strategy 
Ministry of Health and Social 
Policy 
Spain 
Ferrán Pujol 
Project Manager, NOMS-
Hispanosida and BCN Checkpoint 
Hispanosida Spain 
Bryan Teixeira Chief Executive Naz Project London UK 
Ibidun Fakoya Research Associate 
Centre For Sexual Health and 
HIV Research, University 
College London 
UK 
Kevin Fenton 
Director, National Centre for 
HIV/AIDS, Viral Hepatitis, STD and 
TB Prevention 
Centres for Disease Control and 
Prevention 
USA 
Table 3. Participants in the interviews 
 
A number of interviews (6) were conducted face to face and some others (5) 
over the telephone.   
Group interviews 
Two group interviews were done seizing the opportunity of a two day meeting 
held in ECDC, Stockholm. Each group comprised 15 interviewees, chosen as to obtain 
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the views of the different actors in the field, and were chaired by a member of the 
research team. The two group interviews were face to face. The participants of the 
group interviews are listed in the APPENDIX 8. 
4.4.2. Instruments for collecting data. 
A structured script was prepared for both, the individual and the group 
interviews. For the group interviews, although open discussion was encouraged, the 
groups were asked basically the same questions than in the individual interviews.  
The complete script used for Group interviews (APPENDIX 9) and the scripted 
used for the key informants interviews (APPENDIX 10) are shown in the Appendix 
section.  
Key areas for exploration included:  
- Perceptions about general population HIV testing approaches (based on opt-
out HIV routine screening with no lengthy pre-test counselling);  
- Opinions on how health care providers are implementing more active 
approaches for HIV testing and how migrants perceive targeted pro-active HIV 
testing strategies; 
- Considerations of ethical issues related with performing HIV testing to migrants 
with uncertain status in countries where HIV care and treatment are not 
granted; 
- Awareness and description of novel initiatives that promote HIV testing at 
community levels targeting migrants and ethnic minorities, in particular, those 
who do not access regular health care settings; 
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- Awareness of initiatives targeting heterosexual men in general and migrant and 
ethnic minority men in particular and innovative proposals to engage men in 
health care. 
4.4.3. Analysis of the information 
Data collection was performed between March and September 2010. Information 
was tape recorded, transcribed and analysed.  
A descriptive manifest content analysis approach was carried out. The content 
analysis method was defined by Leedy and Ormrod79 as “a detailed and systematic 
examination of the contents of a particular body of materials for the purpose of 
identifying patterns, themes, or biases”. 
In order to systematize the analysis, the information was classified by the themes 
addressed following the questions asked to the participants.  
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4.5. Methods for Objective 5. European HIV surveillance data 
and Eurostat European migration data analysis. 
4.5.1. Epidemiological data analysis 
Study design and methods 
 A cross sectional study with surveillance data from all the new HIV cases 
reported in the EU/EEA countries was carried out. Data from 29 countries within 
EU/EEA were analysed. Data reported between 2007 and 2012 were analysed.  
 The TESSy database was used. All EU Member States (28) and the 3 EEA 
countries report their available data on communicable diseases to the TESSy. The 
database was provided by ECDC. All new HIV cases reported to the European 
Surveillance System (TESSy) were analysed.  
Variables definition 
- “Migrant status”, was defined based on information on either the country 
of birth, country of nationality and/or region of origin of the cases which 
has been systematically collected from 1998 onwards.  
- “Geographical origin” (GO). A new variable on geographical origin was 
generated combining the information provided by the previously cited 
primary variables. When more than one primary variable was available, 
country of birth was the preferred one. If country of birth was not available, 
country of nationality was used as the second best option. Only when 
neither country of birth nor countries of nationality were available, region 
of origin was then used.  
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 Geographical origin was classified as native if the reporting country was the 
same as the country of birth or country of nationality and for the rest of the cases as 
European (Western Europe, Central Europe, Eastern Europe), Sub Saharan Africa (SSA), 
Latin America (LA), East Asia and Pacific, Australia and New Zealand, South and South 
East Asia, North Africa and Middle East, North America, the Caribbean, and unknown. 
SSA was further divided into Western, Central, Eastern and Austral Africa using the 
classification provided by UNAIDS80. An additional category “Unknown” was used for 
cases from SSA with no data on the actual country or sub-region of origin. LA was also 
divided into Central, Andina and South America. Similarly to SSA, an additional 
category of “Unknown” was also created. Countries’ classification is included in 
APPENDIX 11. 
- “Late HIV disease” (LHD). Was defined according to the definition proposed 
by the European Late Presenter Consensus Working group60 as both, having 
a CD4 count below 350 cells/mm3 or an AIDS defining event in the six 
months following diagnosis. 
Missing data 
 Of the 181,881 HIV diagnoses reported to the European Surveillance System 
during the period 2007-2012, 738 had no information on sex (0.5%) and 32,328 (18%) 
had no data on geographical origin. Table 4 shows missing information on 
Geographical Origin, that varied widely by country of reporting. In 18 of the 29 
countries, missing data were less than 10%, while others like Estonia and Latvia were 
75% and 68%, respectively. Belgium, Norway and France had GO missing values in 
approximately 30% of their cases. Italy had no reported data since 2010.   
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Country 
Cases and GO 
availability 
2007 2008 2009 2010 2011 2012 
Austria 
Total  335 345 301 317 309 306 
Unknown GO 5 4 1 0 2 0 
Belgium 
Total  1063 1087 1127 1196 1182 1226 
Unknown GO 290 287 313 317 297 338 
Bulgaria 
Total  126 123 171 163 201 157 
Unknown GO 0 2 0 0 0 0 
Cyprus 
Total  46 37 38 41 54 58 
Unknown GO 0 0 0 0 0 1 
Czech Republic 
Total  121 148 156 180 153 212 
Unknown GO 0 0 0 0 0 0 
Germany 
Total  2776 2826 2869 2908 2881 2950 
Unknown GO 445 456 414 458 429 243 
Denmark 
Total  306 285 236 275 266 200 
Unknown GO 8 1 2 8 4 2 
Estonia 
Total  633 545 411 376 366 315 
Unknown GO 633 545 374 220 221 0 
Spain 
Total  2671 3188 3340 3575 3244 3210 
Unknown GO 4 2 1 1 1 3 
Finland 
Total  187 147 172 184 172 156 
Unknown GO 2 6 3 4 14 13 
France 
Total  5659 5743 5428 5527 5374 4066 
Unknown GO 1463 1491 1444 1505 1598 1396 
Greece 
Total  551 603 592 626 940 1059 
Unknown GO 19 21 28 33 58 61 
Hungary 
Total  98 119 122 151 133 200 
Unknown GO 1 0 0 0 0 1 
Ireland 
Total  391 404 395 330 323 339 
Unknown GO 100 88 86 53 62 121 
Iceland 
Total  13 10 15 24 23 19 
Unknown GO 3 0 7 1 4 3 
Italy 
Total  1960 2038 2563 3925 3748 3896 
Unknown GO 1960 2038 2563 116 30 35 
Lithuania 
Total  106 95 180 153 166 160 
Unknown GO 0 1 0 0 6 5 
Table 4.(I) Distribution of HIV total diagnoses and HIV diagnoses without information about 
geographical origin according to reporting country of the UE/EEA (I). 
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Country 
Cases and GO 
availability 
2007 2008 2009 2010 2011 2012 
Lithuania 
Total  106 95 180 153 166 160 
Unknown GO 0 1 0 0 6 5 
Luxemburg 
Total  44 57 54 49 48 54 
Unknown GO 0 0 0 1 0 1 
Latvia 
Total  350 358 275 274 299 339 
Unknown GO 246 266 172 179 208 234 
Malta 
Total  14 4 8 18 21 30 
Unknown GO 4 0 0 0 3 0 
Netherland 
Total  1219 1288 1173 1157 1083 976 
Unknown GO 2 3 3 1 0 2 
Norway 
Total  248 299 282 258 269 242 
Unknown GO 1 0 2 155 152 152 
Poland 
Total  727 762 883 865 1073 1058 
Unknown GO 28 19 172 211 244 201 
Portugal 
Total  1861 1900 1708 1511 1218 721 
Unknown GO 23 26 26 30 11 9 
Romania 
Total  173 259 253 274 427 489 
Unknown GO 0 0 0 0 0 0 
Sweden 
Total  472 414 409 448 382 362 
Unknown GO 12 14 18 19 16 30 
Slovenia 
Total  37 48 48 35 55 45 
Unknown GO 1 1 1 0 1 1 
Slovakia 
Total  39 53 53 28 49 50 
Unknown GO 0 1 1 1 0 0 
United 
Kingdom 
Total  7381 7268 6672 6358 6211 6358 
Unknown GO 1525 1251 737 806 861 1469 
Total 
Total  29607 30453 29934 31226 30670 29253 
Unknown GO 6775 6523 6368 4119 4222 4321 
Total included in the analysis 22832 23930 23566 27107 26448 24932 
Table 4 (II). Distribution of HIV total diagnoses and HIV diagnoses without information about 
geographical origin according to reporting country of the UE/EEA (II). 
   
Statistical methods 
 Absolute numbers and calculated proportions of interest were examined and 
plotted and medians and their Interquartile ranges (IQR) were calculated.  
 Differences in socio-demographic characteristics were assessed through the 
Mann-Whitney test for continuous variables and the chi squared test for independence 
HIV/AIDS in migrant populations in Europe: epidemiology, testing strategies and access to antiretroviral 
treatment 
 
75 
for categorical variables. Relative changes in the number of HIV reports from 2007 to 
2012 were calculated.  
 A linear regression was performed to calculate the change in the average cases 
per year in the different geographical origins.  
 Logistic regression was used to examine the association between Geographical 
Origin and LHD for men and women. Crude Odds Ratios (OR) and their 95% Confidence 
Intervals (95%) were calculated, as well as adjusted OR (ORa), controlling for the 
confounding effect of age and transmission category. Interactions by sex (a priori 
effect modifier) through Likelihood Ratio Tests (LRT) were assessed. Analyses did not 
take into account notification delay. Analyses were performed using Stata version 
13.081. 
Sensitivity analysis 
 Additional sensitivity analyses were performed to test the presence of potential 
misclassification of the main exposure variable and rerun the analyses using nationality 
instead of country of birth as the first option.  
 Separate analyses were performed for the two countries (Italy and Spain) which 
had experienced changes in their HIV reporting systems during the study period. 
4.5.2. Migrant population data in EU/EEA registries 
Data sources 
 In order to retrieve data of migrant population living in the EU/EFTA countries 
two main have been explored: 
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- Eurostat database. Eurostat is the EU statistical resource that contains, 
among other, data on migration and citizenship, including information on 
population stocks by citizenship and country of birth.  
- National Statistical Institutes. NSI were contacted by email and asked to 
provide total population living in the country between 2007 and 2010 and 
migrant population by country of birth (or country of citizenship if not 
available) in the period 2007-2012. Data was claimed for both men and 
women separately. An example table about that requested was provided to 
avoid confusion. 
Data retrieved 
 Sources and availability of demographic data by country are explained in 
APPENDIX 12. From the 29 countries of interest, 17 (59%) had information on native 
population and global foreign population for the full period 2007 to 2012 (See Table 5). 
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Country 
Native population/foreign population 
data available for 2007-2012 
Austria All data 
Belgium 2007-2011 
Bulgaria All data 
Cyprus 2010-2012 
Czech Republic 2010-2012 
Denmark All data 
Estonia 2011 
Finland All data 
France 2009-2010 
Germany All data 
Greece All data 
Hungary All data 
Iceland 2008-2012 
Ireland All data 
Italy 2007-2011 
Latvia All data 
Lithuania All data 
Luxembourg All data 
Malta 2008-2011 
Netherlands All data 
Norway All data 
Poland All data 
Portugal 2008-2012 
Romania 2007-2009 and 2012 
Slovakia  2012 with missing data 
Slovenia All data 
Spain All data 
Sweden All data 
United Kingdom 2009-2012 
Table 5. Information on native population and global foreign population by each of 29 reporting 
countries (Sources: Eurostat and National Statistical Institutes) 
 
 Information of foreign population by country of birth/ country of nationality/ 
country of origin, is shown in Table 6 for each reporting country. Only half of all 29 
countries (14 countries, 48%) reported data on migrants specifying country of origin. 
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Country 
Foreign population by country available for 
2007-2012 
Variable 
Austria All data Country of birth 
Belgium 2007-2011/different groups each year Nationality 
Bulgaria All data Nationality 
Cyprus 2011 Country of birth  
Czech Republic 2010-2012 Nationality 
Denmark All data Country of origin 
Estonia 2011 Country of birth 
Finland All data Country of birth 
France 2009-2010 Country of birth 
Germany All data Nationality 
Greece Not provided - 
Hungary 2007-2011 - 
Iceland 2008 and 2010-2012 Nationality 
Ireland All data Country of birth 
Italy 2007-2011 Nationality 
Latvia 2007-2011 Country of birth 
Lithuania All data Country of birth 
Luxembourg Not provided - 
Malta Not provided Country of birth 
Netherlands All data Nationality 
Norway All data Nationality 
Poland All data Nationality 
Portugal 2008-2012 Nationality 
Romania 2007-2009 and 2012 Country of birth 
Slovakia All data Nationality 
Slovenia All data Country of birth 
Spain All data Country of birth 
Sweden All data Country of birth 
United Kingdom Not provided - 
Table 6. Data on country of origin of foreign population by reporting country. (Sources: Eurostat and 
National Statistical Institutes) 
 
  
Data analysis 
All the data provided was recoded into UNAIDS geographical areas and 
restructured in a unique Excel database. Descriptive trends analyses were performed 
for the two main variables retrieved.  Two different analyses were performed: 
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a) Trend analysis of cumulative number of global foreign population only. 
Countries with complete information for all years within 2007-2012 
were included. 
b) Trend analysis of cumulative number of foreign population by country 
of origin. Only countries with complete information for all years within 
2007-2012 and without major changes in the classification of migrant 
groups were included. 
 
Due to data availability restrictions, analyses were repeated only for the years 2008 
to 2011. 
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5.1. Results for Objective 1: To describe European countries' 
policies regarding HIV diagnosis and testing in migrant 
populations and ethnic minorities in 2010. 
 
 The content of the documents retrieved was organized and described following 
these sections: 
 Rationale for early HIV testing 
 Migrants and ethnic minorities vulnerable populations for HIV 
 Reasons for considering migrant and ethnic minorities vulnerable to HIV. 
 HIV testing recommendations addressing migrants and ethnic minorities  
 HIV testing sites: importance of community settings for migrants and ethnic 
minorities  
 Legal consequences of HIV testing for migrants 
5.1.1. Rationale for early HIV testing 
Documents from seven countries (Denmark, France, Norway, Portugal, Spain, 
Switzerland and the United Kingdom) discuss the benefits of early HIV diagnosis at 
both individual and community levels.  
At the individual level; cART reduces HIV related morbidity and mortality.  At 
the community level, HIV testing and counselling may reduce transmissibility through a 
reduction in high risk practices and through identifying subjects who can undergo HIV 
treatment, thus reducing HIV potential infectivity. 
Testing and counselling are also reported to be linked to positive behavioural 
change, which is linked to a reduction in high-risk practices, although the French 
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Guidelines underline this has only been documented for HIV-positive individuals. The 
UK Guidelines describes that long pre-counselling can be replaced by brief pre-test 
information about the benefits of testing, its voluntary nature and the need of 
requesting informed consent.  
Post-test counselling content depends on test results. In case of a positive test, 
some documents stress that the person should receive information about HIV 
transmission and safe behaviours to decrease the risk of transmission to others. At the 
same time, adequate referral to specialized services in order to evaluate the initiation 
of cART is mentioned in most documents. 
5.1.2. Migrants and ethnic minorities as vulnerable populations for HIV 
Table 7 summarizes if countries consider or not migrants and ethnic minorities 
as vulnerable populations for HIV, based on their national policy documents (provided 
by Country Representatives or found trough the web search). Some countries, but not 
all, identify migrants and/or ethnic minorities as groups at risk for HIV infection (see 
Figure 7). The arguments are based on migrant/ethnic minorities' high HIV prevalence 
and/or on high risk behaviours (sexual behaviour and injecting drug use).  
The higher proportion of delayed HIV diagnosis in migrants is also mentioned, 
linking this to barriers to access health care and increased social vulnerability. 
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Approach Countries 
Identify migrants as vulnerable to HIV 
Belgium, Bulgaria, Denmark, Finland, France, 
Germany, Iceland, Ireland, Italy, Lithuania, 
Luxembourg, Malta, Netherland, Norway, Poland, 
Portugal, Romania, Slovakia, Spain, Sweden, 
Switzerland and UK 
Do not identify migrants as 
vulnerable to HIV 
Cyprus and Slovenia 
Identify ethnic minorities as 
vulnerable to HIV 
Bulgaria, Slovakia*, Romania** and UK*** 
Do not identify ethnic minorities as 
vulnerable to HIV 
Belgium, Cyprus, Denmark, Finland, France, 
Germany, Iceland, Ireland, Italy, Lithuania, 
Luxembourg, Malta, Netherlands, Norway, Poland, 
Portugal,  Slovenia, Spain, Sweden and Switzerland 
No data (no documents provided by 
country representatives or found in 
web research) 
Austria, Czech Republic, Hungary, Estonia, Greece, 
Latvia and Liechtenstein 
Table 7. Countries identifying migrants or ethnic minorities as vulnerable populations to HIV infection 
(from both documents provided by National Representatives or found trough the web search).(*) It 
considers some marginalized groups coming from different ethnic or social environments (Roma, 
homeless, refugees)(**) Roma people are identified as part of disadvantaged communities(***) In the 
UK, Black and Ethnic Minorities (BME) are identified as vulnerable to HIV in the National Strategy 
although the UK National Guidelines of HIV Testing 2008 does refer to migrants rather than BME.  
 
In the documents, migrants are mainly defined based on their region of origin. 
Overall, 22 of the 31 countries (71%) identify migrants as populations at risk for HIV 
infection and specifically mention people from high HIV prevalence regions such as SSA 
and the Caribbean, and some specific groups from Eastern Europe, Asia and South 
America. 
The specific groups of migrants mentioned in the documents are contained in 
Table 8.  
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Country Groups mentioned 
Belgium Migrants 
Bulgaria  Migrants and mobile populations 
Denmark 
Migrants from Africa, Asia, South America and Eastern Europe. 
Anyone who has had sex with persons from high risk areas or 
has been in such areas 
Finland Migrant populations 
France  
People originating from regions of high prevalence countries 
(SSA and  the Caribbean)  
Germany 
People with migration background; specifically those coming 
from high prevalence countries (>1%) (SSA, Asian and Eastern 
Europe). 
Iceland Migrants 
Ireland High prevalence countries 
Lithuania Migrant populations 
Luxembourg 
People from SSA, Asia, Eastern Europe. Target groups of 
residents with foreign origin (especially Luxophon community) 
Malta Migrant populations 
Netherlands High HIV prevalence countries  (SSA) 
Norway 
Asylum seekers, refugees and people with a migrant 
background from high prevalence countries 
Poland Migrants 
Portugal  Migrants, Refugees and Displaced persons 
Romania  Roma communities 
Slovakia 
Migrants- all foreigners coming to Slovak Republic for a long 
time 
Spain Migrants 
Sweden People from foreign backgrounds 
Switzerland People from countries with a generalized epidemic 
UK  High HIV prevalence countries 
Table 8. Groups of migrants considered as vulnerable for HIV 
 
Some documents only use the term “migrant” and fewer documents refer to 
ethnic minorities. Only Bulgaria, Slovakia, Romania and the UK identify ethnic 
minorities as vulnerable to HIV. The Romanian Guidelines published on 2007 explicitly 
acknowledge the vulnerability of Roma people given their high prevalence of risk 
contexts and behaviours. The Bulgarian HIV National Program also supports this and 
the Slovakian program goes as far as to consider Roma community as part of 
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marginalized groups coming from different ethnic or social environments. Black and 
minority ethnic groups (BME) are identified as vulnerable for HIV infection in the UK 
National Strategy although the National HIV Testing Guidelines, issued on 2008, refer 
to migrants rather than BME. 
5.1.3. Reasons for considering migrant and ethnic minorities as 
vulnerable to HIV groups. 
The reasons for increased vulnerability to HIV infection included in the 
documents reviewed were: the social, economic and legal problems these groups are 
confronted with and the issues arising from culture and gender differences. Regarding 
social vulnerability, documents mention stigma, lack of community support and 
isolation, as well as racism and discrimination (double discrimination for being a 
migrant and HIV-positive).  
These are key issues, since social networks are fundamental for supporting, 
both emotionally and economically, the migrant population. Legal vulnerability for 
migrants is related to fear that disclosure of HIV status could affect migrant status and 
visa application process. In some countries, test on arrival is compulsory to enter the 
country.  
On the whole, the documents justify these recommendations to provide early 
and appropriate HIV counselling, referral and care. Four documents (from France, Italy, 
Spain and the UK) mention the higher proportion of delayed HIV diagnosis in migrants, 
attributed to barriers to access health care such as stigma, lack of community support, 
isolation, racism and double discrimination for being an HIV-positive migrant. Cultural 
vulnerability arises from different concepts of health in general and HIV in particular. 
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Other cultural aspects, such as religion and language, represent additional barriers to 
access prevention and care.  
A disadvantaged socio-economic situation (poverty, low education, 
unemployment or poor working conditions) is also taken into account in a number of 
documents (from Bulgaria, Germany, Italy, Luxembourg, Romania and Spain) together 
with the higher vulnerability of some migrant women due to their deprived 
socioeconomic conditions and low status and empowerment.   
Since migrants largely come from traditional societies, double moral standards 
to judge female and male sexual behaviour take place. In addition, the French 
Guidelines and the Spanish Plan on HIV/AIDS describe how women may be exposed to 
gender violence, a source of vulnerability for HIV infection; women in abusive 
relationships have increased risk of HIV infection because of fear to oppose coercive 
sex. 
5.1.4. HIV testing recommendations addressing migrants and ethnic 
minorities  
Even though 22 country representatives or national documents explicitly 
acknowledged that migrants were vulnerable to HIV infection (Table 7), not all 
explicitly recommend HIV testing for migrants (Table 9).  
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Approach Countries 
Recommend HIV 
testing for migrants 
Belgium, Bulgaria, Denmark, Finland, France, Iceland, Lithuania, 
Luxemburg, Netherlands, Norway, Poland, Romania, Slovakia, 
Sweden, Switzerland and UK  
Do not recommend 
HIV testing for 
migrants 
Austria, Cyprus, Estonia, Germany, Greece*, Hungary, Ireland, Italy, 
Latvia, Malta, Portugal, Slovenia and Spain 
Do not recommend 
HIV testing for ethnic 
minorities** 
Austria, Belgium, Bulgaria, Cyprus, Denmark, Estonia, Finland, France, 
Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, 
Luxemburg, Malta, Netherlands, Norway, Poland, Portugal, Romania, 
Slovakia, Slovenia, Spain, Sweden, Switzerland and UK 
No data Czech Republic and Liechtenstein 
Table 9. Countries recommending HIV testing for migrants and ethnic minorities (information provided 
by National Country Representatives).(*) Country representative informed that by 2013 Greece would 
publish new HIV testing procedures that recommend HIV testing for migrants. (**) None of the countries 
with data provided by National representatives recommend HIV testing for ethnic minorities. 
 
  
 On the whole, 16 countries explicitly recommend HIV testing in migrant 
population while none recommend it in the case of ethnic minorities. The groups 
expressly stated in each country’s document to be offered testing are described in 
Table 10. Some countries refer generically to “migrant populations” while others are 
more specific with their recommendations and mention “migrants originating from 
high prevalence countries”. 
  
5. Results                                          Débora Álvarez del Arco 
90 
Country Groups mentioned 
Belgium  Migrant population  
Bulgaria  
Refugees and asylum seekers; persons from high HIV prevalence 
countries and their sexual partners  
Denmark  
Persons from Africa, Asia, South America and Eastern Europe 
Finland Migrant populations 
France  High HIV endemic countries, especially SSA, Caribbean 
Iceland  
All migrants intending to stay for over 1 year in Iceland as part of 
general health screening 
Lithuania  Migrant populations 
Luxembourg  
People from SSA, Asia, Eastern Europe. Target groups of 
residents with foreign origin (especially Luxophon community) 
Netherlands  
High HIV prevalence countries (SSA, Surinam, Netherlands 
Antilles, South America, Eastern Europe and Asia); partners of 
people from HIV endemic area 
Norway  People from high HIV endemic countries 
Poland  
All migrants are offered to have a voluntary HIV test on arrival as 
part of general health screening. 
Romania Migrant populations 
Slovakia  
All migrants to have an HIV test on arrival as part of general 
health screening 
Sweden  People from high endemic areas 
Switzerland  People from countries with generalized epidemic 
UK  People from high HIV prevalence countries 
Table 10. Groups of migrants targeted for HIV testing. (*) Country representative informed that by 2013 
Greece would publish new HIV testing procedures that recommends HIV testing in individuals originated 
from generalized epidemic countries (Sub-Saharan Africa) and men and women who report sexual 
contacts with individuals originated from high prevalence countries 
 
Documents from Denmark, France and the UK recommended frequency of HIV 
testing for migrants. Denmark recommends testing on the first contact with the health 
care system (regardless of the reason), whereas France and the UK recommend to 
perform systematic screening for people originating from regions of high HIV 
prevalence. French Guidelines also suggest repeating HIV testing every year for 
persons with multiple partners originating from sub-Saharan Africa and the Caribbean.  
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5.1.5. HIV testing sites: importance of community settings for migrants 
and ethnic minorities 
Documents from various countries highlight the importance of identifying the 
most appropriate setting and the need to broaden the scope of health services 
performing the test to be able to scale up HIV testing in migrant populations (Belgium, 
Bulgaria, France, Luxembourg, Norway, Portugal, Romania, Spain, Switzerland and the 
UK). In this line, documents from Belgium, Bulgaria, France, Norway, Portugal, Spain, 
Switzerland and the UK mentioned the benefits of HIV testing in community settings 
where people who would not be reached through conventional services can be 
accessed. In this regard, NGOs and Community Based Organizations (CBOs) are settings 
explicitly identified as suitable. The use of rapid HIV tests in community settings is also 
mentioned in six documents (Bulgaria, France, Portugal, Spain, Switzerland and the UK) 
as being progressively accepted to increase HIV testing uptake in people who would 
not be reached otherwise. 
The participation of the community is also identified as essential in the design 
of interventions aimed at increasing HIV testing in these populations. Trust in 
“community pairs” can contribute to success if initiatives are developed with the 
community. The use of rapid HIV tests in community settings is being progressively 
accepted as it allows reaching people who would not be reached otherwise, and gives 
the chance to know the result immediately. 
5.1.6. Legal consequences of HIV testing for migrants 
Fear that disclosure of HIV status would affect migrant status and Visa 
application process is mentioned in Ireland as a disincentive to testing. In France, a 
law82 allows irregular migrants to obtain the residence permit if they are diagnosed 
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with a serious disease as HIV and treatment is not accessible in their country of origin. 
The German Guidelines state that migrants of uncertain status involved in a 
deportation process will not be deported if antiretroviral treatment is not available in 
their home country. Iceland, Poland and Slovakia offer HIV testing upon arrival as part 
of general health screening claimed to provide early and appropriate HIV counselling, 
referral and care.  
In Slovakia, all foreigners staying for a period longer than three months due to 
studies or work are required to undergo an HIV test. An HIV-negative result is required 
for their sojourn permit and they can be requested to undergo HIV-testing by the 
police if they cannot provide a document confirming HIV-negativity.  
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5.2. Results for Objective 2: To describe International 
Organizations recommendations regarding HIV diagnosis 
and testing in migrant populations and ethnic minorities 
in 2010. 
 
A review of the documents is summarized in Table 11, published by 
international organizations (WHO, UNAIDS, IOM, ILO, IUSTI).  
Document Organizations 
Year of 
publication 
Populations identified as 
most-at-risk 
Dublin Declaration on 
partnership to fight HIV/AIDS in 
Europe and Central Asia 
Country 
representatives 
2004 
Migrant populations which 
have close links to high 
prevalence countries 
IOM Guide for HIV Counsellors  
International 
Organization for 
Migration (IOM) 
2006 Migrants and refugees 
HIV and International Labour 
Migration. 
International Labour 
Organization  (ILO), 
International 
Organization for 
Migration (IOM), Joint 
United Nations 
Programme on 
HIV/AIDS (UNAIDS) 
2007 
International labour 
migration, or the 
movement of people 
across national borders for 
employment 
2008 European Guideline on HIV 
Testing  
The International 
Union against 
Sexually Transmitted 
Infections (IUSTI) 
2008 
People from countries with 
a high prevalence of HIV 
infection 
Guidance on provider-initiated 
HIV testing and counselling in 
health facilities.  
World Health 
Organization (WHO), 
Joint United Nations 
Programme on 
HIV/AIDS (UNAIDS) 
2007 Migrants and refugees.  
Scaling up HIV testing and 
counselling in the WHO 
European Region. 
World Health 
Organization (WHO) 
2010 
Some migrant and mobile 
populations; national 
minorities 
Table 11. Identification of migrants and ethnic minorities at risk for HIV infection in International 
documents 
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5.2.1. Data on HIV testing in migrant in the International Organizations 
(IO) documents. 
 Data about HIV testing in migrant contained in these documents have been 
organized in the following sections: 
 The importance of encouraging HIV testing 
 The importance of counselling, pre and post-test information 
 HIV testing sites: importance of community settings for migrants and ethnic 
minorities 
 Legal issues regarding access to treatment 
 Legal issues related with HIV testing at arrival 
5.2.2. The importance of encouraging HIV testing 
Most documents explicitly identify the benefits of HIV testing at individual and 
community level. The benefits derived from cART uptake are noted; overall increase of 
life expectancy, decrease of morbidity and mortality and reduction of mother to child 
transmission; testing HIV positive can also lead to behaviour change and prevention of 
further HIV transmission. On the same line, the reduction in HIV viral load - and thus 
transmission risk - derived from cART uptake is one of the main benefits at community 
level. The 2010 WHO Guide49 states: “the importance of this for HIV prevention is 
enhanced in settings where antiretroviral treatment (cART) is available and accessible 
to all who need it, given its value in reducing viral load and the amount of virus 
circulating in the community”. WHO guidelines support the implementation of 
Provider-initiated HIV testing and counselling in health care settings (PITC) in countries 
with generalized HIV epidemics and a favourable context, and in selected health care 
settings in countries with low prevalence or concentrated epidemics. PITC is based on 
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the recommendation of test performance by health providers to people attending 
health services.  
This recommendation is not necessarily directed towards the whole population, 
but can target people with high risk exposure when the HIV epidemic is concentrated 
in “key populations at risk”.    
 All these international guidelines identify migrants as at risk for HIV infection 
but only three49;71;83 explicitly recommend testing them for HIV infection, as seen in 
Table 12.  
Document Subjects identified as candidates for HIV test 
2008 European Guideline on HIV Testing 
(IUSTI, 2008) 
Individuals who had sexual exposure in 
countries with a high HIV prevalence 
Guidance on provider-initiated HIV testing 
and counselling in health facilities. (WHO, 
UNAIDS, 2007) 
Migrants and refugees.  
Scaling up HIV testing and counselling in the 
WHO European Region.(WHO, 2010) 
Migrants/mobile populations; ethnic /national 
minorities. Healthcare settings and other 
community settings 
Table 12. Documents that recommend HIV testing migrants and ethnic minorities 
 
5.2.3. The importance of counselling, pre and post-test information 
Guides elaborated by IUSTI, IOM, WHO and UNAIDS collect practical 
information about the desirable contents of Pre and Post counselling. IOM has 
developed a specific document for counsellors: IOM Guide for HIV Counsellors84, in 
which the characteristics and content of counselling process are carefully specified.  
Regarding pre-counselling, IUSTI states that the main objective of this phase is 
to obtain informed consent and establish a pre-test discussion about HIV issues with 
the client, while IOM considers that pre-counselling is the best opportunity to educate 
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and inform individuals on HIV and AIDS. In the IOM guide, this moment is weighed up 
as a process that can help to reduce stigma in the community.  Guides developed by 
WHO and UNAIDS are based on PITCS, and the principal aim of this stage is to discuss 
with the patient the reasons of HIV testing recommendation. This guide states that 
counselling can be performed both individually and in a group session.  
Guidelines consider post-test counselling as a part of HIV testing process 
regardless of test result, although content varies depending on the result. Overall, for 
those testing negative, this moment would be employed to stress health benefits of 
prevention strategies. For positive results, post-counselling has to satisfy all questions 
related with care referral, information about transmission routes and risk behaviours. 
Moreover, at this stage the individuals should be given information on key institutions 
or other resources that can provide them with emotional support to cope with the 
result. 
5.2.4. HIV testing sites: importance of community settings for migrants 
and ethnic minorities 
The document “Scaling up HIV testing and counselling in the WHO European 
Region”49 points out the existing barriers to access traditional health services for most-
at-risk populations. Strategies aimed at increasing access and uptake of HIV testing has 
to be developed. The community’s participation in the design of interventions is 
necessary in order to identify adequate and acceptable practices related with HIV 
testing71. Examples proposed by documents, based on client-initiated strategy, include 
outreach programs: services by mobile clinics or in community settings. The principle 
behind it is to offer the HIV test “where they are”, through non-governmental and 
community-based organizations. 
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ILO guide addresses the importance of “ensuring, through funding public-health 
services, non-governmental and private organizations that international labour 
migrants and their families have the same access as nationals to HIV prevention, 
treatment, care and support programmes which are sensitive to gender and culture, 
and in a language or medium the migrant worker can understand”.  
5.2.5. Legal issues regarding access to treatment  
One of the objectives proposed by the Dublin Declaration (2004)21 was “By 
2005, provide universal access to effective, affordable and equitable prevention, 
treatment and care including safe anti-retroviral treatment to people living with 
HIV/AIDS in the countries in our region”. Despite efforts made in this direction, there 
are still many countries in which migrants of uncertain status have no formal access to 
HIV treatment.  
The 2010 WHO guide states that testing by itself is not the goal: “The ultimate 
goal is not simply to increase access to and uptake of HTC, but to support HIV 
prevention and provide treatment (including ART), care and support to all who need 
it”. Countries have to ensure care and referral to those individuals tested. The 
document expresses concern about the lack of treatment in many countries of the 
region, especially for the most marginalized populations like migrants, and stresses the 
need to expand cART coverage to these vulnerable populations.  
5.2.6. Legal issues related with HIV testing at arrival 
In some countries, migrant populations and asylum seekers are required by law 
to have an HIV test upon arrival in the country. In other countries HIV test at arrival is 
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recommended but remains voluntary. The 2010 document from the WHO denounces 
that “The purpose of such testing is not to provide access to HIV prevention, 
treatment, care and support, but most often to exclude people with HIV from access to 
certain services, or otherwise impose restrictions on them. Such mandatory or 
compulsory forms of testing violate ethical principles and basic rights of consent, 
privacy and bodily integrity; they cannot be justified on public health grounds”. In the 
same document, WHO demands the abolition of any law, policy or regulation that 
contemplates any mandatory HIV test, based on the ethical principle of voluntariness 
of the HIV test.  
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5.3. Results for Objective 3. To analyse available evidence on 
HIV testing and counselling strategies targeting migrants 
and ethnic minorities in high-income countries. 
 
The selection of available evidence on HIV testing and counselling strategies 
resulted, on the whole, on the inclusion of 37 articles in the in-depth analysis of the 
systematic review. The majority of the studies were conducted in Anglo-Saxon 
countries – 12 in the United States (US), four in Canada, 13 in the UK, and eight from 
other European countries. None of the articles were from Australia. Most studies 
(n=35) were conducted in a single country, most (n=20) had a local scope. Studies were 
conducted in health settings (n=15) and community settings (n=11). All the articles 
description is included in APPENDIX 14. 
 Regarding methodological approaches used, 25 studies (68%) used quantitative 
methodology, two combined quantitative and qualitative methodology, six used 
qualitative methodology and four were literature reviews.  
 Operational definitions for “migrant”, “race” or “ethnicity” (understood as 
concept defining racial/ethnic minorities) that were present in all papers are collected 
in Table 13.  
 In the articles, more than one definition was often present. 14 articles defined 
migrants based on country of origin, 13 on country of birth, and three on nationality. 
As regards to race and ethnicity, eight studies (mostly from US) defined subjects on 
self-reported ethnicity and nine on documented ethnicity (n=7), ethnic origin (n=1) or 
race (n=1).   
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Migrant/ethnic minority 
definition 
n 
Country of origin 14 
Country of birth 13 
Self-reported ethnicity 8 
Ethnicity 9 
Country of nationality 3 
Ethnic origin 1 
Race 1 
Table 13. Migrant/ ethnic minority definition 
 
 Migrant populations studied in EU countries were mostly Sub-Saharan 
Africans52;53;85-88, Latin-Americans86 and South Asians89. In the US studied populations 
were Hispanics or Latinos90-94, Southeast Asians95 and Africans96. Three papers studied 
asylum seekers, visa applicants and refugees97-99 in Canada and one studied adopted 
foreign children100 in the US. Racial/ethnic minorities studied were largely “Black 
communities” in the UK101-104. One study developed in the US refers to generic “racial 
minorities”105.  
The 37 studies addressed heterogeneous aspects of HIV testing and counselling 
in migrants and ethnic minorities which could be grouped as follows:  
a. Prevalence and risk factors for HIV infection 
b. Barriers to HIV testing 
c. HIV testing uptake 
d. Late HIV diagnosis 
e. Interventions to encourage HIV testing.  
5.3.1. Prevalence and risk factors for HIV infection in migrants and 
ethnic minorities 
HIV prevalence and risk factors in migrants and ethnic minorities came up 
frequently. However, the objective of this research was not to systematically review 
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HIV prevalence. Many articles include general references to this topic and studies 
which report data about differential prevalence of HIV have been included in Table 14.  
Authors 
Country/ 
Date 
Sample 
size 
Target population 
HIV prevalence/ 
incidence 
Design 
Monge-
Maillo B et 
al 
Spain 
(2009) 
2198 
Immigrants referred to 
the Tropical Medicine 
Unit of Ramón y Cajal 
Hospital (Madrid) over 
a 20-year period. 
Incidence: Total 
population: 97 (4.4%); 
Sub-Saharan Africans: 
82 (5.2%); Latin-
Americans: 15 (2.4%) 
Cross Sectional Study 
Forbes KM 
et al. 
UK (2008) 30 
Patients attending an 
outreach clinic for 
those under 25 y.o 
(Jun-Oct. 2007) in an 
area where Black and 
minority ethnic groups 
comprise the majority 
of the local population 
There were no cases of 
HIV 
A retrospective case-
notes review was 
undertaken of those 
attending community-
based sexual health 
services. (Note: Not 
clear if all respondents 
were from minorities) 
Zencovich 
M et al. 
Canada 
(2006) 
634958 
All applicants in 
Canada, 15 years of 
age and older, for 
permanent residency 
between 2002-2003 
Incidence: 932 
(0.146%). Prevalence of 
3% among applicants 
from six African 
countries (Zimbabwe, 
Burundi, Rwanda, 
Uganda, Zambia and 
Chad) 
National data collected 
by Public Health 
Agency of Canada 
Schmid J et 
al. 
Denmark 
(2005) 
DK 
Children <16 years in 
Denmark in 2003.  
Incidence: 89 (5.77 per 
100,000 children). Of 
the 89 newly 
diagnosed: 48% born in 
Denmark, 43% in 
Africa, 9% in other 
places. 
Data from the national 
surveillance system and 
HIV-infected children 
from the Danish 
Paediatric HIV Cohort 
Study 
MacPherson 
DW et al. 
Canada 
(2006) 
256970 
Residency applicants 
<15 years of age 
between 2002-2005. 
36 (0.014%), most of 
them from Africa (89%) 
Data from the 
Canadian migration 
medical examination 
register 
Perez-
Molina JA et 
al. 
Spain 
(2009) 
1609 
Immigrants referred to 
the Tropical Medicine 
Unit of Ramón y Cajal 
Hospital (Madrid) 
during 1997-2006 
77 (4.8%). By 
geographic groups: 
Sub-Saharan Africans 
(5.6%); South-Central 
Americans (3.2%) 
Non-interventional 
retrospective medical 
chart review 
Dougan, S 
et al. 
UK (2005) 1040 
Men who have sex with 
men aged 16–44 in 
England and Wales in 
2002 
Prevalence: 7.4% of 
black and minority 
ethnic MSM; 3.2% 
white MSM 
Cross-sectional study 
with the data from the 
Survey of Prevalent HIV 
Infections Diagnosed 
that estimates the 
number of individuals 
living with diagnosed 
HIV infection in E&W 
since 1995 
Table 14. HIV prevalence in migrants and ethnic minorities 
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High HIV prevalence was identified among the following groups: Sub-Saharan 
Africans in Europe, Black Africans and Black Caribbean in London, and Sub-Saharan 
Africans, Latinos and Blacks in US.  
Some authors conclude that most HIV infections in migrants are imported, 
based on epidemiological patterns in countries of origin and clinical presentations in 
countries of destination. This approach is largely applied to migrants from SSA in 
Europe (Denmark106, France107, Spain86;93, UK87;102;103) and Canada97-99. However, other 
studies consider some migrants may have acquired HIV in countries of destination due 
to unfavourable environment to encourage preventive behaviors52;108;109. In this line, 
some migrants are described as having high risk behaviours; multiple sexual partners, 
low and inconsistent condom use, high alcohol consumption and drug use90;92;110;111.  
Migrant women and ethnic minority men who have sex with men (MSM) are 
considered as especially vulnerable sub-populations. Female migrants are affected by a 
disproportionate burden of HIV infection derived from difficulties in negotiating 
condom use90 and sexual exploitation97. The invisibility of ethnic minority MSM, who 
go unnoticed by the stigma of being MSM, is thought to be key to their vulnerability to 
HIV infection. Some studies show how migrant MSM have high HIV prevalence, unsafe 
sex108 and high prevalence of late HIV diagnosis95;101. 
5.3.2. Barriers to HIV testing in migrants and ethnic minorities 
Barriers to HIV testing occur at the structural, health care provider, health care 
user and community levels.  
Structural barriers to HIV testing are related to poor living conditions, legal and 
administrative status and discrimination in countries of destination. Among barriers to 
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HIV testing and care are mentioned high levels of unemployment and poverty in 
migrants and ethnic minorities, low social status, and inequalities52;53;88;89;93;100. Studies 
from Canada, US, Spain and the UK mentioned that legal status, which ranks among 
the highest priorities, and concerns about implications of testing positive are the main 
barriers. According to these studies, migrants are reluctant to be tested in contexts 
where an HIV diagnosis may adversely affect visa or residence application or where 
there is a fear of deportation52;88;112.  
Lack of entitlement to health care for undocumented immigrants is another 
barrier, largely but not solely, mentioned in the US95;101;112. Lack of clarity among 
health care providers on migrants’ rights to health care is highlighted53.  
On the subject of stigma and discrimination, African people tested for HIV in 
London in the 1990s were twice as likely as whites to be concerned about being 
discriminated against88. Structural racism is also mentioned by Fakoya et al.53 drawing 
attention to the disproportionate number of Sub-Saharan Africans prosecuted for 
allegedly transmitting HIV infection in the UK. 
Within health care structures, communication, language problems and lack of 
cultural sensitivity and underinvestment in culturally competent services lead to 
misconceptions about migrants and minority groups by health-care providers89;93-96;110.  
‘If you don’t speak English they just ignore you, or you can’t even understand your 
name when they call it’. (extracted from Foley et al96). 
Some migrants and ethnic minorities prefer to visit medical practitioners from 
their own community100. Although some communities are described as having good 
knowledge about where to go for HIV testing, Sub-Saharan Africans in the UK52 for 
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example, other studies ascertain poor knowledge among migrant and ethnic minorities 
regarding where to get tested for HIV anonymously and free of charge52;88;91;98.  
Other barriers at health user level include the low priority migrants assigned to 
health care52;112 and their low perception of HIV risk88;91;95;101;113; migrants give priority 
to basic needs but knowing their HIV status ranks low112. Low HIV risk perception at 
individual level is mentioned, even in people with community risk 
awareness88;91;95;101;113. Researchers note there is often a gap between risk perception 
and individual risk behaviours95; some studies describe low risk perception among 
those who test HIV positive52;88;113.  
At the community level, cultural and gender norms may discourage migrant 
heterosexual men and women and MSM from seeking HIV testing. Loss of status and 
community support and social isolation following confidentiality gaps are among the 
main reasons given for not testing52;53;85;88;91;92;96;98;102;112-114.  
Prost et al88 quote Erwin and Peters115 who reported that in the nineties, 
Africans testing for HIV in a London hospital feared to be discriminated against twice 
as likely as whites. 
 “There will be hurdles for me to jump through, for me to say ‘look, accept me, I 
am me. I may be HIV positive, but don’t look at me on that surface.’ So, I think, you 
know, there’s a lot in terms of stigma that I feel still needs to be dealt with. (T8, 
woman, early 30’s)”.Extracted from Flowers et al102. 
This is a particular concern for individuals who need to bring a relative or friend 
to help with translation100. Olshefsky et al.92 report -“machismo” as a barrier among 
Latino men; Foley96 reports that women from SSA have difficulty seeking HIV testing or 
treatment without partners’ approval and economic support. 
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 ‘‘People’s biggest fear is their result being known in their particular community, 
(…) the fear of ‘do they know my auntie, do they know my…’ even if they are supposed 
to be confidential, that for me would be the biggest concern.’’ Extracted from Prost et 
al87. 
5.3.3. HIV testing uptake in migrants and ethnic minorities 
The HIV testing uptake is shown in the following table. 
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Authors 
Country/ 
Date 
Sample 
size 
Target 
population 
Test prevalence/test 
acceptance 
prevalence 
Design 
Forbes KM et 
al. 
UK (2008) 117 
Outreach clinic 
for those under 
25 in an area 
where Black and 
minority ethnic 
groups comprise 
the majority of 
the local 
population 
23% ever tested 
A retrospective case-notes 
review was undertaken of 
those attending community-
based sexual health services. 
(Note: Not clear if all respondents 
were from minorities) 
Conaty SJ et 
al. 
UK (2005) 443 
Sub-Saharan 
women in 
antenatal care 
86% accepted an HIV 
test 
Cross sectional study. HIV test 
acceptance. (Note: Prevalence 
calculated  by our research team 
based on showed article data) 
Fernandez 
MI et al. 
US (2005) 244 
Hispanic 
migrant/seasonal 
farm workers in 
southern Miami-
Dade County, 
Florida. 
21% (51/244) had been 
tested for HIV; 39% 
(94/244) declared they 
would accept on the 
day of the interview; 
69% (134/193 never 
tested) declared they 
would accept if 
recommended by a 
provider 
Cross-sectional study: 
questions about HIV test 
performance and intention to 
test 
Sadler KE et 
al. 
UK (2006) 114 
Black Africans 
(+16 y.o.) living in 
London 
82% (93/114) accepted 
HIV testing in the 
survey 
Cross-sectional study with 
offer of HIV-test  
Dowling T et 
al 
US (2007) 627 
Participants at 
Black gay, 
Hispanic gay or 
gay pride events 
24% (133) of those 
with unknown  or 
negative HIV status 
(543) accepted HIV 
testing 
Cross-sectional study with 
offer of HIV-test. (Note: Not clear 
if all respondents were from ethnic 
minorities. Of all persons willing to be 
tested, not all were finally tested for 
several reasons, mainly resource 
limitations) 
Ostermann J 
et al. 
US (2007) 146868 
Adult 
participants in 
the survey aged 
18-64  years 
Tested in past 12 
months (by ethnicity): 
White non-Hispanic, 
8.1%; Black non-
Hispanic, 19.0%; 
Hispanic, 11.7%; Other, 
9.6%.  Plan to test in 
next 12 months: White 
non-Hispanic, 5.2%; 
Black non-Hispanic, 
19.8%; Hispanic, 12.7%; 
Other, 7.1%   
Cross-sectional analysis of 
data from 146 868 
participants aged 18 to 64 
years in the 2000-2005 
National Health Interview 
Surveys. HIV test in the past 
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Authors 
Country/ 
Date 
Sample 
size 
Target 
population 
Test prev./test 
acceptance  
Design 
Tariq S et al. UK (2007) 458 
Cases were 
defined as the 
first 125 new GU 
clinic attendees 
who self-
identified as 
South Asian. 
Controls were 
defined as 
subsequent new 
presentations 
self-identified as 
non-South Asian.  
Ever tested: Cases: 60% 
(148/229); Controls 64% 
(154/229) 
A retrospective case–
control study was 
performed at a GU Clinic in 
London: HIV test in the 
past 
Huang ZJ et 
al. 
US (2008) 604 
Self–identified as 
Cambodian, 
Laotian, or 
Vietnamese, + 18 
y.o. and 
residence in 
Washington, DC 
Ever tested: Total 
sample, 31% (186/604); 
Laotians, 22% (44/196); 
Vietnamese, 37% 
(72/197); Cambodians, 
38% (79/211) 
Cross sectional study. 
Have had an HIV test 
Southgate J 
et al. 
UK (2008) 1586 
Pregnant women 
from ethnic 
minority groups 
Prevalence ratio of HIV 
test acceptance: White, 
91% (1094/1214); Black 
African, 92% (145/158); 
Asian, 90% (138/153); 
Chinese, 80% (4/5) 
Cross sectional study. 
Antenatal HIV screening 
routinely proposed 
López 
Quintero C 
et al. 
US (2005) 4261 
Hispanic 
subgroups living 
in the United 
States 
Ever tested: Total 
sample, 34% 
(1444/4261); Puerto 
Ricans, 44% (197/444); 
Mexicans, 28% 
(419/1480); Mexican 
Americans, 33% 
(355/1079); 
Cubans+Cuban 
Americans, 29% 
(80/277); Central/South 
Americans, 41% 
(259/640); Other 
Hispanics, 39% 
(133/341) 
Cross sectional study. 
Have had an HIV test (Note: 
Prevalence by our research team 
based on showed article data) 
Dougan S  et 
al. 
UK (2005) 1040 
Black and 
minority ethnic 
men who have 
sex with men in 
England and 
Wales  
Prevalence ratio of HIV 
test acceptance: 
Caribbean, 52% 
(138/265); 
Central/South America, 
60% (593/993); Sub-
Saharan African, 54% 
(473/870); Asia, 56% 
(417/739) 
Cross-sectional study with 
offer of HIV-test  
Table 15.Uptake of HIV testing in migrant and ethnic minorities 
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These studies describe an HIV testing uptake in migrants and ethnic minorities 
ranging from 21% to 73% in the US and 23% - 64% in Europe89;91;95;111;116.  Overall, a 
higher proportion of ethnic minority and migrant women have been tested for HIV 
compared with men; this is partially due to women’s acceptance of routine HIV 
screening during antenatal care104;111;114;117. However, beyond this, several studies 
support a gender difference in HIV testing uptake, with migrant men being not only 
less exposed to HIV testing but also less willing to be tested53. 
Among important determinants of test acceptance is the context in which 
testing is offered and who offers the test. For example, in a US study, 70% of Hispanic 
migrant farm workers reported they would accept HIV testing recommended by a 
health care provider, with women more likely than men to accept testing29. In 
contrast, MSM from ethnic minorities in the US were more prone to accept HIV testing 
outside health settings; rapid HIV testing of MSM in racial/ethnic minority groups in 
settings such as gay pride events is a useful way to enable HIV-infected MSM to learn 
their HIV status. 
5.3.4. Late HIV diagnosis in migrants and ethnic minorities 
High prevalence of delayed diagnosis of HIV infection in migrants and ethnic 
minorities was reported, in the UK52;53;87;88;109;112, Spain86 and France107 largely among 
Sub-Saharan Africans and in the US92;95 and Canada118 among Latinos and Asian-
Americans. 
López-Quintero et al.91 report that delayed HIV diagnoses is more frequent 
among Hispanics than whites and Afro-Americans. The article of Prost et al.88 cite the 
Health Protection Agency and the Mayisha II Study119 which estimate that by 2005, 
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approximately 21,500 Africans were living with HIV in the UK and that one-third of 
them were undiagnosed. Fakoya et al.53 report that most SSA people diagnosed with 
HIV in the UK acquired the infection in the countries of origin and tend to present with 
advanced disease. Chadborn et al.112 also in the UK, report high prevalence of late 
diagnosis in heterosexual whites (36%), black Caribbean (36%) and black Africans 
(43%). This article describes lower rates of delayed diagnosis in women diagnosed 
through antenatal testing than other people diagnosed elsewhere. For SSA, late 
diagnosis was present in 21% of women diagnosed during antenatal care, 44% of 
women diagnosed elsewhere, and 50% of men. In France, though women were less 
likely to be diagnosed late because of routine prenatal testing, this was not the case 
among migrants.  Acquisition of HIV infection at early ages prior to arrival to France 
could underlie these differences107. 
5.3.5. Interventions to encourage HIV testing in migrants and ethnic 
minorities 
The literature identified two main approaches to HIV testing: general 
population approaches in health care settings and targeted approaches aimed to HIV 
vulnerable populations, including migrant and/or ethnic minorities. In both cases, 
specific interventions to encourage the participation of migrants and ethnic minorities 
are discussed. Finally, voluntary or compulsory HIV testing strategies are analysed. 
Antenatal screening is mentioned as an example of a population-wide 
approach. Various studies support routine antenatal testing for all pregnant women as 
an effective strategy for achieving good coverage of HIV testing in migrant and ethnic 
minorities114. Along these lines, a study in Canada found that women from HIV-
endemic countries prefer non-targeted strategies integrated within health services98 to 
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avoid discrimination. Some countries have taken targeted approaches to HIV testing in 
antenatal care. For example, Denmark substituted routine antenatal HIV testing to HIV 
selective antenatal screening in 1995. Following this approach, HIV testing was only 
offered to women from high prevalence countries since almost all HIV-positive 
pregnant women identified were migrants or married to migrants from high 
prevalence countries106. However, a few HIV-positive babies were born subsequently, 
resulting in the reintroduction of universal screening.  
Health care provider endorsement was identified as a significant predictor of 
HIV testing. A number of authors recommend mixed approaches; introducing HIV 
screening in routine medical practice in addition to targeted strategies in place, 
particularly in areas with high HIV prevalence and a concentration of migrant 
population98;111;113;114.  
Many authors stated that culturally sensitive HIV testing and counselling 
interventions are needed to improve institutional access to health services and to 
promote HIV testing among migrants and ethnic minorities52;98;111. Community 
partnerships and participation are identified as critical to increase HIV testing uptake. 
The Burns et al. study developed in the UK, calls for community involvement in 
promoting testing along with the benefits of accessing cART52. In other studies, 
provision of testing services in client’s language is also mentioned98;110. 
Innovative targeted approaches to reach people who might not otherwise use 
testing services are also mentioned. Among other interventions, the provision of HIV 
rapid testing in non-traditional health care settings outside normal working hours111 is 
included. Provision of Point of Care Testing by NGO and CBO and testing by outreach 
services, mobile clinics and in venues such as barber shops and hair salons, social clubs, 
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sporting events or street corners92;105 are recommended. To increase uptake among 
MSM are considered interventions such as offering HIV testing at gay pride events105, 
saunas113 and other venues.  
Finally, some studies described the HIV screening on arrival in the host country, 
which is specific for migrants. US policy requires HIV testing for asylum seekers120 and 
in 2008, when the Jones et al. article was published, those who were HIV-infected 
could only obtain temporary admission to the US. Children who arrive in the US 
needing a permanent visa are required to be screened for HIV, hepatitis B and C, and 
tuberculosis, and screening is repeated 6 months after arrival. The implications of HIV 
test results for visa status are not discussed100. In Canada HIV testing is also mandatory 
for migrants and asylum seekers entering in the country. Screening includes clinical 
referral and information that is sensitive to the gender, cultural and linguistic profile of 
the client97;99. This approach is reported to have resulted in an increased number of 
cases of HIV diagnosed in immigrants and uptake of health care in this country118. 
Delpierre et al. article recommends offering HIV testing to migrants on arrival to 
reduce late diagnosis107.  
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5.4. Results for Objective 4. To examine the challenges for 
implementing and expanding HIV testing and counselling 
strategies targeting migrants. 
 
The aim of this section is to evaluate how the key informants felt the 
recommendations regarding HIV testing in migrants and ethnic minorities were being 
implemented and intends to identify best practices in terms of increasing testing 
uptake in migrants and ethnic minorities ensuring high quality services in the EU/EFTA 
Member states.  
5.4.1. Perceptions about general population HIV testing approaches, 
opt-out HIV routine screening with no lengthy pre-test 
counselling 
Interviewees felt that recommendations aiming for a general population HIV 
testing approach with no lengthy pre-test counselling in areas with a high HIV 
prevalence would increase the number of HIV tests performed in migrant populations 
and ethnic minorities, but also described both advantages and disadvantages to this 
approach. Participants insisted on legal and administrative barriers specific to migrants 
only.  
This general population approach is viewed as having the advantage of not 
selecting people on the bases of their skin colour or region of origin which can be 
perceived as discriminatory by service users and to being uncomfortable for service 
providers. Indeed, health care providers in general medicine settings do not like, on 
the whole, screening by other than medical reasons; they are happier recommending 
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an HIV test for someone with tuberculosis, but feel less comfortable asking a black 
woman from Sub-Saharan Africa because of her origin.  
“Migrants don’t like being offered an HIV test because they are black or foreign-looking so, 
from that point of view, a general strategy in primary care seems good. However, 
communities do not necessarily know that they are being offered the test on a routine bases 
together with the general population so, there is a need to communicate this message” 
Academic researcher 
 
Among the disadvantages interviewees described were: danger of coercive 
testing with implications on their residency permits, fear of deportation and lack of 
rights to access treatment and care for the undocumented migrants. Fear of being 
discriminated against and of being deported was quoted by various interviewees as 
the strongest barriers to HIV testing in migrant populations. Discussions around the 
stigma and fear of discrimination surrounding HIV infection came up and how, for 
migrants, many of whom rely for day to day survival on the support from their own 
community network, this had additional implications. Criminalization of HIV 
transmission was also mentioned and how court case was felt to have 
disproportionally affected migrants from Sub-Saharan Africa in some countries. 
“Stigma around HIV in the countries of origin of some migrants is very strong and perhaps 
they bring it with them when they move to a new country. (...) When an HIV-positive result is 
given, there is a brutal drop in self-esteem, because the previous concept that they had had 
about HIV was so negative. If this can be true for most of the population, for some immigrants 
it is even worse.”   
NGO representative 
“We are not in the game of playing into stigma – we need to reduce late diagnosis and HIV 
related mortality”. 
Public Health Researcher. 
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A number of respondents identified the success of antenatal testing of HIV as a 
good example of how an opt-out approach was a good strategy that has led to 
dramatic reduction in mother to child transmission of HIV in Europe. It was also 
pointed out that issuing recommendations for HIV testing to the general population 
accessing health care setting is not the absolute solution for reaching the most 
vulnerable; the people who do not access health care services. 
Regarding an abridged pre-test counselling, there were mixed opinions. Many 
participants felt it was a good strategy as lengthy pre-test counselling may dissuade 
people from testing. Migrants are usually overwhelmed by the different issues and 
events related to their adaptation to a new country making them avoid time-
consuming activities. Besides, the concept of counselling might not necessarily be 
understood by most of them. On the other hand, some participants fear that an 
abbreviated counselling might be insufficient to tackle migrants’ misconceptions 
regarding HIV infection. 
“I am ambivalent about the idea of shortening the pre-test counselling as migrants and ethnic 
minorities. At least in London, migrants and ethnic minorities still need discussion to discard 
misconceptions about HIV and fight stigma at community level.”  
Academic researcher 
“Although I see the advantages of shortening testing time, I fear the most vulnerable will not 
benefit from HIV counselling”. 
Policy maker 
“Counselling skills should be acquired by any health professional working in HIV testing sites. 
Our institute has been conducting counselling training courses for many years. The 
relationship established between the person and the information and helping line operator is a 
professional one and cannot be improvised” 
Academic researcher 
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5.4.2. Opt-out routine HIV testing for the general population and 
targeted approaches; recommendations and implementation 
issues for migrants and ethnic minorities 
Results from studies and initiatives to promote HIV testing in migrants were 
described by the participants, who also mentioned inconsistencies within one country 
regarding testing recommendations for migrants and ethnic minorities. Respondents 
from the UK acknowledged that implementation of their guidelines based on an Opt-
Out strategy was a real challenge. In Portugal, preliminary data from Lisbon show very 
high uptake of HIV tests by Portuguese speaking migrants, highlighting the importance 
of the language. In The Netherlands, migrants registering at the city hall are provided 
with HIV testing information but this has failed to increase HIV testing uptake.  
Generally, participants underlined the need to place in a global frame all the 
described initiatives, addressing also other complex issues. 
“Individual strategies to fight HIV are necessary but not sufficient. We must address the social 
determinants of health such as poverty, access to health care, racism and discrimination” 
Policy maker. 
 
The misconceptions and assumptions about migrants and ethnic minorities 
came up in the discussions as a barrier to the correct implementation of testing 
guidelines.  Since each migrant community has its specificities, highlighting the need to 
incorporate a trans-cultural vision in the implementation of programs was also 
mentioned.  
Targeted approaches are considered as more cost effective interventions. 
However, a number of participants believed that a general population approach may 
be more acceptable to service providers and users. Service providers prefer to offer 
screening for medical reasons.  
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“Epidemiologically and financially it makes sense to talk of high prevalence groups – for 
example, migrants from sub-Saharan Africa and men who have sex with men – but it doesn’t 
make sense in terms in delivering services and the risk of discrimination and stigma. The 
history of migrants is different from that of men who have sex with men. The latter had a solid 
network of solidarity that helped them to withstand potential stigma and discrimination, 
whereas migrants do not. Although it is tempting epidemiologically to target them as a group, 
the strategy needs to be embedded in the general population” 
Group interviewee 
5.4.3. Promoting HIV testing for migrants of uncertain residency status 
when access to antiretroviral treatment is not guaranteed. 
Participants felt this was a very difficult though timely question that raised a 
number of ethical issues. On the whole, the unanimous feeling was that HIV testing 
must be linked to care for the program to be effective. However, they also 
acknowledged that, unfortunately, even in Europe, there are some migrants of 
uncertain residency status that are not entitled to antiretroviral treatment. There were 
mixed views on what to do which ranged from not recommending HIV testing unless 
access to antiretroviral medication can be guaranteed to recommending the test in 
spite of this while highlighting the need of trust building and avoidance of paternalism.  
“It is clear that it makes no sense to perform the test when the disclosure of a positive result 
does not guarantee access to care (...). Denying access to care is opposite to Human Rights 
Declaration, in which access to health care is guaranteed to all individuals. It is a paradox to 
allow the person to access the test and then not allowing them to be treated. (...)” 
Academic researcher 
“HIV testing on its own has been proven to be good, it has been shown to be beneficial in 
reducing unsafe sexual behaviour and thus, decreasing HIV transmission. Besides, even if cART 
may not be entitled, other supportive care aspects can be provided such as prophylaxis and 
treatment against opportunistic infections”.  
Policy maker. 
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“What is the result if you say to someone you are HIV positive but you don’t have access to 
treatment, to housing, to social help; it is terrible to do this to someone. We have to test 
people because we have solutions, so we have to defend a package of testing, good access to 
treatment and access to social rights, and then people can go to hospital, quietly take the 
treatment. But when you arrive to the country you don’t have papers, you don’t have anything 
and then we say to you just that you are an HIV positive, it is terrible to do that”. 
NGO representative. 
“It is a human rights issue, it hasn’t gone away and the nature of this problem has not 
changed: it is a human rights problem: you shouldn’t offer testing to anyone who you then 
can’t treat, and treatment for HIV should be available without any economic implications for 
the person, to everyone. That is a basic public health concept, we do it for TB, and we do it for 
other things. Why can’t we get this happening for HIV?”  
NGO representative. 
5.4.4. On-going initiatives promoting HIV testing in the community 
targeting migrants and ethnic minorities 
Promoting HIV testing in the community was viewed as one of the key aspects 
to the success of the implementation of guidelines. Developing POCT (point of care 
testing) within CBOs and NGOs was seen as an excellent initiative by most 
respondents.  
Participants stressed the need to find strategies that were both flexible, 
allowing migrants to access HIV tests in their community organizations’, and, at the 
same time, guarantee the maximum quality in the whole testing process; 
confidentiality, post-test counselling and immediate health care referral should not be 
compromised and should fulfil all ethnical and technical requirements. Confidentiality 
concerns are behind some people not wanting to be tested in their own community, 
preferring to attend an STD clinic far from their homes. Developing more CBO POCTs 
that provide people with information about where these sites are located is essential. 
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Unsupervised HIV testing could lead to undocumented migrants being forced into 
being tested without appropriate counselling and health care referrals.  
5.4.5. Feminization of the HIV epidemic in migrant women in Europe 
versus feminization of HIV testing. How to reach heterosexual 
migrant men? 
All respondents agreed that migrant heterosexual males were hard to reach. 
Those familiar with the high proportion of women among HIV-cases in Sub-Saharan 
Africans in surveillance reports felt that a diagnostic bias is certainly present, as 
women get tested during their pregnancy. They admit that there are few initiatives 
targeting heterosexual men. Strategies proposed by participants were to extend 
testing sites opening hours, organize outreach activities targeting men such as testing 
in work and community settings, faith communities and local championships. They also 
suggested partner services as well as couple testing in antenatal care.  
“The role of caring for the family, caring for the health of the family, getting information about 
health, accessing health care, you cannot think they should be the same in every culture. In 
some cultures these roles are more gender-specific defined, and that means it is difficult to 
reach the men directly, but it doesn’t mean you can’t reach the men, you may need to reach 
the men through the women. The solution is not necessarily (and we don’t have any project 
that does that) to target heterosexual men from Sub-Saharan Africa for testing; that may 
make sense on paper, because you want to increase the number of heterosexual men from 
Sub-Saharan Africa that take the test, but it may in fact work better if you try to reach these 
men through the women”.   
NGO representative. 
“Perhaps, migrant women have less internalized the concept of gender equality between men 
and women, and this is an additional barrier for defending the rights of girls and women 
within their communities. It is very important that women have the information on how to 
access health care, particularly because women are the ones conveying family health care”.  
Policy maker. 
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“It can be dangerous because a lot of women are not happy about disclosing her status to 
their partners (…) Part of the emphasis of community services is to reach men who don’t 
necessarily go to health services, including STI services, so those point-of-care-in-community 
testing projects are about looking at what is engaging men in other settings different from 
health care settings” 
Group interview 2. 
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5.5. Results for Objective 5: To describe HIV/AIDS 
epidemiology between 2007 and 2012 in male and female 
migrant populations in Europe. 
5.5.1. Epidemiological characteristics by geographical origin and sex 
 Of the 148,815 HIV diagnoses reported from 2007 to 2012 with information on 
GO, 110,103 were males (74%) and 38,712 females (26%). Migrants accounted for 
57,133 (38% of the cases). Among males, 32,677 cases (29%) were reported in 
migrants and among women 24,456 cases (63%) were reported in migrants. Migrants 
accounted for 56,573 (41%) in Western EE/EEA countries, 530 (5%) in Central EE/EEA 
countries and only 30 (2%) in Eastern EE/EEA countries (Baltic States). 
 For all migrant cases with information on GO, the commonest geographical 
origin, accounting for 52% (29,845) was SSA, followed by 21% (11,933) from other 
European countries and 13% (7,181) from LA (Table 16). 
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GO Total Male Female 
Natives 91,682 77,426 14,256 
Sub Saharan Africa 29,845 11,960 17,885 
West 11,689 5,316 6,373 
Central  7,033 2,509 4,524 
East 9,276 3,415 5,861 
Austral 1,575 599 976 
Unknown 272 121 151 
Europe 11,933 9,338 2,595 
West 5,577 4,911 666 
Central  3,803 2,835 968 
East 2,553 1,592 961 
Latin America 7,181 5,776 1,405 
Central 885 619 266 
Andina 2,786 2,305 481 
South 3,453 2,814 639 
Unknown 57 38 19 
South & south-east Asia 2,946 1,721 1,225 
Caribbean 2,265 1,401 864 
North Africa & Middle East 1,583 1,23 353 
North America 648 620 28 
East Asia & Pacific 429 339 90 
Australia & New Zealand 303 292 11 
Total 148,815 110,103 38,712 
Table 16. Distribution of cumulative HIV diagnoses between 2007-2012 according geographical origin 
and gender 
  
 Among persons from SSA, 39% were from Western Africa, 31% from Eastern 
Africa, 24% from Central Africa and 5% from Austral Africa. Migrants from Western 
Europe represented 47% of the intra-European migrant cases while Central and 
Eastern Europe accounted for 32% and 21% of the cases, respectively. As for LA, the 
main geographical sub-region was South America 48%, followed by the Andina region 
39%, and Central America, 12%. 
 The composition of the HIV-positive migrant population varied between 
countries. SSA accounted for the majority of migrant cases in Western EU/EEA 
countries except for Spain, where the commonest origin was Latin American (LA). 
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Eastern European countries from the EU/EEA as well as others such as Ukraine and 
Russia were the commonest origin of migrants within Central EU/EEA countries. 
 Of all HIV diagnoses, 74% (110,103) were men. For all origins except for SSA, 
men accounted for the majority of HIV reports though their proportion varied by GO 
(Table 16). Women accounted for 60% of reports from SSA and for approximately 40% 
of diagnoses from South & South-East Asia, Caribbean and Eastern Europe.  
 MSM represented 51% of the HIV diagnoses among native populations and was 
also the most frequent route for migrants from Western (64%) and Central Europe 
(40%), Latin America (61%), East Asia &Pacific (55%), Australia & New Zealand (84%) 
and North America (81%). Heterosexual transmission was the most common 
transmission mechanism for cases from Eastern Europe (42%), SSA (87%), South & 
South-East Asia (56%), North Africa and Middle East (49%) and the Caribbean (64%), 
Injecting drug use accounted for 25% of new HIV diagnoses in migrants from Eastern 
Europe (Figure 9).  
 
Figure 9. Distribution of HIV diagnoses according to category of transmission and geographical origin 
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 There were no statistically significant differences in the age at HIV diagnoses by 
geographical origin, neither for men nor for women (Figure 10). 
 
Figure 10. Median age at HIV diagnosis (and IQR) for men and women according to category of 
transmission. 
5.5.2. Presentation with late HIV disease by geographical origin and sex 
 For the 92,256 HIV reports with available CD4 cell count data, median CD4 cell 
count at HIV diagnosis was 379 (IQR: 177-575) for native diagnoses; 360 (162-552) for 
68,512 men and 310 (139-510) for 23,744 women. Figure 11 describes median CD4 cell 
count at HIV diagnosis for male and female migrants from SSA, Western, Central and 
Eastern Europe and Latin America.  
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Figure 11. Median CD4 count (and IQR) at HIV diagnosis for main migrant groups according to gender 
 
 Overall, 35% native HIV reports were LHD; 34% in males and 38% in females 
(Table 17). Compared to native reports, male migrants from High-income settings had 
similar proportions of LHD; Western Europe (ORa 0.95, 95%CI: 0.89-1.01), Australia & 
New Zealand (ORa 0.77, 95%CI: 0.57-1.03) and North America (ORa 0.86, 95%CI: 0.71-
1.04), whereas those from Middle and Low-income settings had a higher risk of LHD. 
For HIV-positive women, nearly all migrant groups – except for Australia & New 
Zealand and North America who accounted for a very low number – had a higher risk 
of LHD than natives (Table 17). 
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GO n/N (%) OR CI 95% ORa* CI 95% 
Male (110,103)           
Natives 24,942/77,426 (32.2) 1   1   
West Europe 1,476/4,911 (30.0) 0.87 0.82-0.93 0.95 0.89-1.01 
Centre Europe 847/2,835 (29.9) 0.91 0.84-0.99 1.08 0.99-1.18 
East Europe 476/1,592 (29.9) 0.92 0.82-1.03 0.95 0.85-1.07 
Sub Saharan Africa  5,794/11,960 (48.4) 2.09 2.01-2.18 1.62 1.54-1.70 
East Asia & Pacific 148/339 (43.7) 1.80 1.43-2.28 2.27 1.79-2.89 
Australia & New Zealand 66/292 (22.6) 0.63 0.48-0.84 0.77 0.57-1.03 
South & South-East Asia 787/1,721 (45.7) 1.97 1.78-2.19 2.15 1.93-2.39 
North Africa & Middle East 496/1,230 (40.3) 1.44 1.27-1.62 1.31 1.16-1.50 
North America 166/620 (26.8) 0.80 0.66-0.96 0.86 0.71-1.04 
Caribbean 596/1,401 (42.5) 1.50 1.34-1.68 1.34 1.20-1.51 
Latin America 2,209/5,776 (38.2) 1.27 1.20-1.35 1.67 1.57-1.77 
  
    
  
Female (38,712)           
Natives 4,614/14,256 (32.4) 1   1   
West Europe 340/666 (36.0) 1.21 1.02-1.43 1.24 1.04-1.47 
Centre Europe 350/968 (36.2) 1.27 1.10-1.46 1.57 1.35-1.81 
East Europe 280/961 (29.1) 0.91 0.78-1.06 1.08 0.92-1.25 
Sub Saharan Africa  7,597/17,885 (42.5) 1.61 1.54-1.69 1.7 1.61-1.79 
East Asia & Pacific 36/90 (40.0) 2.08 1.28-3.40 2.4 1.43-3.89 
Australia & New Zealand 3/11 (27.3) 0.84 0.21-3.36 0.99 0.24-4.02 
South & South-East Asia 577/1,225 (47.1) 2.13 1.87-2.42 2.24 1.96-2.55 
North Africa & Middle East 145/353 (41.1) 1.46 1.16-1.83 1.49 1.18-1.87 
North America 4/28 (14.3) 0.35 0.12-1.04 0.36 0.12-1.06 
Caribbean 347/864 (40.2) 1.36 1.18-1.58 1.28 1.10-1.49 
Latin America 615/1,405 (43.8) 1.56 1.39-1.75 1.65 1.47-1.86 
 
Table 17. Prevalence of LDH by GO for male and female HIV+ people. Logistic regression models of the 
OR for LHD for each GO. (*): Odds Ratio Adjusted by age and transmission category 
5.5.3. Trends in HIV cases from 2007-2012 by geographical origin and 
sex 
 From 2007 to 2012, the number of all HIV reports in the EU/EEA rose by 9%, 
largely at the expense of increases of 21% of cases among the native population. The 
number of male HIV diagnoses in native populations increased by an average of 711 
cases per year from 2007 to 2012, whereas the number of female cases remained 
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fairly stable, rising an average of 10 cases per year with (Figure 12; Figure 14). For all 
migrant groups globally, a decrease of 8% was observed during the period studied 
though distinct patterns by geographical origin and sex can be appreciated in Figure 12 
and Figure 14.  
 
Figure 12. Distribution of HIV diagnoses among men according geographical origin 
 
 For all male migrant HIV reports, an increase of 84 cases per year was observed 
from 2007 to 2012 due to growing numbers from LA, Central and Eastern Europe 
coupled with decreases from SSA (Figure 12). The number of men from LA peaked in 
2010 and has decreased since then. These increasing numbers of male HIV migrant 
cases are largely MSM and, to a lesser extent, IDUs, as male heterosexual migrant 
diagnoses have decreased at the time rising native heterosexual HIV diagnoses are 
observed (Figure 13).  
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Figure 13.  Trends in HIV diagnoses by geographical origin and category of transmission. 
 
 The peak in native and migrant HIV diagnoses in IDU is observed in 2009, likely 
due to increased inclusion of cases from Italy, disrupting the decreasing trend in this 
group in the last decade.  
 Female migrant HIV reports experienced a decrease of 188 cases for year 
(Figure 14).  
 
Figure 14. Distribution of HIV diagnoses among women according geographical origin 
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 Because migrant women account for a very large proportion of all female 
reports in the EU/EEA, the net consequence is that the number of HIV reports in 
women, irrespective of their geographical origin, has experienced a decrease of 178 
cases per year in the study period. The group driving this marked decrease is that of 
heterosexually infected women from SSA, which decreased from 3,364 cases in 2007 
to 2,258 in 2012, though decreases for all other geographical origins, namely LA, South 
East Asia, the Caribbean and Western Europe also took place. Women from LA show a 
pattern similar to the men from the same origin with cases peaking in 2010 to 
decrease since then but in both sexes. 
5.5.4. Data on migrant population living in the EEA/EFTA countries. 
 This section summarises the available data on migrant population registered in 
EU/EFTA countries in the period 2007-2012, firstly showing foreign cumulative data 
and secondly showing foreign data split by country of birth or nationality. 
Data on migrant population 2007-2012 
 The following figure shows cumulative number of migrants across the 17 
countries with complete data and between 2007 and 2012h.  
 
                                                     
h
These countries were: Austria, Bulgaria, Denmark, Finland, Germany, Greece, Hungary, Ireland, Latvia, 
Lithuania, Luxembourg, Netherlands, Norway, Poland, Slovenia, Spain, Sweden 
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Figure 15. Cumulative foreign population registered in 17 EU/EFTA reporting countries with all 
information available. 
 
 Migrant population has not ceased to increase between 2007 and 2012. The 
most significant increase took placed during 2007-2009. After 2009, the trend 
continued to grow, but the increase was less pronounced. 
 This migratory trend could be related with the 2007 EU enlargement. In this 
year, two countries joined the previous EU of 25 countries: Romania and Bulgaria, 
becoming the EU-27. In spite of the theoretical “freedom of movements” in the area, 
the nationals from these two countries were not automatically authorized to work in 
all EU countries. Restrictions to work were applied depending on the countries and 
some countries planned to apply these restrictions until January 2014. However, 2007 
led to increases in the UE of nationals from Romania and Bulgaria, though these 
citizens were still considered as part of Central Europe and thus classified as migrants. 
 The Figure 16 shows cumulative numbers between 2007-2012 by sex in the 17 
EU/EFTA countries with all information available. Men have been the largest group 
over the period, although in the recent years both lines men and women tend to 
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converge.  The slowdown is clearest among men than among women and could be 
related with the type of work performed by each gender. While traditional male labour 
has been affected by financial constrains (building sector, for example), some 
employments traditionally carried out by women were less affected by the crisis (for 
example, for the sick and the elderly particularly in the EU where the population 
ageing is growing). 
 
Figure 16. Cumulative foreign population by sex living in 17 EU/EFTA reporting countries with all 
information available
i
. 
 
 Regarding the area of origin of migrants established in Europe, there was 
information only for 14 of 29 EU/EFTA countries for the whole period 2007-2012. 
Figure 17 shows the cumulative number of male migrants by areas of origin over the 
period described:   
                                                     
i
 These countries were: Austria, Bulgaria, Denmark, Finland, Germany, Greece, Hungary, Ireland, Latvia, 
Lithuania, Luxembourg, Netherlands, Norway, Poland, Slovenia, Spain, Sweden. 
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Figure 17. Cumulative foreign males by country of birth/nationality in 14 EU/EFTA reporting countries 
with all information available
j
. 
 
Looking at migratory trends by sex and area of origin we can observe that 
migrants from Central Europe are the most important group among both, male and 
female migrants, followed by migrants from Western Europe. Migrants from Central 
Europe drive the trend observed in Figure 16 for the total number of migrants. After 
the initial increase of migrants from Central Europe between 2007 and 2009, due to 
the opening borders following the 2007 EU enlargement the trend of migrants coming 
from Central Europe seems to be stable. In the first two years after 2007, nationals 
from Romania and Bulgaria did not have free access to the labour market of other EU 
                                                     
j
 These countries were: Austria, Bulgaria, Denmark, Finland, Germany, Ireland, Lithuania, Netherlands, 
Norway, Poland, Slovakia, Slovenia, Spain, Sweden. 
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countries. Free labour market access depended on bilateral agreements between 
specific countries121. 
Among males, LA is the third largest group, followed by North African and 
Middle Eastern people. The number of migrants from each of these areas, after the 
period of growth (2007-2009), appears to have stabilized. South and South-East Asia 
and Eastern Europe are the fifth and the sixth groups in importance among males, 
showing similar numbers of migrants and slight increases over time. 
Regarding female migrants, as previously stated, migrants from Central Europe 
and Western Europe are the largest groups in the 14 reporting countries. A similar 
trend to that described in men is also observed in migrant women from Central 
Europe. The following figure shows the trends among female migrants by countries of 
birth/nationality over the period. It is also important to state that the “Unknown” 
category experienced an important increase in 2011-2012, possibly deriving in 
information bias. 
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Figure 18. Cumulative foreign females by country of birth/nationality in 14 EU/EFTA reporting countries 
with all information available
k
 (I). 
 
Among migrant women, the third largest group is that of Latin Americans, with 
an initial increase in 2009 and a stable trend after that year. Eastern European women 
are the fourth largest group, followed by women from North Africa and Middle East 
and from South and South-East Asian countries. All three groups show a similar trend 
over the period: a very slight increase over the period. 
Data on migrant population 2008-2011 
 Finally, and in order to provide data from most of the countries, we look at all 
the countries with available data in the period 2008-2011. 
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 For the global datal on foreign population, only six countries (21%) did have not 
this information (Cyprus, Czech Republic, Estonia, France, Romania, UK). Figure 19 
shows the absolute number of migrants registered in Europe within the period 2008-
2011. 
 
Figure 19. Cumulative foreign population by sex registered in 23 EU/EFTA reporting countries with all 
information available for the period 2008-2012. 
 
 In spite of the differences in absolute numbers of males and females migrants 
at the beginning of the period, both lines seem to converge by 2011. A total of 
27,279,381 migrants were registered in the 23 reporting countries in 2011. In general, 
there are major changes comparing this graph with the one with information about 17 
countries: the convergence among men and women seemed to be clearer and the 
migration slowdown seems to occur.  
 Information on migrants by area of origin (grouped from country of birth or 
country of nationality) for the period 2008-2011 was not available for 10 countries 
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(34%) (Cyprus, Czech Republic, Estonia, France, Greece, Iceland, Luxembourg, Malta, 
Romania, UK).  
 Figure 20 shows the cumulative numbers of male migrants by area of origin 
within the period 2008-2011 in the 19 reporting countries. Once again, male migrants 
from Central Europe are the largest group, presenting an increasing trend since 2009. 
After this, males from Western Europe are the second larger group. North African and 
Latin American are the third and the fourth groups by importance among male 
migrants. 
 
Figure 20. Cumulative foreign males by country of birth/nationality in 19 EU/EFTA reporting countries 
with all information available (2008-2011)
m
. 
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 Among migrant women, the largest group was that from Central Europe. This 
group has not ceased to increase over all the period. After this, the second largest 
group is that composed by West European foreign females, followed by Latin American 
(slightly increased) and Eastern Europe (Figure 21). 
 
Figure 21. Cumulative foreign females by country of birth/nationality in 19 EU/EFTA reporting countries 
with all information available (2008-2011)
n
. 
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6.1. Discussion of results 
This Doctoral Thesis provides an in-depth analysis of the HIV testing policies 
and strategies in migrant populations in Europe and provides evidence on important 
changes in the epidemiology of HIV infection in these populations. These results are 
key to design appropriate preventive and diagnostic interventions, as well as health 
care services that meet the specific needs of migrants in Europe. 
All the data sources used in this Doctoral Thesis –surveillance data, literature 
review, review of HIV testing guidelines, AIDS National Plans and other documents of 
national and international scope and semi-structured individual and group interviews-  
identify migrants, largely but not only those from HIV endemic countries, as 
populations at a higher risk of HIV infection and its consequences. These consequences 
can be summarized in three aspects: a higher prevalence of HIV infection compared to 
the general population, a higher frequency of delayed HIV diagnosis compared to 
other groups and higher social vulnerability. Most of EU/EFTA countries consider 
migrant population as vulnerable for HIV in their policies or recommendations and 
specifically mention people from high HIV prevalence regions such as SSA, Eastern 
Europe, the Caribbean, Asia and South America. However, only half of the countries 
recommended HIV testing for migrants, showing an important gap between needs and 
interventions. 
The first objective of this study was “to describe European countries' policies 
regarding HIV diagnosis and testing in migrant populations”.  We have shown 
remarkable disparities in the policies and guidelines documents within Europe. This, in 
some ways, reflects the differential contribution of migrants and ethnic minorities to 
the total number of HIV and AIDS cases in the countries that conform the EU/EFTA 
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and, accordingly, HIV testing legislation and practices are bound to vary among 
Member States. 
Seven out of ten policy documents from the 31 EU/EFTA Member States 
identify migrants as a vulnerable population for HIV infection. It is necessary to remark 
that the various policy documents used different definitions and concepts of the terms 
“migrant” and “ethnic minorities”29;84. Some countries consider migrants in general as 
“vulnerable populations for HIV”, while others provide a more specific definition. Both, 
“migrants from HIV endemic countries” and “migrants from Sub-Saharan Africa” are 
the subgroups most frequently mentioned by the countries, when specified. However, 
no specific ethnic minorities are cited as vulnerable groups for HIV except in the UK, 
Bulgaria, Slovakia and Romania.  
Reasons for considering migrants as vulnerable populations include the 
disproportionate burden of delayed presentation to HIV diagnosis and care in this 
group and also with the disadvantaged socio-economic situation that they experience.  
However, regardless of this higher vulnerability acknowledged in the countries’ 
policy documents, only 52% explicitly recommend HIV testing for migrant populations. 
Once again, “migrants in general” and “migrants from HIV endemic countries” are 
targeted for HIV testing. Importance of how to perform HIV testing is also highlighted 
in some documents, particularly the frequency and the more suitable settings. 
However, the frequency in which HIV testing has to be performed only appears in the 
documents from three countries, that recommend HIV testing for migrants upon their 
first contact with the national health system (Denmark) and systematic screening for 
people from high HIV prevalence areas (France and UK). 
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Regarding the most adequate sites for HIV testing, the various policy 
documents call to expand the type of settings performing the test. This can be reached 
through reinforcement of proactive testing strategies within health services as well as 
in involving NGOs and Community Based Organizations in the development and 
implementation of interventions. Such interventions could include offering the test in 
the places where people live, work or spend their leisure time or expanding testing 
hours. In these interventions, point of care testing and use of rapid tests are key in 
order to increase the coverage in difficult to reach migrant populations.   
In the UK, Germany, the Netherlands, Norway, Spain and Switzerland122, 
General Practitioners remained at the centre of HIV testing strategies aimed at the 
general population. General Practitioners’ proactivity offering HIV testing has proved 
to be a key factor in increasing the uptake of HIV testing22. Actually, regardless of the 
content of the policy documents, unawareness of national HIV testing policies by 
health care professionals has been identified as a barrier to put in practice 
recommendations, and this may explain123;124 the low and variable coverage of HIV 
testing in the most vulnerable groups122. 
Universal strategies such as those developed by the UK and France are helping 
in the normalization and de-stigmatization of HIV testing, even if the documents 
recommend their application in selected contexts, such as in areas with high HIV 
prevalence rates. This approach should not substitute HIV testing programmes 
targeted at HIV more vulnerable groups, as for example migrants from HIV endemic 
countries, men who have sex with men and injecting drug users. However, the design 
of interventions should be guided by results from cost-economic analyses in each 
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context and knowledge about implementation challenges in order to prioritise 
available resources125. 
Regarding the gender axis in the HIV epidemiology, it is remarkable that 
epidemiological data shows a higher number of HIV-positive women from SSA 
compared with SSA men. This fact is probably reflecting the effect of the expansion of 
universal antenatal HIV screening strategies in Europe that are reaching women. In 
fact, these strategies researched in-depth by Deblonde et al.123 are not reaching men 
and derive in HIV diagnosis diagnostic bias. 
Finally, regarding mandatory HIV testing for migrants upon arrival to the host 
country, policy documents revealed this practice may be facilitated in some European 
countries. The objective of this research was not to assess the extent of this practise, 
but this finding raises concerns on whether the general principle that the test must be 
voluntary is being respected. 
The second objective of this study was “to describe International 
Organizations recommendations regarding HIV diagnosis and testing in migrant 
populations”. The six international guidelines reviewed – IOM, WHO, ILO, IUSTI, 
UNAIDS- identify migrants at risk for HIV infection. However, only half of them 
recommend testing migrants for HIV infection.  
On December 2010, the ECDC published “HIV testing: increasing uptake and 
effectiveness in the European Union”62 which described the recommendations on HIV 
testing at European level. This guideline stated that “migrants, especially from 
countries with higher prevalence” and their sexual partners were among the groups 
with higher risk for HIV infection and thus, recommended HIV testing. 
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In general, International Organizations acknowledge HIV testing benefits at 
both the individual and the community levels, which are also remarked in the scientific 
literature126-130. IO acknowledged the reduction of the community viral load is the 
most important benefit at the community level, whereas the benefits at individual 
level derived from cART uptake include decrease of morbidity and mortality and 
reduction of MTCT. International Organization’s documents also recognize the 
importance of the way in which HIV test is performed. The setting is the most 
discussed feature and agreement has been reached in order to promote HIV testing in 
community settings with the final objective of reaching out to migrants and ethnic 
minorities at their local points of gathering. The 2010 ECDC Guideline62 recommends 
making testing available in a variety of settings, including community services.  
On the topic of legal issues related to HIV testing at arrival, the position of 
these organizations is clearly manifested: documents from ECDC24;62 and WHO49, 
among others, strongly advice against mandatory HIV testing for migrants as it is 
considered a discriminatory practice. They declare that mandatory HIV testing for 
migrants and asylum seekers when entering a country, which takes place in some 
settings, violates the core principles that HIV testing must be confidential, voluntary 
and performed with informed consent. 
The third objective of this Doctoral Thesis was “To analyse available scientific 
evidence on HIV testing and counselling strategies targeting migrants and ethnic 
minorities in high-income countries”. In this regard, the systematic review has found 
that migrants, mainly those from HIV-endemic countries, are at high risk of HIV 
infection and its consequences52;53;86-88;92;95;107;109;112;118.  
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Migrants have higher HIV prevalence compared to the general population, 
higher frequency of delayed HIV diagnosis and they are more vulnerable to the 
potential negative effects of HIV status disclosure 52;96.  
Their socio-economic position in the destination country put migrants, 
including those from countries with low HIV prevalence, in a position of increased risk 
of acquiring HIV in host countries52;108;109. Burns et al. in collaboration with ECDC have 
compiled the available scientific evidence on post-migration sexual transmission of HIV 
among migrants from countries with generalised HIV epidemics131. A systematic review 
was carried out and a number of the retrieved papers show how in many cases HIV 
transmission had occurred during the post-migration period; the rate of HIV post-
migration acquisition ranged from 2% among SSA in Switzerland132, to 62% among 
black Caribbean MSM in the UK133. Burns et al. show that 15 out of 26 EU/EE countries 
collected information on probable country of HIV infection of new HIV cases through 
their surveillance network, either based on interview of the case or through the 
clinician’s reports. 
Additionally to their social and economic vulnerability, migrants have to deal 
with the barriers to HIV testing shared with other groups at risk and also with migrants’ 
specific barriers. These barriers are of diverse nature. Articles described legal and 
administrative obstacles in accessing general health care services53;88;96;110 and 
specifically HIV testing services. This important issue that will be further discussed later 
derives, among other factors, from the fact that undocumented migrants are not 
entitled to health care in some countries95;101;112. 
The literature also pointed at other specific barriers such as racism and 
xenophobia88, cultural and linguistic barriers89;93-96;110, criminalization of HIV 
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transmission88 and fear of stigma and discrimination from their communities88.In this 
line, other barrier that came up is the low priority assigned to health in general, and 
HIV in particular77;88 linked with the poverty and socio-economic disadvantage. 
General population strategies in health care settings and targeted approaches 
for specific sub-populations are described as feasible for migrant population. HIV 
testing interventions aimed at the general population should deal with the 
heterogeneous sub-populations among migrants and their perceptions about these 
general interventions. The scientific evidence supports that this strategy is perceived 
as less stigmatizing; it has been documented that women from HIV-endemic countries 
prefer general population approaches in health services settings than targeted 
ones104;114. 
The heterogeneity within migrant populations calls for developing strategies 
adapted to particular groups rather than one encompassing “all migrant populations”. 
Further, the role of the Community is key to discuss and implement HIV testing 
interventions. Innovative HIV testing approaches, as for example test performance in 
non-traditional settings92;105;113, during off-hours111 or rapid tests use91;105;111 are 
needed. Indeed, the papers recommend providing HIV testing from a culturally 
sensitive perspective. On the other hand, it is remarkable that very little information 
on counselling was retrieved from the literature that might be better found elsewhere, 
for example in programme-based ‘grey’ literature.  
The strong gender differences affecting HIV testing have been also raised from 
the literature review. The traditional gender roles culturally assigned to men and 
women in some migrant communities may deter heterosexual men and women as well 
as MSM from undergoing HIV testing. While routine antenatal HIV testing has worked 
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very well for all women, irrespective of their geographical origin, testing in other sites 
needs to acknowledge gender imbalances. Actually, the literature review overall shows 
HIV testing uptake in antenatal settings in migrants is high and similar to that of non-
migrant women, but compared to men, a higher proportion of migrant women have 
been tested for HIV, partially due to high acceptance of routine antenatal HIV 
screening. Men are less exposed to HIV testing and are also less willing to be tested111. 
Reaching migrant men, both heterosexual and MSM, remains a challenge. The 
literature shows that migrant MSM are a hard to reach group and that “machismo” 
and homophobia are deterrents to HIV prevention92.  
Finally, the literature review has shown how HIV testing can be mandatory for 
migrants and asylum seekers when entering a country in some settings97;99;120, even if 
it violates the previously described core principles.  
Regarding the fourth objective “To examine the challenges for implementing 
and expanding HIV testing and counselling strategies targeting migrants”, all 
participants in the interviews recognized the benefits of expanding HIV testing to reach 
out migrant populations. 
Strategies based on ‘general population’ approaches and ‘targeted approaches’ 
are each associated with both benefits and disadvantages. Reaching migrants and 
ethnic minority populations with HIV testing and counselling programmes is perceived 
as a challenge. As previously stated in this document, migrants and ethnic minorities 
are very heterogeneous populations, determined by country of origin, ethnicity, 
gender, sexual orientation, religion, legal status and time in the country of destination. 
While some groups of migrants will be reached through general population 
programmes, other groups of migrants may be reached through targeted approaches.  
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In settings where these strategies for general population are being 
implemented, uptake of HIV-test by migrants seems to be successful, though little data 
are available so far. This strategy avoids the perception of stigmatization associated 
with risk-group targeted programmes98. In many clinical settings HIV testing is 
currently offered together with pre-test information and no lengthy pre-test 
counselling. Interviewees expressed ambivalence as to whether this is adequate for 
migrant populations as it is felt that a lot of misconceptions regarding HIV infection can 
be tackled during counselling sessions, particularly those related to the stigma within 
the community. 
Once more, the interviews reveal that engagement with the communities and 
building partnership is fundamental for testing at community sites and for developing 
culturally sensitive interventions. Difficulties to reach these populations respond to 
barriers for accessing HIV testing services and these barriers are linked with the overall 
vulnerability of migrants and ethnic minorities. Innovative strategies are needed to 
emphasize community participation. Mentioned options include broadening the scope 
of facilities performing the test, strengthening proactive testing strategies, putting in 
place outreach programmes based on community approaches, which could rely on 
POCT and rapid testing, offering the test where people live, work or spend their leisure 
time, expanding testing hours and involving NGOs and CBOs. Several studies have 
shown the benefits of this type of interventions and de-stigmatization of HIV testing 
within the communities92;111;113. Innovative interventions have demonstrated their 
effectiveness particularly among migrant MSM, a mainly at-risk group traditionally 
invisible to HIV prevention activities and facing various and multiple forms of 
discrimination105. 
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Regarding the gender dimension, the high number of HIV-positive women from 
SSA as compared to the number of men from SSA and the number of women of 
European origin is linked by various respondents of this report to the success of 
antenatal testing which has resulted in a feminization of testing, especially apparent 
among migrant women. Reaching men is more challenging and various initiatives to 
stimulate partner testing in the context of antenatal testing have been mentioned.  
The HIV treatment cascade–also referred as “HIV care continuum”- developed 
in 2010 by Gardner et al.134 aimed to identify chances to improve services for people 
living with HIV across the HIV continuum of care. The final objective of this model 
would be to achieve hypothetical scenario in which community viral load is suppressed 
and infectivity of new individuals does not take place. This model is divided in different 
stages: People living with HIV, People diagnosed with HIV; People linked to care; 
People retained in care; People who need antiretroviral therapy; People treated with 
antiretroviral therapy; and People who has adherence to the treatment and reached 
viral load suppression. These stages explain final treatment effectiveness at the 
community level, since not all HIV positive people are diagnosed, linked to care or get 
into treatment. The benefits of HIV testing at the community level is underlined by the 
scientific literature and supported also by national and IO Guidelines49;126-130. 
Actually, all major IO HIV testing guidelines acknowledge that HIV testing on its 
own cannot be the final goal. HIV testing must be linked to care, support and 
treatment, ensuring a comprehensible referral pathway for positive 
individuals49;50;62;70;134. Additionally, all interviewees also insist on the need of linking 
HIV testing with care and treatment. Various informants stress that migrant 
populations should be especially protected from being tested for HIV when access to 
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cART is not guaranteed and that this fact singles them out from the rest of people 
living with HIV. HIV/AIDS Epidemiological data also supports the overwhelming 
agreement in that availability of cART for HIV positive people should be a public health 
priority for every country, similar to other transmissible diseases such as Sexual 
transmitted diseases (STI) or Tuberculosis (TB) treatment. 
A particularly dramatic situation is that of migrants of uncertain residency 
status who are not entitled to cART in some countries48. After the economic crisis, 
some countries of the EU/EFTA area reduced the total public spending in medical care 
or the volume and quality of health care135;136. The Organisation for Economic Co-
operation and Development (OECD) shows in a recent report how health spending has 
fallen in 2010136 for the first time in Europe since 1975. In Spain, for example, in 2012 
the Government ruled the Real Decree-Law of 12/2012 of 20th April against universal 
access to health care for migrants of uncertain legal status137;138. Pérez-Molina and 
Pulido139 have analysed the consequences of this measure in people living with HIV 
and pointed out that expected savings in the short term would be lower than 
expected. Moreover if this measure was applied, the increase in mortality and 
morbidity due to communicable diseases would increase spending in the medium and 
long term, questioning not only the ethics of this measure, but also its economic 
impact. This Royal Decree-Law has not been fully implemented in the HIV field due to 
civil and medical protests, although some HIV services remain inaccessible for 
undocumented migrants. Indeed, the European Social Charter (a treaty of the Council 
of Europe aimed to guarantee social and economic human rights) published in 2014 
the “Conclusions XX-2 (2013)”140 for Spain in which considers that “the Committee 
states that this denial of access to health care for adult foreigners (aged over 18 years) 
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present in the country illegally is contrary to Article 11 of the Charter”. The Committee 
has already held that the States Parties to the Charter “have guaranteed to foreigners 
not covered by the Charter rights identical to or inseparable from those of the Charter 
by ratifying human rights treaties – in particular the European Convention on Human 
Rights – or by adopting domestic rules whether constitutional, legislative or otherwise 
(…)”. The opinions of our key informants about whether actively promoting or not HIV 
testing under circumstances when treatment is not ensured are ambivalent. What is 
clear from all the sources of information is that if HIV testing is not linked to rights and 
is viewed as having a potential negative impact on the short term – refusal of 
residency permit or fear of deportation – these populations will not come forward for 
HIV testing.  
Results derived from this section, and also those from the one dedicated to 
policies review and the one dedicated to scientific literature systematic review, are in 
line with the implementation science approach141. These studies specifically aimed to 
assess the implementation of the scientific evidence on the benefits of HIV early 
diagnosis into policies. Implementation science examines the ways in which healthcare 
practitioners can use research findings more effectively in routine clinical practice, in 
order to carry out a more research-informed practice141 and has been used for our 
purposes in a wide way, examining the gap between available evidence from 
researches and real implementation.             
The linkage of HIV testing to care is key, specially taking into account the results 
of the Epidemiological data analysis. The fifth objective of this Doctoral Thesis was “To 
describe HIV/AIDS epidemiology between 2007 and 2012 in migrant populations in 
Europe”. Our analysis show that migrants represented two fifths of all HIV reports in 
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the EU/EEA from 2007 to 2012, though their contribution to the HIV epidemics in 
Central and Eastern EU/EEA countries is very small. Migrants from Sub-Sahara Africa, 
Latin America and Western Europe, each with distinct epidemiological profiles, are the 
most common origins in Western EU/EEA whereas migrants from Eastern Europe are 
the most frequent origin in Central Europe.  
Male and female HIV-positive migrants from low and middle-income settings 
have higher proportions of Advance HIV Disease than native populations. Whereas no 
differences were observed in these proportions between native men and migrants 
from high-income settings, namely Australia and North America, women from these 
origins did also have higher rates of AHD than native women.  
The different patterns of the new HIV diagnoses in migrant populations across 
the EU/EEA require analyses that take into account the gender and the geographical 
origin for all HIV transmission categories, and not only for the heterosexually infected. 
Sexual mixing between people of different ethnic and geographical origins is well 
known to happen among MSM community, and to a lesser extent among 
heterosexuals131.   
The absolute and relative number of HIV positive migrants has declined from 
2007 to 2012 driven by striking decreases in the number of HIV diagnoses in 
heterosexual women from SSA, and to a lesser extent of men from SSA and by cases in 
women from other GO. In contrast, increases in male diagnoses in MSM from LA and 
IDUs from Central and Eastern Europe have also taken place. 
The reasons for these changes are largely unknown and a number of 
hypotheses can be put forward but that may be difficult to test. One of the main 
hypotheses could be related with changes in the migratory trends over the period.  
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The HIV epidemiological trends described have to be interpreted in the context 
of global migration flows in Europe which are heavily influenced by the economic 
crises in the different parts of the world and the influence of the European policies on 
migration, control of external borders and asylum.    
 Regarding EU migration policies, after the 2004 Hague Program, the Stockholm 
Programme was signed in 2009. This Programme was aimed at provide the legal 
framework for the EU in the area of justice, freedom and security for 2010-14. 
However, in this Programme, no new policies about migration have been developed. In 
this regard, the paper developed by Collett142 states that the European Union 
traditional approaches towards developing a policy in the area of migration and 
asylum have been replaced in the last years by approaches more focused on ensuring 
coherent and complete implementation of previously agreed policies. The objective of 
finding ways to develop a common strategy based on the further rapprochement of 
the 28 national migration and asylum systems has been put on hold. This Doctoral 
thesis has been written during this period characterized by the increase in specific 
efforts to maintain external borders control. 
 Available data on migration flows are heterogeneous and incomplete and do 
not allow to confirm what has happened with migrant flows, in particular when looking 
at different geographical origins, in the current scenario of financial constraints. 
However, the IOM report “Migration and the Economic Crisis in the European Union: 
Implications for Policy” considers that the current economic crisis has had an 
important impact on migration flows in Europe during 2008-2010. This report shows a 
deceleration in migration flows, predominantly in countries that received a large 
number of migrants during the pre-crisis period (Ireland, Spain and the UK)143. Along 
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this same line of thought, the Eurostat document “Demography report 2010. Older, 
more numerous and diverse Europeans”144 shows how in 2009, the EU Member States 
issued 2.3 million new residence permits, 8% less new residence permits for nationals 
of non-EU countries compared to 2008.  
 The IOM “World Migration Report”27 described in 2013 four migration 
pathways in the word: South–North and South–South (that represents the two major 
migratory flows in the word), North-North and North-South. This report analyses 
migration flows in the world using three different country-based classifications: United 
Nations Department of Economic and Social Affairs (UN DESA), the World Bank (WB) 
and the United Nations Development Programme (UNDP). This IOM report describes 
two important changes in the traditional migration flows: a new migration flow from 
Europe to Africa, Latin America and the Caribbean and a return migration flow -the 
returning of migrants to their country of origin- both due to the financial crisis in the 
Western countries. 
 Though our data does not allow to fully understanding the nature and the 
causes of the changes in migratory trends in the HIV positive populations, we think 
that a shift in the migratory trends is likely to be occurring. This is possibly derived 
from decreases in migration flows, increased remigration to countries of origin or to 
places less affected by the economic crisis together with hardening of immigration 
laws and restrictions to access to health care and social rights, largely but not solely, 
for the undocumented migrants.  
 Further, the decreases in new HIV reports of SSA origin, particularly in women, 
may be the consequence of a true reduction in HIV incidence – either in countries of 
origin and/or in countries of destination, or may reflect lower uptake of HIV testing. A 
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closer look into the evolution of LHD overtime could shed some light into these 
aspects. Additionally, scaling up ART coverage in many low and middle-income 
countries may have favoured HIV-positive migrants in the context of the European 
crisis to re-migrate to their countries of birth.  
Indeed, some of these questions can be tested while some others may remain 
speculative in the absence of data. Analysing population registries would allow 
comparing fluctuations of populations of given geographical origins – or at least 
attempting to do it given the poor quality of these data sources -. We could also 
explore if the patterns observed are more marked in the Southern European countries, 
most hardly hit by the economic crisis, than in Central and Northern EU/EEA countries. 
Exploring trends in the prevalence of AHD by gender, transmission category and 
geographical origin would also provide indirect evidence of changes on HIV testing 
practices.              
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6.2. Methodological discussion 
The results presented in this Doctoral Thesis need to be interpreted in the line 
of its methodological limitations. 
First of all and regarding the policy review, the analyses of policies and 
recommendations about HIV testing and counselling collected by official documents 
has been complex, given their heterogeneity. Not all countries have specific 
documents on HIV testing and when documents exist, they have different structures 
and often were only available in local languages. Countries’ representatives were 
contacted in order to overcome translation issues, but not all were located and 
subsequently there is missing information from two countries. In spite of this, data 
provided by the key informants was very useful and especially valuable in the cases of 
countries with languages unknown by the research team. 
Regarding country representative’s response rate, the majority responded to 
the survey and only representatives from Czech Republic and Liechtenstein did not 
reply. This high response rate allows us to consider that information provided was 
representative for the EU/EFTA Member States.  
 Policies and recommendations show inconsistencies within a single country 
according to the source of information. Several countries had no guidelines for HIV 
testing, a few others were planning to develop them and some were updating their 
AIDS Plans. Because of this, some reviewed documents may have been out-dated even 
if we asked country representatives to provide us with the most updated versions. This 
fact could also contribute to explain the inconsistencies found between the 
information provided by country representatives and the information retrieved from 
documents.  National policies and recommendations often not reflecting the reality of 
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practice and, in addition, due to decentralisation, many countries have sub-national 
policies which have a stronger influence on such issues. 
Regarding the methodological limitations arisen in the systematic review, we 
found a high number of articles on HIV prevalence and risk factors in migrants and 
ethnic minorities which, although not conceptualized as a primary aim, were included 
in the review. Nevertheless, as we had not aimed primarily to address this objective, 
we may have missed a number of relevant articles as the search strategy used did not 
specifically contemplate this. On the other hand, according with the designed search 
strategy the research team only included articles in English. Further, grey literature 
documents and conference -abstracts were not included either. 
The qualitative research also presented several methodological limitations that must 
be addressed. Since a semi-structured script was used in the interviews, the answers of 
the respondents may have been strongly determined by the areas of interest of the 
researchers. Furthermore, the selection of interviewees was made based on feasibility 
criteria. Therefore, although the research team tried to have a balanced 
representation of the different profiles (academic researchers, policy makers, and 
NGO’s representatives) the respondents’ testimonies refer to very different contexts 
and different realities. Even if the respondents’ experiences were not representative of 
the European Union reality on the topic of interest, some similar experiences were 
shared and different point of view emerged. However, no respondents from Central 
and Eastern Europe were interviewed and the point of view of experts working in 
these areas was not collected. 
 Regarding epidemiology data, the principal limitation was the missing data on 
the GO variable, particularly in Eastern European Countries and Central European 
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Countries, that changed over time for certain countries. Similarly, we also identified an 
important lack in the CD4 cell count availability. For missing data, performing multiple 
imputation using Chain equations (MICE) was not an option given there were not 
enough variables that could predict missing data. 
Regarding population data, the heterogeneity of the information provided by 
the different sources does not allow us to fully understand the migratory trends over 
the period. Additionally, it is necessary to take into account the underestimation of 
migrant populations living in some countries, due to the nature of population registries 
which are largely available only for legal migrants or with the registration process itself 
(people less willing to register themselves). In the same line, overestimation could 
occur in other places, where population registries are not reviewed and updated 
within the periods between censuses and allow for people to remain registered over 
after their departure.  
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Conclusion 1. Migrants are disproportionately affected by HIV infection. Migrants, 
largely but not only those from HIV endemic countries, are identified as populations at 
a higher risk of HIV infection and its consequences. These consequences can be 
summarized as: higher prevalence of HIV infection compared to native population, 
higher frequency of delayed HIV diagnosis and higher social vulnerability. 
 
Conclusion 2. There is overwhelming evidence and consensus on the benefits of HIV 
testing both for the individual and the community which is particularly relevant for 
migrant populations in Europe. At an individual level, knowledge of HIV-positive status 
will lead to treatment and, consequently, to a reduction of HIV associated morbidity 
and mortality. At the community level, knowledge of HIV-positive status has been 
associated to safer sex practices and, through treatment (when clinically indicated) to 
a reduction in HIV viral load and thus, reduction of HIV transmission.  
 
Conclusion 3. Though most of EU countries consider migrants as vulnerable for HIV, 
not all specifically recommend HIV testing in this sub-population. Some national policy 
documents recommend voluntary HIV testing for migrants as the first step to decrease 
the higher undiagnosed fraction in this population in the EU/EFTA region.  
 
Conclusion 4. That said, how to reach migrants and ethnic minorities populations 
within HIV testing and counselling programmes remains a challenge. Some groups of 
migrants could be reached through general population programmes; but another 
sector may not, and will need specific approaches. In this respect, engagement with 
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the communities is fundamental through building partnerships for testing at 
community sites. 
 
Conclusion 5. IOs Guidelines identify migrants at risk for HIV infection, but not all 
specifically recommended HIV testing. International Organizations acknowledge HIV 
testing benefits at both the individual and the community levels and strongly advise 
against mandatory HIV testing for migrants as it is considered a discriminatory 
practice. 
 
Conclusion 6. HIV testing is affected by gender differences. The traditional gender 
roles culturally assigned to men and women in some migrant communities may deter 
heterosexual men and women as well as MSM from up taking HIV testing. While 
routine antenatal HIV testing has worked very well for all women, irrespective of their 
geographical origin, testing in other sites needs to acknowledge gender imbalances.  
 
Conclusion 7. HIV testing approaches relies on the pillar that testing must be linked to 
care. The fact that there are countries which do not provide universal HIV prevention, 
treatment and  care for migrants of uncertain legal status challenges the ethics and the 
effectiveness in the application of the pro-active HIV testing and are a deterrent for 
the control of an important public health problem in the region. 
 
Conclusion 8. New HIV diagnoses in migrant populations in the EU/EEA have declined 
from 2007 to 2012, especially among SSA women. Reasons for this reduction are 
largely unclear but could be related with changes in migratory trends, a reduction of 
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HIV incidence both in origin and destination or may be reflecting a lower uptake of HIV 
testing secondary to legal restrictions to access health care. 
 
Conclusion 9. In spite of data limitations, migrants’ flows shows a deceleration and this 
could partly explain the decrease in new HIV diagnosis among migrants. 
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Belza MJ, Rivero-Montesdeoca Y, Noori T, Del Amo J; the Study Working Group. HIV 
testing policies for migrants and ethnic minorities in EU/EFTA Member States.Eur J 
Public Health. 2013. [Epub ahead of print]. 
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Alejos B, Caro AM, Perez Cachafeiro S, Ramirez-Rubio O, Bolumar F, Noori T, Del Amo J. 
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REPORTS 
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9.2. ANNEX 2. Materials and other contents of the study 
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9.2.1. APPENDIX 1. List of National representatives. 
Country Country representative Position Institution 
Austria  Jean-Paul Klein 
Technical expert HIV/AIDS, 
tuberculosis, immunisation 
Ministry of Health 
Belgium  André Sasse Epidemiologist 
Scientific Institute of Public 
Health 
Bulgaria  Tsvetana Yakimova Chief Expert Ministry of Health 
Cyprus  Anna Nouska AIDS Programme Manager Ministry of Health 
Denmark  Susan Cowan 
Medical Consultant, Public 
Health 
Department of Epidemiology, 
Epidemiology Division 
Estonia  Aljona Kurbatova Researcher 
Infectious Diseases and Drug 
Abuse Prevention 
Department, National 
Institute for Health 
Development 
Finland  Henrikki Brummer Research Manager 
HIV Laboratory, National 
Institute for Health and 
Welfare 
France  Caroline Semaille Medical Epidemiologist Institut de Veille Sanitaire 
Germany  Osamah Hamouda Researcher Federal Ministry of Health 
Greece  Georgios Nikolopoulos Epidemiologist 
HIV Infection Office, Hellenic 
Centre for Diseases Control 
and Prevention 
Hungary  Maria Dudas Epidemiologist 
Hungarian National Centre 
for Epidemiology 
Iceland  Sigurlaug Hauksdóttir Social Consultant 
Centre for Infectious Disease 
Control, Directorate of 
Health 
Ireland  Aidan O'Hora 
Consultant in Public Health 
Medicine 
Health Protection 
Surveillance Centre 
Italy  
Anna Maria Luzi // Anna 
Colucci 
Scientific Chief. 
Communication and Training 
Operating Unit and Italian 
National Focal Point for 
Infectious Diseases and 
Migrant // Research 
Coordinator. Communication 
and Training Operating Unit. 
Department of Infectious, 
Parasitic and 
Immunomediated Diseases, 
National Institute of Health 
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Country Country representative Position Institution 
Latvia  Inga Upmace 
Head of AIDS Programme 
Department 
Infectology Centre 
Lithuania  Oksana Strujeva Epidemiologist 
HIV/AIDS/STI and Hepatitis 
Epidemiological Surveillance 
Department, Centre for 
Communicable Diseases and 
AIDS 
Luxemburg Robert Hemmer 
Chairman, National AIDS 
Committee 
National Service of Infectious 
Diseases, Centre Hospitalier 
de Luxembourg 
Malta  Jackie Melillo Public Health Physician 
Infectious Disease Prevention 
and Control Unit, Health 
Promotion and Disease 
Prevention Directorate, 
Ministry for Social Policy 
Netherlands  Eline Op de Coul Epidemiologist 
Centre for Infectious Disease 
Control, National Institute for 
Public Health and the 
Environment 
Norway  Hans Blystad Deputy Director 
Department of Infectious 
Disease Epidemiology, 
Norwegian Institute of Public 
Health 
Poland  
Anna Marzec-
Bogusławska 
 Director National AIDS Centre 
Portugal  Sónia Dias 
Assistant Professor, 
International Health 
Department 
Institute of Hygiene and 
Tropical Medicine, University 
of Lisbon 
Romania  Mariana Mardarescu 
Consultant in Infectious 
Diseases, Head of Paediatric 
and Adolescents 
Immunosuppression 
Department, Coordinator 
Compartment for Monitoring 
and Evaluation of HIV/AIDS  
National Institute for 
Infectious Diseases "Prof. Dr. 
Matei Bals" of Bucharest 
Slovenia  Mario Poljak 
Head of Laboratory for 
Molecular Microbiology and 
Slovenian HIV/AIDS Reference 
Centre 
Institute of Microbiology and 
immunology, Faculty of 
Medicine, University of 
Ljubljana 
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Country Country representative Position Institution 
Slovakia  
Danica 
Stanekova//Alexandra 
Zampachova 
Head, National Reference 
Center for HIV/AIDS 
Prevention // Epidemiologist 
National Reference Center 
for HIV/AIDS 
Prevention//Public Health 
Authority 
Spain  Olivia Castillo 
Head, Prevention and 
Coordination, Department for 
National AIDS Strategy 
Ministry of Health and Social 
Policy 
Sweden  Robert Jonzon 
Senior Programme Officer, 
National Coordination of 
HIV/STI Prevention Unit 
National Board of Health and 
Welfare 
Switzerland  Luciano Ruggia 
Project Manager, International 
Affairs 
Federal Department of Home 
Affairs, Federal Office of 
Public Health, Division of 
Communicable Diseases. 
Prevention and Promotion 
Section 
UK  Valerie Delpech 
Consultant Epidemiologist and 
Head of HIV and AIDS 
Reporting Section 
Centre for Infections, Health 
Protection Agency 
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9.2.2. APPENDIX 2. National websites searched 
 
Country Website 
Austria www.bmg.gv.at 
Belgium www.sante.cfwb.be 
Bulgaria 
www.undp.bg 
www.ncaids.government.bg 
Cyprus www.moh.gov.cy 
Czech Republic www.mzcr.cz 
Denmark www.ssi.dk 
Estonia www.tai.ee 
Finland www.stm.fi 
France 
www.sante.gouv.fr 
www.cns.sante.fr 
www.invs.sante.fr 
www.has-sante.fr 
Germany www.bmg.bund.de  
Greece www.ermis.gov.gr 
Hungary www.eum.hu 
Iceland www.eng.heilbrigdisraduneyti.is 
Ireland www.dohc.ie 
Italy  www.ministerosalute.it 
Latvia www.vm.gov.lv 
Liechtenstein www.liechtenstein.li 
Lithuania www.undp.org 
Luxembourg www.ms.public.lu 
Malta www.ehealth.gov.mt 
Netherlands www.minvws.nl 
Norway www.norad.no 
Poland www.aids.gov.pl 
Portugal www.min-saude.pt 
Romania www.unicef.org/romania 
Slovakia www.uvzsr.sk 
Slovenia www.mz.gov.si 
Spain www.msc.es 
Sweden www.sweden.gov.se 
Switzerland www.bag.admin.ch 
United Kingdom  https://www.gov.uk 
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9.2.3. APPENDIX 3. Questionnaire for the EU/EFTA country 
representatives 
 
Dear colleague,  
In the framework of the ECDC project “ HIV testing and counselling inventory of good 
practices in migrant populations & ethnic minorities in the EU/EEA/EFTA Member 
States ” we would like to kindly ask you 3 questions focusing specifically on migrants 
and ethnic minorities additional to the testing questionnaire you received a while ago:  
1. Does your country currently have specific HIV testing & counselling 
recommendations targeting migrant population and/or minorities?  
 Yes  
 No  
 Other comment __________________________  
 
2. If you have answered yes to question 1, please state the year of publication of those 
recommendations? ______________  
 
3. If you have answered yes to question 1, are there any particular geographical origins 
specifically mentioned (ie: Sub-Saharan Africa, Caribbean). Please, provide detail below  
__________________________________________  
Finally, we would like to access these recommendations so, we kindly ask you to send 
us a copy of the document. If the document is written in a language different to 
English, French, Portuguese, Italian or Spanish, we ask you to please highlight the 
section where migrants and ethnic minorities are mentioned.  
Thank you very much for your help, we know you are very busy and sincerely 
appreciate the time dedicated to this. 
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9.2.4. APPENDIX 4. Data collection form on HIV testing and counselling 
guidelines in the EEU/EFTA countries and IO 
 
Data collection form on HIV testing & Counselling Guidelines in the 
EEU/EFTA countries 
 
Name of the document:  
 
Country:  
 
Number of document: 
 
Date of publication of the 
document: 
 
Source of document 
(website): 
 
Sent under request: 
Contact:  
Languages of 
publication: 
 
Date of information collection: 
 
 
 
A. General information 
 
1. Type of document (ie, guidelines, health plan, other…). 
 
_________________________________________________ 
 
2. Organization issuing the document 
 
 Specify organization 
Public Health Body:  
Professional Association:  
Other  
 
 
 
 
3a. Does the document contain background information on WHY test for HIV 
infection? 
 
 Mark 
“X” 
Yes  
No  
NA  
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3b. If yes in P3a. What arguments are presented for WHY test? 
 
 Mark 
“X” 
High frequency of late diagnosis  
Good uptake shown in previous studies  
Cost-economic  
Testing as prevention strategy  
Other (specify):   
 
4. Types of benefits of early test 
 
 Specify 
At individual level  
At community level  
 
 
5. Does the document identify any vulnerable or most-at-risk group regarding HIV? 
 
 Mark “X” Which? Please specify if further details 
MSM   
IDU   
Migrants    specify 
Ethnic Minorities   specify 
Pregnant women   
Sex workers   
Male sexual workers   
Transsexual people   
Truck drivers   
Prisoners   
Young people   
General population   
Other populations   specify 
 
 
6. Does the document justify why migrants and ethnic minorities are vulnerable 
populations? Please, summarize briefly 
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7. Who to test? Please, tick the groups where HIV testing is recommended 
 
 Mark “X” Which? Please specify if further details 
MSM   
IDU   
Migrants    specify 
Ethnic Minorities   specify 
Pregnant women   
Sex workers   
Male sexual workers   
Transsexual people   
Truck drivers   
Prisoners   
Young people   
General population   
Other populations   specify 
 
 
10. Who, where, how often to test, and which testing strategy? Please, if group no targeted 
for‎HIV‎testing‎state‎“No‎policy‎on‎this‎group”. 
 
Population How often? Where? Define testing 
strategy 
MSM    
Female contacts 
of MSM 
   
IDU or History of 
IDU 
   
Migrants. Please, 
specify migrants 
groups targeted: 
 
___________ 
 
   
Contacts of 
migrants 
 
 
   
Contacts of HIV-
positive people 
 
 
   
Ethnic Minorities. 
Please, specify 
minority groups 
targeted: 
 
 
 
 
  
People with an 
STI 
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Pregnant women    
Sex workers  
 
 
  
Male sexual 
workers 
   
Transsexual 
people 
   
Truck drivers    
Prisoners    
Young people    
General 
population 
   
Population 
attending STI 
Clinics 
   
Population 
attending TB 
Clinics 
   
Population 
attending TOP 
Clinics 
   
Population 
attending Drug 
programmes 
   
People with 
clinical suspicion 
of HIV 
   
Other populations    
    
    
 
11. Where to test? 
Opt-out strategy VTC strategy 
  
 
 
 
 
 
 
 
 
 
12. Are novel testing approaches mentioned? 
 Specifications: who, where, 
when…  
Rapid test  
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Home test  
 
Others  
 
 
 
13. Please, describe briefly any recommendation about pre and post counselling. Pay 
special attention to specific recommendations for migrant and ethnic minorities 
 
 
 
 
 
 
B. Specific issues for migrant or minorities populations 
 
 
14. Please, provide the definition of migrant and ethnic minority (if available)  
 
14a. (If migrant or ethnic minority definition available) In case of migrant definition, it refers… 
 
 Mark  
X 
Country of birth  
Country of nationality  
Country of origin  
Other (specif.)______  
No one  
 
 
15. Does the document address testing in community setting for migrant populations?  
 
 
 
 
 
16. Does the document mention testing barriers for migrant/ethnic minorities? Please, 
summarize briefly.  
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17. Does the document mention HIV screening migrants on arrival?  
 
 Mark  
X 
1. Yes  
2. No  
3. DK  
 
 
17.a(If Yes in 17). Please, summarize the information about testing on arrival  
 
 
 
 
18. Please, summarize the information about consequences of testing results in migrant 
legal status 
 
 
 
 
19. Are there references to the gender dimension of testing policies?  
 
 
 
20. Other issues  
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9.2.5. APPENDIX 5. List of documents used (provided by National 
informants or found in web search) 
 
Country Document Type Language 
Belgium  
Les strategies concertées du secteur de la 
prévention des IST/SIDA en Communauté 
française de Belgique; Les migrants (2009). 
Proactief HIV-testen en –counselen voor subsah 
(2010) 
Recommendations 
issued by French and 
Flemish Communities  
French 
Bulgaria  
National Programmes for Prevention and Control 
of HIV and STIs (2008-2015) 
HIV National strategy Bulgarian 
Cyprus  
Strategic plan 2004 – 2008 HIV/AIDS Cyprus (in 
drafting a new version) 
HIV National 
strategy/National plan 
English 
Czech 
Republic  
Národní program řešeníproblematiky HIV/AIDS v 
Českérepublice v období let 2008 – 2012 (dálejen 
program) 
HIV National 
strategy/National plan 
Czech 
Denmark  
EPI-news. National surveillance of communicable 
diseases. No. 46, 2009 
Communicable 
diseases unit 
communiqué  
English 
Estonia  
Eesti riiklik HIV ja AIDSi strateegia aastateks 
2006 – 2015  
HIV National 
strategy/National plan 
Estonian 
Finland  
Suomenhiv-strategia 2013-2016 Pakolaisten 
jaturvapaikanhakijoiden infektio-
ongelmienehkäisy.  
Recommendations Finnish 
France  
HIV screening in France – Public health 
guidelines, 2009 
Guide French 
Germany  
Action Plan to implement the Strategy of the 
Federal Government to fight HIV/AIDS, 2007 
HIV National 
strategy/National plan 
English 
Hungary  Nemzeti AIDS stratégia 2004 –2010 
HIV National 
strategy/National plan 
Hungarian 
Iceland  
Procedures for the Medical Examination of 
Immigrants to Iceland. 2007 
Law English 
Ireland  
HIV and AIDS Education and Prevention Plan 
2008 – 2012 
HIV National 
strategy/National plan 
English 
Italy  
Aggiornamento delle conoscenze sulla terapia 
dell’infezione da HIV -Documento 
Complementare su Specifiche Materie, Febbraio 
2008 
Work document Italian 
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Country Document Type Language 
Lithuania  
National HIV / AIDS and STI Prevention and 
Control Programme for 2010- 2012 
HIV National 
strategy/National plan 
English 
Luxembourg  Strategie et plan action sida 2006-2010 
HIV National 
strategy/National plan 
French 
Malta  
Communicable disease control strategy for 
Malta. 2003 
National strategy English 
Netherland 
Regeling. Aanvullende Curatieve Soa-bestrijding. 
2008 
Work document Dutch 
Norway  
Strategy: Acceptance and coping. National HIV 
strategy 2009-2014 (2009)  
HIV National 
strategy/National plan 
English 
Poland  
Polskie Towarzystwo Naukowe AIDS. 
REKOMENDACJE PTN AIDS 2006 Zasady Opieki 
Medycznej nad Osobami Zakażonymi HIV  
Recommendations Poland  
Portugal  
Programa nacional de prevenção e controlo da 
infecçãovih/sida. 2007-2010 
HIV National 
strategy/National plan 
Portugues
e 
Romania* 
National strategy for surveillance, control and 
prevention of HIV/AIDS 2004-2007  
HIV National 
strategy/National plan 
English 
Slovakia  
ODBORNÉ USMERNENIE 
nazabezpečenieprevencieinfekciespôsobeneivírus
omimunitnejnedostatočnostičloveka v 
Slovenskejrepublike. 
HIV National 
strategy/National plan 
Slovak 
Slovenia  
Strategija prepreevanja in obvladovanjaokužbe s 
hivzaobdobje 2010–2015 
HIV National 
strategy/National plan 
Slovene 
Spain  
Plan Multisectorial frente a la infección por VIH y 
el sida España 2008-2012 
HIV National 
strategy/National plan 
Spanish 
Sweden  
Nationell strategi mot hiv/aids och visa andra 
smittsamma sjukdomar. National Strategy to 
Combat HIV/AIDS and Certain Other 
Communicable Diseases (2007) 
HIV National 
strategy/National plan 
Swedish/ 
English 
Switzerland  
Recommandations de l’OFSP sur le conseil et le 
dépistage volontaire du VIH (VCT) au moyen d’un 
test VIH rapide dans les centres de dépistage 
Guide French 
UK  UK National Guidelines for HIV Testing 2008 Guide English 
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9.2.6. APPENDIX 6. International websites searched 
 
International Organization Website 
WHO www.who.int 
UNAIDS www.unaids.org 
ILO www.ilo.org 
IUSTI www.iusti.org 
IOM www.iom.int 
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9.2.7. APPENDIX 7.Data collection form for the systematic review 
 
 
Data collection form for the systematic review 
PERSON WHO FULFILS THE FORM:  
 
Nº of reference 
 /      /      /      / 
Year of paper publication: 
Title of the paper: 
 
 Date of data collection: 
/____/____/ /____/____/ 2.010 
 
 
SECTION 0.Paper validation. 
 
P.0.Please, mark the criteria the article fulfils. Mark with X where necessary 
 Mark with “X” 
About migrant/ethnic minorities populations  
About HIV testing  
In English   
Is an original paper  
In the selected countries (Europe, US, Canada or Australia)  
 
P0B. (Only if not all marked in P0).Although the article does not meet all of the inclusion criteria, 
do you think it's interesting collect relevant information?  
 
Yes   Go to P1: Data collection 
form 
No   Go to P1b and then END 
 
P0C. (Only if P0B is “No”).Please make a brief description of the paper (objectives, target 
population) and argue why do you think you should not collect information on it. 
Brief description of the paper: 
 
Reasons for not collecting information: 
 
 
 
  
Si all marked 
go to P1 
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Data collection form 
 
P1.- (For all selected articles).Brief summary of the aim of the article, including a brief 
description of the methodology. 
 
 
 
 
 
P2. Theme/s. Mark withX where necessary. Multiple responses are possible. 
 
 Mark 
with “X” 
Policies/ recommendations at policies level   
Recommendations derived from a research  
Migrants/ethnic minorities as group most at risk  
Barriers to access to the HIV test/health services   
Research about interventions  
Evaluation programs   
Economic evaluations  
HIV testing acceptance prevalence  
Risk behaviours   
VIH prevalence  
Other (specify)_____________________________  
 
P3.- Place where has been made the study / research. Mark with X where necessary. Multiple 
responses allowed.  
 
 Mark with “X”  
Specify country  
Europe   Where?  
USA   
Canada  
Australia  
Other   Where?  
 
P4. In which year have been carried out the fieldwork/data collection? We refer to the dates 
of fieldwork or data collection, NOT to the year of article publication. 
Year /_/_/_/_/ 
**If different years or longitudinal researches collect here the dates:______________ 
 
P5a.Research type 
  M
a
rk
 w
it
h
 “
X
” 
 Research type M
a
rk
 w
it
h
 “
X
” 
Instrument for data collection  M
a
rk
 w
it
h
 “
X
” 
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S
e
le
c
t 
a
n
 o
p
ti
o
n
 
  
In depth interview   Script   
Focus group   Semi-structured questionn.   
1. Qualitative     Life story   Structured questionnaire   
  
Participant Observation 
   Other(specify)   
Other(specify)   Not know   
 
 
How the interviews have been 
done? 
How the questionnaire has been 
applied? 
  
Telephone   Self-administered   
Personal   With interviewers   
2. Quantitative     Mail   There are not interview   
  
Prevalence study   Other (specify)   
Other (specify)   Not know   
 
3. Narrative: description of events or 
interventions. Paper in which there are not 
field work nor is there a systematic review 
of documentation 
  Describe the methodology  
    
 
 
  Describe inclusion criteria and methodological details 
4. Systematic review     
  
 
P5b.Methodological characteristics of the study. 
Research design: Brief summary of research 
design: indicate whether transversal or 
longitudinal, etc. .   
Population (universe): target description   
Sample strategy: Sample size and sampling 
distribution, contact strategies with participants ...   
Scope of investigation and type of 
sample 
Clinic   Sample from population    
Street   Convenience sample   
Home   
Other (Specify) 
  
Other (Specify)   
Scope of the study 
1.International    Specify ____________
2.National   Specify ____________ 
3.Local   Specify ____________ 
5.Other   
Specify ____________ 
Comments   
 
P6a. Definition of migrant / minority in the article. 
 
 
 
P6b. In the definition of migrant the article refers to ... 
 Mark  
X 
Country of birth  
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Country of nationality  
Country of origin  
Other (Specify)______  
None  
 
P7. Justification of the authors of the reasons why the publication is specifically about 
migrants / minorities. 
 
 
 
 
P8a. Do the authors consider explicitly migrants as a most at risk group regarding to 
HIV? We refer to explicitly consider whether this is a more vulnerable population to HIV. 
 Mark 
with “X” 
Yes  
No  
 
P8b. (if P8a=Yes.) Why migrant are considered as most at risk populations regarding to 
HIV? 
 
 
 
 
P9.(If it is about HIV testing prevalence).HIV testing prevalence data.Indicate numerator and denominator of 
the estimation. We have included several columns for the case there would be disaggregated data for different targets 
(Indicate in the column header or target profile of the group referred to: e.g. general population, migrants ...) 
 
 Target 1 
(specify) 
Target 2 
(specify) 
Target 3 
(specify) 
Target 4 
(specify) 
Prevalence of acceptance     
Numerator     
Denominator     
 
P10. (If is about testing barriers). Testing barriers in migrant/ethnic minorities and causes of 
these barriers 
 
Barriers:  
Causes of the barriers:  
 
 
P11. Specific interventions/policies recommended improving HIV testing and 
counselling. Specify indicating the specific interventions proposed. 
 
Testing interventions  
Counselling interventions  
 
P12. Main finding (explained briefly) 
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P13. Add other questions that the researcher consider relevant 
 
 
 
P14a. Quality assessment. Mark with “X”  
 Very Good Good Poor Very Poor 
Without 
information 
1. The article is based on a clearly defined 
research question           
2. Internal validity: the study is well 
designed, according to its characteristics, 
allowing, where appropriate, to minimize 
bias.           
3. Results are well described, are useful 
and accurate           
4. External validity. The results are 
generalizable to the population and context 
in which they are interested in be applied           
 High Medium Low   
5. Overall quality rating for the article         
 
P14b. Comments about the quality assessment. 
 
 
 
15. Does the article include any reference to gender specific issues? Please, explain it briefly. 
 
 
 
P16. Does the article include any reference to the legal implications of the HIV testing 
uptake and the results of the test for immigrants? If yes, please briefly explain what kind of 
implications 
 
 
 
 
P17. References in the bibliography of the article to articles of interest for our 
research 
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9.2.8. APPENDIX 8.Participants in the group interviews. 
Participants Organization Country 
Group 1 
Ana M. Caro Instituto de Salud Carlos III Spain 
Fiona Burns University College London UK 
Georg Bröring Netherlands Former AIDS & Mobility 
Wilhelm Miebach Ministry of Health Germany 
Robert Jonzon National Board of Health and Welfare Sweden 
Valerie Delpech Health Protection Agency UK 
Kevin Fenton Centre for Disease Control USA 
Ann Singleton University of Bristol UK 
Debora Alvarez Instituto de Salud Carlos III Spain 
Mary Haour-Knipe Consultant – HIV Data Project Switzerland 
Maria Jose Peiro IOM Brussels Belgium 
GiedriusLikatavicius ECDC Sweden 
Tobias Bergroth KarolinskaInstitutet Sweden 
Group 2 
Julia del Amo Instituto de Salud Carlos III Spain 
Brian Rice Health Protection Agency UK 
Olivia Castillo Ministry of health Spain 
Dermot Gorman University of Edinburgh UK 
Maureen Louhenapessy AIDS & Mobility focal point Belgium 
IbiFakoya University College London UK 
Jonathan Elford University College London UK 
Roger Drew Dublin Declaration consultant UK 
Sonia Dias Instituto de Higiene e Medicina Tropical Portigal 
RoumyanaPetrova-Benedict IOM Brussels Belgium 
Susana Monge Instituto de Salud Carlos III Spain 
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Mika Salminen ECDC Sweden 
Johann Fontaine ECDC Sweden 
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9.2.9. APPENDIX 9. Group interview script 
 
1. How are HIV testing recommendations being implemented in migrants? 
How are migrants and ethnic minorities in the community perceiving this 
implementation? 
 
2. What are the implications of a more active HIV testing promotion for those not 
entitled to ART (irregular migrants) 
 
3. Could public health criteria to treat TB also be applicable to treatment for HIV? 
 
4. Are you aware of any HIV testing initiative targeting migrant men? 
 
5. Key issues regarding late presentation? 
 
6. Other issues 
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9.2.10. APPENDIX 10.Script for the key informants interviews. 
 
Person and his institution: Short presentation. 
1.  Recent guidelines issued by CDC, France or  UK have a general population testing 
approach, opt-out routinely screening with no lengthy pre-test counselling. Do you 
think this strategy is a good strategy to improve uptake of testing in migrants and 
ethnic minorities? Please, expand your answer (yes or no). In particular, most studies 
suggest that uptake of testing, when testing is universal, has increased. Do you think 
this is also the case for migrants and ethnic minorities? 
2. Over the last few years, a more active approach to HIV testing is being adopted by 
most Public Health Bodies; most recommend an opt-out approach for the general 
population given certain HIV prevalence values. What is your perception about: 
1) How are health care providers implementing this strategy? In general and in 
particular for migrants and ethnic minorities. 
2) How do migrants perceive this move towards more pro-active testing? Are 
there any differences in their perception you want to highlight according to 
geographical origin, gender or sexual orientation? In particular, how are 
migrants of uncertain residence status taking the new recommendations?. 
3. We tell people: “we want to test you, we want to treat, we want to retain you”. In 
some settings though, migrants of uncertain status are not entitled to antiretroviral 
treatment. What are your thoughts about promoting active testing in settings where 
the law does not guarantee universal access to treatment? 
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4. Are you aware of any novel initiatives that promote HIV testing at community levels 
targeting migrants and ethnic minorities, in particular, those who do not access health 
care settings? If so, can you describe them? 
5. When examining the number of HIV infected women from sub Saharan Africa in 
Europe the number nearly doubles the number of reported sub Saharan men. We are 
progressively speaking about “Feminization of the epidemic” but this may also reflect 
feminization of testing, as most women are been diagnosed in prenatal care. So, one 
would have the impression that we have more African women diagnosed than men. 
Are you aware of any initiative targeting heterosexual men in general and migrant and 
ethnic minority men in particular? Could you think on innovative ways to engage men 
to use health care systems? 
6. For UK only…recommendations state to offer test to people registering in GP 
practices… what about those already registered. 
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9.2.11. APPENDIX 11. Main countries classification 
Western Europe Turkmenistan 
North Africa & Middle 
East North America 
Andorra Ukraine Algeria Canada 
Austria Uzbekistan Bahrain United States of America 
Belgium  Egypt   
Denmark 
Sub-Saharan Africa 
Iraq Caribbean 
Finland Jordan Antigua and Barbuda 
France Angola Kuwait Bahamas 
Germany Benin Lebanon Barbados 
Greece Botswana Libya Cuba 
Iceland Burkina Faso Libyan  Dominican Republic 
Ireland Burundi Morocco Grenada 
Israel Cameroon Oman Haiti 
Italy Central African Republic Qatar Jamaica 
Luxembourg Chad Saudi Arabia St. Vincent & Grenadines 
Malta Comoros Sudan Trinidad and Tobago 
Monaco Congo Syria   
Netherlands Dem. Rep. Congo Tunisia Latin America 
Norway Cote d’Ívore United Arab Emirates Argentina 
Portugal Djibouti Yemen Belize 
San Marino Equatorial Guinea 
 
Bolivia 
Spain Eritrea Eastern Asia Pacific Brazil 
Sweden Ethiopia China Chile 
Switzerland Gabon Fiji Colombia 
United Kingdom Gambia Hong Kong Costa Rica 
Central Europe Ghana Japan Ecuador 
Albania Guinea Korea Democratic El Salvador 
Bosnia & Herzegovina Guinea Bissau Korea Republic of Guatemala 
Bulgaria Kenya Mongolia Guyana 
Croatia Lesotho Papua new guinea Honduras 
Cyprus Liberia 
 
Mexico 
Czech Republic Madagascar South & S-East Asia Nicaragua 
Hungary Malawi Bangladesh Panama 
Macedonia Mali Bhutan Paraguay 
Montenegro Mauritania Brunei Peru 
Poland Mauritius Cambodia Suriname 
Romania Mozambique India Uruguay 
Serbia Namibia Indonesia Venezuela 
Slovakia Niger Iran   
Slovenia Nigeria Laos   
Turkey Rwanda Malaysia   
Eastern Europe Sao Tome and Principe Maldives   
Armenia Seychelles Myanmar   
Azerbaijan Sierra Leone Nepal   
Belarus Somalia Pakistan   
Estonia South Africa Philippines   
Georgia Swaziland Singapore   
Kazakhstan Tanzania Sri Lanka   
Kyrgyzstan Togo Thailand   
Latvia Uganda Vietnam   
Lithuania Zambia 
 
  
Moldavia Zimbabwe Australia & New Zea.   
Moldova, Republic of Cape Verde Australia   
Russian federation Senegal New Zealand   
Tajikistan Seychelles 
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9.2.12. APPENDIX 12. Population data sources 
 
Country Variable 
Data 
available 
Source Contact Comments 
Austria 
Country of 
birth 
2007-
2012 by 
sex 
Statistik Austria 
Dagmar 
Lentsch 
- 
Belgium Nationality 
2007-
2011 
DirectiongénéraleStatistique 
et Information économique 
Cécile Cuypers 
**Period changes are 
due to changes in the 
aggregation provided 
by the source 
Bulgaria Nationality 
2007-
2012 
National statistical Institute 
of Bulgaria 
Generic 
response 
- 
Cyprus 
Country of 
birth 
(broad 
groups) 
2010-
2012 
Statistical Service of Cyprus Loukia Makri 
Population by 
citizenship and 
country of birth is only 
available for the years 
2010-2012. Countries 
of citizenship and birth 
are only available by 
broad groups, i.e. 
Nationals, EU, non-EU 
etc. 
Czech 
Republic 
Nationality 
2010-
2012 
Czech Statistical Office 
Barbora 
Serbusova 
Population from 
reporting country / 
foreign population: 
own calculations 
based on the total 
population and 
disaggregated data 
Denmark 
Country of 
origin 
2007-
2012 
Statistics Denmark 
Anna Dorthe 
Bracht 
- 
Estonia 
Country of 
birth 
2011 Statistics Estonia Evelin Oimandi 
Official statistics about 
population by country 
of birth only available 
from Housing Census 
once every 10 years. 
Total population data 
differs among years 
because we use two 
different sources 
(census vs. population 
register) 
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Country Variable 
Data 
availabl
e 
Source Contact Comments 
Finland 
Country of 
birth 
2007-
2012 
Statistics Finland Irma Pitkanen - 
France 
Country of 
birth 
2009-
2010 
Institut National d'Etudes 
Demographiques 
Martine Deville  
The last results are for 
the year 2010. The 
previous results 2006-
2008 are not available 
because technical 
problems. Population 
from reporting country 
/ foreign population: 
own calculations based 
on the total population 
and disaggregated 
data 
Germany Nationality 
2007-
2012 
Eurostat Daniela Glock 
Information provided 
by country was not 
disaggregated by sex 
Greece Nationality 
2007-
2012 
(aggrega
ted) 
ELSTAT  
Nektaria 
Tsiligaki 
Available only by 
grouped citizenships 
Hungary Nationality 
2007-
2012 
(not 
disaggre
gated) 
Hungarian Central 
Statistical Office 
Edit Pék 
Very grouped into 
continent's countries. 
Population from 
reporting country / 
foreign population: 
own calculations based 
on the total population 
and disaggregated 
data 
Iceland Nationality 
2008, 
2010-
2012 
Eurostat No response 
Not available for 2007 
and 2009 
Ireland 
Country of 
birth 
2007-
2012 
(not 
disaggre
gated) 
Eurostat Neil Nugent . 
Italy Nationality 
2007-
2011 
Istat 
Antonella 
Ciccarese 
Not available for 2012. 
Population from 
reporting country / 
foreign population: 
own calculations based 
on the total population 
and disaggregated 
data 
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Country Variable 
Data 
availabl
e 
Source Contact Comments 
Latvia 
Country of 
birth 
2007-
2011 
Eurostat Baiba Zukula 
Country representative 
didn't send 
disaggregated data. 
We take information 
from Eurostat 
Lithuani
a 
Country of 
birth 
2007-
2012 
Statistics Lithuania 
Vilma 
Malinauskienė 
- 
Luxemb
ourg 
Nationality 
2007-
2012 
(only 
aggrega
ted 
data) 
Eursotat No response 
Data by single country 
are not available 
Malta 
Country of 
birth 
2008-
2011 
(aggrega
ted 
only) 
National Statistics Office of 
Malta 
Margaret 
Zammit 
They don't have data 
on immigrants by 
single countries.  
Netherl
ands 
Nationality 
2007-
2012 
Statistics Netherlands Cor Kooijman 
To calculate the total 
population we used 
the disaggregated 
data, and the result is 
not the same that total 
population data 
provided by country 
representative 
Norway Nationality 
2007-
2012 
Statistics Norway Jan Bruusgaard - 
Poland Nationality 
2007-
2012 
Central Statistical Office of 
Poland/Eurostat 
Halina 
Dabrowko 
They have also people 
they consider migrants 
born in Poland. Finally 
we use data from 
Eurostat 
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Country Variable 
Data 
availabl
e 
Source Contact Comments 
Portugal Nationality 
2008-
2012 
Instituto Nacional de 
Estadística (Portugal) 
Generic 
response 
- 
Romania 
Country of 
birth 
2007-
2009; 
2012 
Eurostat No response - 
Slovakia Nationality 
2007-
2012 
Eurostat No response - 
Slovenia 
Country of 
birth 
2007-
2012 
Statistical Office of the 
Republic of 
Slovenia/Eurostat 
Barica 
Razpotnik 
- 
Spain 
Country of 
birth 
2007-
2012 
Instituto Nacional de 
Estadística/Eurostat 
Not contacted 
We use data from 
Eurostat, because in 
the INE data appears 
also "Spain" as country 
of birth 
Sweden 
Country of 
birth 
2007-
2012 
StatisticsSweden 
Inge 
Göransson 
Population birth on 
reporting country 
based on own calculate 
UK 
Country of 
birth 
2007-
2012 
(only 
aggrega
ted) 
Office for National Statistics 
/Eurostat 
Claire Burridge 
They have data split 
only for the 50 main 
nationalities (and are 
estimations). Finally we 
use aggregated data 
from Eurostat 
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9.2.13. APPENDIX 13. Distribution of HIV total diagnoses about 
geographical origin according to reporting country of the UE/EEA. 
    2007 2008 2009 2010 2011 2012 
Austria Total  335 345 301 317 309 306 
  Unknown GO 5 4 1 0 2 0 
Belgium Total  1063 1087 1127 1196 1182 1226 
  Unknown GO 290 287 313 317 297 338 
Bulgaria Total  126 123 171 163 201 157 
  Unknown GO 0 2 0 0 0 0 
Cyprus Total  46 37 38 41 54 58 
  Unknown GO 0 0 0 0 0 1 
Czech Republic Total  121 148 156 180 153 212 
  Unknown GO 0 0 0 0 0 0 
Germany Total  2776 2826 2869 2908 2881 2950 
  Unknown GO 445 456 414 458 429 243 
Denmark Total  306 285 236 275 266 200 
  Unknown GO 8 1 2 8 4 2 
Estonia Total  633 545 411 376 366 315 
  Unknown GO 633 545 374 220 221 0 
Spain Total  2671 3188 3340 3575 3244 3210 
  Unknown GO 4 2 1 1 1 3 
Finland Total  187 147 172 184 172 156 
  Unknown GO 2 6 3 4 14 13 
France Total  5659 5743 5428 5527 5374 4066 
  Unknown GO 1463 1491 1444 1505 1598 1396 
Greece Total  551 603 592 626 940 1059 
  Unknown GO 19 21 28 33 58 61 
Hungary Total  98 119 122 151 133 200 
  Unknown GO 1 0 0 0 0 1 
Ireland Total  391 404 395 330 323 339 
  Unknown GO 100 88 86 53 62 121 
Iceland Total  13 10 15 24 23 19 
  Unknown GO 3 0 7 1 4 3 
Italy Total  1960 2038 2563 3925 3748 3896 
  Unknown GO 1960 2038 2563 116 30 35 
Lithuania Total  106 95 180 153 166 160 
  Unknown GO 0 1 0 0 6 5 
Luxemburg Total  44 57 54 49 48 54 
  Unknown GO 0 0 0 1 0 1 
Latvia Total  350 358 275 274 299 339 
  Unknown GO 246 266 172 179 208 234 
Malta Total  14 4 8 18 21 30 
  Unknown GO 4 0 0 0 3 0 
Netherland Total  1219 1288 1173 1157 1083 976 
  Unknown GO 2 3 3 1 0 2 
Norway Total  248 299 282 258 269 242 
  Unknown GO 1 0 2 155 152 152 
Poland Total  727 762 883 865 1073 1058 
  Unknown GO 28 19 172 211 244 201 
Portugal Total  1861 1900 1708 1511 1218 721 
  Unknown GO 23 26 26 30 11 9 
Romania Total  173 259 253 274 427 489 
  Unknown GO 0 0 0 0 0 0 
Sweden Total  472 414 409 448 382 362 
  Unknown GO 12 14 18 19 16 30 
Slovenia Total  37 48 48 35 55 45 
  Unknown GO 1 1 1 0 1 1 
Slovakia Total  39 53 53 28 49 50 
  Unknown GO 0 1 1 1 0 0 
United Kingdom Total  7381 7268 6672 6358 6211 6358 
  Unknown GO 1525 1251 737 806 861 1469 
 
Total  29607 30453 29934 31226 30670 29253 
 
Unknown GO 6775 6523 6368 4119 4222 4321 
 
Total included in the 
analysis 22832 23930 23566 27107 26448 24932 
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9.2.14. APPENDIX 14. Description of articles included in the systematic 
review 
Author/ 
date 
Main objective Location Design 
Sample 
size 
Study population Setting 
Monge-
Maillo B 
et al. 
(2009) 
To determine which infectious diseases 
were most common among two mobile 
immigrant groups (sub-Saharan Africans 
and Latin Americans) in Spain. Two aims 
of the study were to improve awareness 
among clinicians of emerging infections 
associated with human mobility and to 
provide additional information about 
imported diseases.  
Spain 
(Madrid) 
Cross-sectional 2198 
Latin American and 
sub-Saharan 
African immigrants 
seeking health care 
at TMU  
Health 
(hospital) 
Boyd AE 
et al. 
(2005) 
To establish whether there were ethnic 
differences in demographic 
characteristics, the stage at HIV diagnosis 
and reasons for and location of HIV 
testing between 1998 and 2000 in a large 
ethnically diverse HIV-1-infected clinic 
population in south London in the era of 
highly active antiretroviral therapy. 
UK 
(London) 
Medical history 
review 
494 
Patients with new 
HIV-1 diagnoses 
attending a 
hospital between 
January 1998 and 
December 2000  
Health 
(hospital) 
Vissman 
AT et al. 
(2009) 
To explore the experiences of male Latino 
LHAs (Lay Health Advisers) within an HIV 
and STD prevention intervention: 
psychosocial and sociocultural influences 
on HIV risk, settings for risky behaviour, 
and personal changes from serving as 
Navegantes.  
US (South 
Carolina) 
Life histories 9 
“Navegantes”: 
Latinos men 
trained to advise 
about STD and HIV 
risk behaviours  
Community 
(Association) 
Forbes 
KM et al. 
(2008) 
To explore STI test acceptability and 
patient socio-demographic characteristics 
in a local STI clinic for young people. 
UK (city not 
specified) 
Medical history 
review 
117 
Young people 
under 25 years 
attending a sexual 
health clinic in an 
area populated 
mostly by "non-
white people" 
Health 
(Health 
centre/ 
clinics/ GU's) 
Fakoya I 
et al. 
(2008) 
To describe the major cultural, social, and 
structural barriers to testing for HIV in 
black African immigrants (SSA) in western 
Europe (particularly in the UK and 
Netherlands). The article includes a brief 
literature review. 
UK and 
Nether-
lands 
Documents/reports 
review 
Not 
applicable 
Migrant black 
Africans 
Not 
applicable 
Olshefsky 
AM et al. 
(2007) 
This article describes the development, 
implementation and evaluation of an 8 
week culturally specific Spanish-language 
social marketing campaign targeting 
Latinos living on the California-Mexico 
border.  
US (Califor-
nia) 
Cross-sectional+ 
focus group 
5 focus 
group (40 
Latinos), 
429 
media 
exposure 
surveys 
As the campaign 
was in Spanish, the 
targeted audience 
was Latinos living 
near the California-
Mexico 
border, including 
high-risk Latinos, 
transborder, farm 
workers, youth sex 
workers and MSMs 
Community 
(various) 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study 
population 
Setting 
Ehrlich SF 
et al. 
(2007) 
To identify the characteristics of Latino 
migrant day labourers that are related to 
their intentions to test for HIV.  
US 
(Berkeley, 
Oakland 
and 
Richmond) 
Cross-
sectional 
290 
Sexually active, 
male Latino 
migrant day 
labourers who 
were 18 years of 
age or older.  
Community (Street) 
Delpierre 
C et al. 
(2007) 
To develop new strategies aimed at 
reducing the delay in seeking HIV 
diagnosis, the authors proposed to 
identify correlates of late diagnosis of 
HIV infection in France. The survey 
aimed to describe the impact and 
determinants of HIV infection on the 
social situation of persons living with 
HIV-AIDS.  
France 
(National) 
Cross-
sectional 
1077 
Patients diagnosed 
with HIV1-
infection for at 
least 6 months, 
aged 18 or older, 
and living in 
France for at least 
six months. 
Patients with very 
poor 
understanding of 
the French 
language were 
excluded  
Health (several 
hospitals) 
Zencovich 
M et al. 
(2006) 
Results of the first two years of an active, 
migration medical screening program for 
HIV antibodies in applicants for 
permanent or temporary residency in 
Canada.  Implications for immigrant 
health outcomes, program impacts at 
the national and regional public health 
level, and the considerations for global 
public health policy related to HIV/AIDS 
are presented. 
Canada 
(National) 
Cross-
sectional 
634958 
Applicants for 
long-term visas or 
asylum in Canada 
during 2003 and 
2002 who were 
over 15 years of 
age 
Not applicable 
Mitra D et 
al. (2006) 
To describe the decision support needs 
of immigrant and refugee women from 
HIV endemic countries regarding 
decision-making about voluntary 
counselling and testing for HIV (VCT) in 
Canada; and the needs of practitioners 
who support these women in making 
this decision, in a culturally appropriate 
manner. 
Canada 
(Ottawa) 
In-depth 
interviews 
12 
practitioners 
and 8 
patients  
1) Informant group 
consisted of adult, 
English-speaking, 
immigrant and 
refugee women 
from HIV-endemic 
countries 
presently living in 
Ottawa; 2) The 
practitioner 
informant group 
consisted of VCT 
providers from 
diverse clinical 
backgrounds who 
primarily worked 
with immigrant 
populations.  
Health (Health 
centre/clinics/GU's) 
Conaty SJ 
et al. 
(2005) 
Audit of three obstetric units serving 
typically diverse multi-ethnic inner city 
populations regarding antenatal HIV 
testing with the aim of assessing 
progress towards the NHS target of 90 
per cent uptake and characterizing 
women who declined HIV screening. 
UK 
(London) 
Cross-
sectional 
2710 
All pregnant 
women that 
accessed antenatal 
care in the three 
maternity units 
during the study 
period.  
Health (hospital) 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study 
population 
Setting 
Chadborn TR 
et al. (2006) 
To describe the proportion of 
heterosexual individuals diagnosed 
late, to identify factors associated 
with this, and to estimate the level of 
short-term mortality that could have 
been prevented had heterosexual 
individuals been diagnosed earlier. 
UK (England 
and Wales) 
Cross-sectional 15523 
HIV-infected 
heterosexual 
individuals (aged 
15 years and over) 
newly diagnosed 
in England and 
Wales between 
January 2000 and 
December 2004 
(reported by the 
end of June 2005).  
Not 
applicable 
Fernandez 
MI et al. 
(2005) 
To examine the predictors of HIV 
testing and the factors associated 
with intention to accept a free HIV 
test in a community sample of 244 
Hispanic migrant/seasonal farm 
workers recruited in South Florida. 
US (South 
Florida) 
Cross-sectional 244 
Participants were 
18 years of age or 
older, self-
identified as 
Hispanic/Latino, 
and employed as 
farm workers 
Community 
(public 
places) 
Foley EE  
(2005) 
This qualitative study explores the 
perspectives of HIV service providers 
who are treating this new patient 
group, and it examines the cultural 
and structural barriers African women 
face in the area of HIV prevention, 
testing, and treatment in the city of 
Philadelphia 
US 
(Philadelphia) 
Focus Group + in-
depth interviews 
8 focus 
groups, 3 
in depth 
interviews 
in HIV-
positive 
African 
women 
African immigrants 
infected with HIV 
in the Philadelphia 
area and 
healthcare 
providers 
Community 
(Home and 
African 
community 
associations) 
Levy V et al. 
(2005) 
To evaluate HIV risk behaviour and 
access to medical care and HIV 
testing among low-income Hispanic 
immigrant men, comparing recent 
immigrants with more established 
immigrants, in 3 northern California 
counties. The authors compare HIV 
risk-related behaviours and access to 
care and testing among recent (in the 
U.S. less than 5 years) versus 
established (in the U.S. more than 5 
years) Latino immigrants. 
US (North-
California) 
Cross-sectional 410 
Hispanic 
immigrant men 
18-35 years 
residing in low-
income census 
block group in 3 
northern 
California counties 
(US)  
Community 
(Home) 
Schwarzwald 
H (2005) 
To summarize the major infectious 
diseases commonly diagnosed in 
children newly arrived in the U.S., 
with particular interest in children 
internationally adopted by U.S. 
citizens. 
US (National) 
Documents/reports 
review 
Not 
applicable 
Children under 16 
years, immigrants 
in the U.S. With 
special emphasis 
on children 
adopted by U.S. 
citizens 
Not 
applicable 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study population Setting 
Schmid J et 
al. (2005) 
To describe the socio-demographic and 
clinical characteristics of children <16 years 
with HIV infection in Denmark. This is a 
descriptive analysis of a paediatric cohort that 
includes all children <16 years with HIV in 
Denmark. Estimation of the prevalence and 
incidence of HIV in this population. 
Denmark 
(National) 
Cohort 
study 
89 
Children diagnosed 
with HIV infection 
before the age of 16 
Health 
(hospital) 
MacPherson 
DW et al. 
(2006) 
To describe the results of the first 3 years of a 
medical screening program for HIV antibodies 
in selected children who were applicants for 
residency in Canada. Personal Information 
and migration medical screening data were 
provided by Citizenship and Migration 
Canada. 
Canada 
(National) 
Cross-
sectional 
256970 
The HIV-tested 
migrant groups 
included children 
(identified as being 
at risk) of applicants 
for permanent 
residence 
(immigrants and 
refugees) and those 
who filed refugee or 
asylum claims in 
Canada. Migration 
medical screening, 
including routine 
HIV testing for 
those >15 years of 
age is also required 
for some other 
persons arriving in 
Canada, including 
visitors staying >6 
months from 
certain locations. 
Not 
applicable 
Sadler KE et 
al. (2006) 
Pilot study to assess the feasibility and 
acceptability of conducting anonymous HIV 
testing using oral mucosa samples within a 
population survey on sexual habits and 
lifestyles in communities of "black Africans" in 
London. To estimate prevalence of HIV in this 
community in relation to potential risk 
practices and habits. 
UK (London) 
Cross-
sectional+ 
in-depth 
interviews 
114 
“Black African 
communities” over 
16 years of age 
living in London  
Community 
(associations) 
Dowling T 
(2007) 
To describe and present results of rapid 
behavioural assessments and rapid HIV testing 
conducted in racial-ethnic minority men at 11 
at gay pride events in 9 US cities between 
2004 and 2006. 
US (9 cities) 
Cross-
sectional 
627 
MSM from social or 
racial minorities 
participating in gay 
pride events 
(Detroit, Baltimore, 
Jackson, Charlotte,  
St. Louis, District of 
Columbia, Oakland, 
San Francisco, 
Chicago) 
Community 
(gay pride 
events) 
Ostermann 
J et al. 
(2007) 
To describe longitudinal trends in HIV testing 
rates in the US population and differences 
between planned and actual testing across 
demographic and risk groups 
US 
(National) 
Cohort 
study 
146868 
Participants aged 18 
to 64 years in the 
2000-2005 National 
Health Interview 
Surveys  
Community 
(Home) 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study 
population 
Setting 
Tariq S et 
al. (2007) 
The objective of the study was to 
evaluate: mode of referral, number of 
sexually transmitted infections (STIs) and 
the uptake of HIV testing in patients of 
South Asian ethnicity compared with 
non-South Asians attending two London 
genitourinary (GU) medicine clinics.  
UK 
(London) 
Case-control 458 
New clinic 
attendees 
between January 
and September 
2003 in two 
London genito-
urinary (GU) 
medicine clinics. 
Cases were 
defined as the first 
125 new clinic 
attendees self-
identified as South 
Asian. Controls 
were defined as 
subsequent new 
presentations self-
identified as non-
South Asian. Each 
case–control pair 
was matched for 
gender and 
centre. 
Health (Health 
centre/clinics/GU's) 
Huang ZJ 
et al. 
(2008) 
To examine self–reported HIV/STI 
testing behaviours and their correlates 
among a sample of Southeast Asians 
living in an urban setting in the United 
States. 
US 
(Washing-
ton) 
Cross-sectional 604 
Self–identified as 
Cambodian, 
Laotian, or 
Vietnamese; age 
18 years or older; 
and residence in 
the Washington, 
DC metropolitan 
area.  
Community (public 
places) 
Prost A et 
al. (2008) 
To describe and summarize the 
literature on social, behavioural, and 
intervention research among African 
communities affected by HIV in the UK 
and other European countries in order to 
make recommendations for future 
interventions. 
Europe  
Literature 
review 
Not 
applica-
ble 
Studies of  people 
of sub-Saharan 
African origin, 
both recent 
migrants and 
second and third 
generation 
migrants 
Not applicable 
Southgate 
J et al. 
(2008) 
To analyse whether women belonging to 
ethnic groups at high risk for HIV reject 
performing the test during pregnancy in 
a higher percentage than other groups. 
UK 
(London) 
Cross-sectional 1586 
Women delivering 
at Milton Keynes 
hospital between 
January-June 2005 
Health (hospital) 
Carnicer-
Pont D et 
al. (2009) 
To identify predictors of late detection 
of HIV infection in a European city with 
increased migration. and determine The 
effects of HAART era in HIV infection 
detection 
Spain 
(Barcelona) 
Epidemiological 
surveillance 
data 
6186 
AII patients 
detected through 
the AIDS registry 
of Barcelona, over 
13 years of age, 
during the period 
1987 to 2006 
Not applicable 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study 
population 
Setting 
Krentz H 
and Gill 
MJ (2009) 
To evaluate the impact of changing 
Canadian migration law in 2001 on the 
epidemiology of HIV in immigrants and 
refugees in Alberta.  
Canada 
(Southern 
Alberta) 
Cohort study 692 
All HIV-positive 
individuals enrolled 
in care at the 
Southern Alberta 
Cohort between 
2001 and 2007 
were included and 
subdivided by self-
reported country 
of birth. 
Health 
(hospital) 
Perez-
Molina JA 
et al. 
(2009) 
To describe the clinical and 
epidemiological characteristics of HIV 
positive immigrants who come for the 
first time to a Tropical Medicine Unit in 
Madrid between 1997-2006 and compare 
their clinical features according to their 
place of origin. 
Spain 
(Madrid) 
Medical history 
review 
1609 
HIV infected 
immigrants 
attending the 
Department of 
Infectious Diseases 
at the Ramón y 
Cajal Hospital in 
Madrid 
Health 
(hospital) 
Udayaraj 
UP et al. 
(2009) 
To analyse patient characteristics, clinical 
presentation, potential cost implications 
and short-term mortality of patients 
admitted with HIV-related illnesses 
UK (West 
Berkshire) 
Medical history 
review 
64 
All patients aged 
over 18 years with 
either a pre-
existing diagnosis 
of HIV infection or 
with a newly 
diagnosed HIV 
infection 
Health 
(hospital) 
Burns FM 
et al. 
(2007) 
To identify the key issues and barriers  
affecting utilization of HIV services for 
Africans in Britain 
UK 
(national) 
In-depth 
interviews 
11 
The sampling 
frame consisted of 
the key 
constituencies in 
the field of HIV and 
African 
communities and 
organizations 
within these. By 
focusing down to 
the organizational 
level key people 
became 
identifiable, as the 
field of HIV and 
African 
communities in the 
UK is 
comparatively 
small. 
Not specified 
Jones KG 
and Jones 
SG (2008) 
To provide a brief overview of U.S. travel 
policies and migration laws related to HIV  
US 
(National) 
Review of 
documents/reports  
Not 
applicable 
Not applicable 
Not 
applicable 
Lopez-
Quintero 
C et al. 
(2005) 
To analyse HIV-test barriers, intention to 
have an HIV test and HIV risk perception 
in Hispanic subgroups living in the US. 
US 
(National) 
Cross-sectional 4261 
Hispanic 
population was 
selected from the 
National Health 
Surrey,  non-
institutionalized 
adults (+18) 
Community 
(Home) 
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Author/ 
date 
Main objective Location Design 
Sample 
size 
Study 
population 
Setting 
Flowers P 
et al. 
(2006) 
To explore the social and psychological 
impacts of an HIV diagnosis on Black 
Africans living in the UK, in the broader 
context of the participants’ lives.  
UK (London) 
In-depth 
interviews 
30 
HIV positive Black-
Africans living in 
the UK 
Health 
(Health 
centre/ 
clinics/ GU's) 
and 
Community 
(associations) 
Prost A et 
al. (2007) 
To explore the feasibility and acceptability 
of translating a successful voluntary 
counselling and testing (VCT) service model 
from Kenya to African communities in 
London. 
UK (London) Focus groups  
5 focus 
groups (42 
participants 
from 14 
African 
countries). 
A workshop 
with 28 key 
informants. 
African population 
and key informants 
of this population 
living in London 
Not specified 
Dougan S 
et al. 
(2005) 
To examine the epidemiology of HIV 
among black and minority ethnic men who 
have sex with men in England and Wales. 
UK (England 
and Wales) 
Epidemiological 
surveillance 
data 
1040 
MSM living in 
England & Wales, 
with HIV diagnosed 
between 1997-
2002 
Not 
applicable 
Manzardo 
C et al. 
(2008) 
To evaluate some epidemiological aspects 
and the main public health issues of 
communicable diseases in Barcelona’s 
immigrant population 
Spain 
(Barcelona) 
Cross-sectional 2464 
Migrants from 
tropical and 
subtropical areas 
and Eastern 
Europe who were 
seen in a tropical 
medicine unit from 
2001 to 2004. 
Health 
(hospital) 
Eisenhut 
M et al. 
(2008) 
To determine whether HIV-infected 
mothers knew the HIV status of their 
children, enabling the offer of targeted 
testing of children at risk.  
UK (Luton) Cross-sectional 297 
All HIV-positive 
women attending 
the GUM 
outpatient clinic of 
a district general 
hospital in the UK 
over a 4-month 
period in 2006 
Health 
(hospital) 
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